Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.152903005646693,0.00302295918447526,0.146978005645122,0.158828005648265,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,42346,-0.479095508309748,0.0118849132401989,-0.502389938260538,-0.455801078358958,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,42611,-0.178792368274658,0.00405949105897098,-0.186748970750241,-0.170835765799075,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.165771485077097,0.00297655936202082,0.159937428727537,0.171605541426658,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,42568,-0.147025391951594,0.00399489097142952,-0.154855378255596,-0.139195405647593,1.55835168424775e-282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,40527,-0.143813090162696,0.00392671461419013,-0.151509450806509,-0.136116729518884,1.20602504359679e-277
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,42721,-0.210280857570207,0.00615665027888364,-0.222347892116819,-0.198213823023595,2.52250885230465e-245
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,42587,-0.285987682742969,0.0087618717678172,-0.303160951407891,-0.268814414078047,6.34920630765048e-225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,40116,-0.315138783427889,0.00982735171366487,-0.334400392786672,-0.295877174069106,1.02888039701119e-215
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,0.0865677382933455,0.00274072456631621,0.0811959181433658,0.0919395584433253,2.62920657607464e-211
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,40511,-0.243627190090771,0.00798377702100514,-0.259275393051942,-0.227978987129601,1.31638714452028e-196
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,42754,-0.150567121589609,0.00498673276938741,-0.160341117817609,-0.14079312536161,6.98230054907761e-194
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,0.342098680646458,0.0116181164303823,0.319327172442909,0.364870188850007,8.74052244884746e-185
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,40532,0.0674439071327947,0.0023117969258377,0.0629127851581528,0.0719750291074366,1.75346245276694e-180
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,42618,-0.157562694287869,0.00548557926006464,-0.168314429637596,-0.146810958938142,3.94344754586058e-176
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,40532,0.140336598665987,0.00516896766168073,0.130205422049093,0.150467775282881,2.55331332320584e-157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,-0.143887138940783,0.00534294413934625,-0.154359309453901,-0.133414968427664,7.338280742023e-155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0908242350551725,0.00341640505217195,-0.0975203889574296,-0.0841280811529155,8.04923519217066e-152
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,-0.0776047972332796,0.00296264188571979,-0.0834115753292903,-0.0717980191372688,1.63805787835459e-147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,40539,0.174756092544958,0.00673780066878022,0.161550003234148,0.187962181855767,3.88651849557641e-144
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,42370,-0.199587195847467,0.00776661891205588,-0.214809768915097,-0.184364622779838,3.78281367286866e-142
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,42663,0.0697081314100633,0.00275292865156436,0.0643123912529971,0.0751038715671294,3.09552157474297e-138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,42636,-0.147974150586322,0.00589979358021347,-0.15953774600354,-0.136410555169104,1.02638663732157e-135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.082704438514951,0.00332179680481979,-0.0892151602523978,-0.0761937167775042,8.93289914063183e-134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,42754,-0.0681308627344365,0.00283538565035829,-0.0736882186091388,-0.0625735068597343,5.60216350014964e-125
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,42600,-0.242815680497687,0.010126158160493,-0.262662950492253,-0.222968410503121,1.88520829196902e-124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,42357,-0.158969610052772,0.00667921066624621,-0.172060862958615,-0.14587835714693,1.25689798218637e-122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,42636,0.108222742137458,0.00456003388152631,0.0992850757296667,0.11716040854525,5.24451333127807e-122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,40511,-0.207939382614281,0.00878476750100687,-0.225157526916254,-0.190721238312307,6.136056122233e-121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,42311,-0.119894614176336,0.00510967688225869,-0.129909580865563,-0.109879647487109,2.66649733445698e-119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,-0.121855603234888,0.00525801609082185,-0.132161314772899,-0.111549891696877,1.71284538677524e-116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,42644,-0.114425239215252,0.00500349973387365,-0.124232098693644,-0.10461837973686,1.36774278268139e-113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,40223,-0.131109290855864,0.00574840343366959,-0.142376161585856,-0.119842420125871,1.49816205608782e-112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,42636,-0.0758117397620422,0.00335031039519615,-0.0823783481366267,-0.0692451313874578,2.70502225885167e-111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,42721,-0.0759550128544612,0.00336919700164954,-0.0825586389776943,-0.0693513867312281,1.6522500693832e-110
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,42594,-0.118385398046728,0.0052594598762519,-0.128693939404182,-0.108076856689274,3.68609252337545e-110
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,42711,-0.303971168503155,0.013527554004237,-0.33048517435146,-0.27745716265485,8.17993179966145e-110
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,-0.173671187966662,0.00797249624997039,-0.189297280616604,-0.15804509531672,2.19207799768291e-103
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,-0.068136652068895,0.00316959000999101,-0.0743490484884774,-0.0619242556493126,2.05807210189844e-100
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,42611,-0.0850921909323255,0.00401702342215507,-0.0929655568397495,-0.0772188250249016,5.47994894185987e-98
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,42661,-0.165440144096248,0.00794561184766939,-0.18101354331768,-0.149866744874816,8.53711503208153e-95
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,42655,-0.0675131891195101,0.00330623392038215,-0.0739934076034591,-0.0610329706355611,2.67030216907465e-91
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,42794,-0.10444920885303,0.00512728014913184,-0.114498677945328,-0.0943997397607316,6.79635276359259e-91
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,42587,-0.0701595382132381,0.0034738495919196,-0.0769682834134005,-0.0633507930130757,2.24000419182502e-89
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,41747,-0.0830072018138892,0.00414396051075654,-0.091129364414972,-0.0748850392128064,6.95143608515014e-88
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,42711,0.0428281363226771,0.00214137213959119,0.0386310469290784,0.0470252257162758,1.01133681777378e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0591482549642331,0.00296498401780914,0.0533368862893272,0.064959623639139,2.77601417870869e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,42569,-0.14413298454395,0.00723080285589054,-0.158305358141495,-0.129960610946404,3.84390225165779e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,42587,-0.158905540705233,0.0079839423375011,-0.174554067686736,-0.143257013723731,6.85812819398295e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,42618,0.0603934245380794,0.00304392874512206,0.0544273241976401,0.0663595248785186,2.28493984877647e-86
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,42416,0.103731773575053,0.00523612005593225,0.0934689782654259,0.11399456888468,4.23899159377657e-86
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,-0.160746438887891,0.00811959306326714,-0.176660841291895,-0.144832036483888,5.49485645175753e-86
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,42721,0.0697310999183684,0.00354276987218081,0.062787270968894,0.0766749288678428,4.68477859791589e-85
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,42689,-0.226099852557951,0.0115013019454274,-0.248642404370989,-0.203557300744913,7.47202508078848e-85
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,42679,-0.0622019723456033,0.0032074561323521,-0.0684885863650134,-0.0559153583261932,1.17813149538491e-82
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.154375137852987,0.00800596529260555,-0.170066829826494,-0.138683445879481,9.62250532626637e-82
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,-0.132015532480368,0.00685377068722742,-0.145448923027334,-0.118582141933402,1.42214173077924e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,42670,-0.124950268870388,0.00649996722249256,-0.137690204626473,-0.112210333114303,2.88695218268345e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,42674,-0.0879241760908949,0.00459129071964055,-0.0969231059013903,-0.0789252462803994,1.13211381415685e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,42636,-0.160296948598221,0.00845119335164216,-0.17686128756744,-0.143732609629003,3.42309749212472e-79
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,-0.0573110064222582,0.00302224385898453,-0.0632346043858679,-0.0513874084586486,3.70753436955067e-79
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,-0.159595711648649,0.00842274508871989,-0.17610429202254,-0.143087131274758,7.64042631720543e-79
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,42794,-0.0859571777072075,0.00456387589556821,-0.0949023744625212,-0.0770119809518938,3.8938403687034e-78
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,40033,0.0811030855345422,0.0043016751507038,0.0726718022391627,0.0895343688299216,4.81174968156808e-78
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,40182,-0.152398835257157,0.00808514646897602,-0.16824572233635,-0.136551948177964,5.03919493441903e-78
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,40532,0.093749900252656,0.00499939234482334,0.0839510912568023,0.10354870924851,2.72439100672565e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,-0.0865235778778808,0.00462704256649892,-0.0955925813082187,-0.0774545744475429,4.67572072370329e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,-0.0678479347049714,0.00363544935883379,-0.0749734154482856,-0.0607224539616572,9.17282128275969e-77
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,-0.117840419206753,0.00634126033796088,-0.130269289469156,-0.105411548944349,4.1379390452713e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,-0.0597742057582302,0.0032253190689037,-0.0660958311332815,-0.0534525803831789,9.70235585990876e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,42658,-0.060236231204938,0.00325284751268931,-0.066611812329809,-0.0538606500800669,1.28134079786029e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,-0.062176806755323,0.00337122201225318,-0.0687844018993392,-0.0555692116113067,7.30223732466018e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,42611,-0.149522614854041,0.00812486543608088,-0.165447351108759,-0.133597878599322,1.02797264185853e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,42654,0.0359734273827356,0.0019606886638166,0.0321304776016551,0.0398163771638162,2.78194208013487e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0669654431031467,0.00364973142418703,0.0598119695117401,0.0741189166945533,4.06865994629712e-74
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,40267,-0.0673775955789401,0.00368404977573226,-0.0745983331393754,-0.0601568580185049,1.2225865398993e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,40449,-0.130786900732508,0.00715448094248737,-0.144809683379784,-0.116764118085233,1.36937901278475e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0458785501629474,0.00251468806567735,0.0409497615542198,0.0508073387716751,1.73670002755252e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,42794,-0.0794289446991499,0.00441461971154934,-0.0880815993337866,-0.0707762900645132,1.51028128293667e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,-0.142514317913314,0.00795017069372237,-0.15809665247301,-0.126931983353618,4.99133641607456e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,42706,-0.036770277351231,0.00206420181204266,-0.0408161129028346,-0.0327244417996274,3.52846388589699e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,-0.0954883878831241,0.00536867522068489,-0.106010991315666,-0.0849657844505817,5.75498012224407e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,42659,0.0933256220549635,0.00531277585645457,0.0829125813763125,0.103738662733614,2.57698405552946e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,-0.175761014236185,0.0100272110565315,-0.195414347906987,-0.156107680565383,5.24109058702194e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,42570,-0.0532301138489016,0.0030532210590728,-0.0592144271246843,-0.0472458005731189,2.51995113016339e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.0886669469924804,0.00511348456028774,-0.0986893767306443,-0.0786445172543164,1.25427990593431e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.0709650709607104,0.00409900458612881,-0.0789991199495229,-0.0629310219718979,1.94939612422017e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,42754,-0.0523720846140502,0.00302967914029633,-0.058310255729031,-0.0464339134990694,3.05268918353314e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,-0.255061049141992,0.0147938898888222,-0.284057073324083,-0.2260650249599,6.80919721111897e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.06640202355957,0.00388697054133408,0.0587835612985552,0.0740204858205848,9.57678916667696e-65
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,-0.0407036580251792,0.00239417184510611,-0.0453962348415872,-0.0360110812087713,3.74221237146073e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0940319430351469,0.00553534463641732,-0.104881218522525,-0.083182667547769,6.69641253665402e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0453151852204829,0.00268024703365868,0.0400619010345119,0.0505684694064539,1.8038996602132e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,0.055857303383421,0.00331937127607975,0.0493513356823047,0.0623632710845373,6.68980569723652e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,42663,-0.0299371339627454,0.00178137876898356,-0.0334286363499532,-0.0264456315755376,9.66317398240337e-63
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,42711,-0.0902782874237235,0.00537804123363689,-0.100819248241652,-0.0797373266057952,1.31852079011643e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,42754,-0.0440307300063017,0.00262541027645437,-0.0491765341481523,-0.0388849258644512,1.69413042360444e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,42587,-0.092233153680866,0.00550784036683778,-0.103028520799868,-0.0814377865618639,2.61181402010288e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,-0.0971731202705355,0.00582728786404145,-0.108594604484057,-0.0857516360570143,8.50101477016966e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,42587,-0.069929398998202,0.00421531338089994,-0.0781914132247659,-0.0616673847716381,3.38980854132886e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,0.0512640211400611,0.0030927686601292,0.0452021945662079,0.0573258477139143,5.66369251058851e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,42721,-0.20240650441869,0.0123326454687472,-0.226578489537434,-0.178234519299945,5.92879661002216e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,42754,-0.0557439405518473,0.00343562690183481,-0.0624777692794436,-0.0490101118242511,1.19163412741577e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,-0.0747347577701898,0.00460912021513124,-0.0837686333918471,-0.0657008821485326,1.86919233472689e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.0766493423835207,0.00473399728865128,-0.0859279770692772,-0.0673707076977642,2.11845313502857e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,-0.126621183291142,0.00783681495857478,-0.141981340609949,-0.111261025972336,3.58043913922994e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,-0.0888033569762739,0.00549732429096127,-0.099578112586558,-0.0780286013659898,3.8518584152265e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0727453877101507,0.00451435539468361,-0.0815935242837306,-0.0638972511365708,7.07312054305987e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,-0.0765727142789576,0.00476645138722415,-0.0859149589979169,-0.0672304695599983,1.56898990147702e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,-0.0498450577904199,0.00310422857387971,-0.0559293457952241,-0.0437607697856157,1.72827986730457e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.0634954881913074,0.00395852580204374,-0.0712541987633132,-0.0557367776193017,2.25565294375146e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,40283,-0.0614977991164814,0.00384635308894188,-0.0690366511708075,-0.0539589470621554,6.62308210309883e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,42346,-0.119710107754525,0.007536236786875,-0.1344811318568,-0.10493908365225,2.70162190544535e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,-0.052557947011421,0.00331613324700018,-0.0590575681755414,-0.0460583258473006,4.60192021142499e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,42721,-0.0446114032566839,0.00285684550496855,-0.0502108204464222,-0.0390119860669455,1.7032925197361e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,-0.0413304672657756,0.0026445135399959,-0.0465137138041676,-0.0361472207273837,1.75076599388184e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,42326,-0.092163113714928,0.00591446658812242,-0.103755468227648,-0.0805707592022081,2.92095287597901e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,42764,0.0850560037598813,0.00546408052595357,0.0743464059290123,0.0957656015907503,3.61902895588625e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,40539,-0.0308197604153484,0.00197816349595126,-0.0346969608674129,-0.026942559963284,3.61999165378983e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,40223,-0.0966189500493653,0.00621430409319818,-0.108798986072034,-0.0844389140266969,6.13882959210131e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,-0.0606226044573664,0.00390513968008555,-0.068276678230334,-0.0529685306843987,6.93812093282228e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,40511,-0.0429869447951934,0.00280139601391665,-0.0484776809824701,-0.0374962086079168,1.2970295223263e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,42594,-0.111645799665256,0.00730958210157968,-0.125972580584352,-0.0973190187461601,3.14138492722533e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,-0.054878906474866,0.0035973879347963,-0.0619297868270667,-0.0478280261226652,4.12422003126307e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,-0.0572553677084753,0.00375743376729459,-0.0646199378923727,-0.0498907975245779,6.6394701579545e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,42794,-0.0912997721021592,0.00600215598715387,-0.103063997836981,-0.0795355463673376,7.95747820374996e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,42621,0.0676102295440714,0.00444785860749721,0.0588924266733769,0.076328032414766,9.43871348721452e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,-0.0856065197448943,0.00564179431008753,-0.0966644365926659,-0.0745486028971227,1.70603892515534e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,-0.0531481793604565,0.00351284853999408,-0.0600333624988449,-0.0462629962220681,2.71437161203155e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,-0.0875961525828778,0.00579379622617732,-0.0989519931861853,-0.0762403119795702,3.23430458506238e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,40511,-0.0397578707196439,0.00263088493942816,-0.0449144052009231,-0.0346013362383647,4.25087473995488e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,42743,-0.0360148512458156,0.0023911822105714,-0.0407015683785355,-0.0313281341130956,7.47915348337977e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,40516,0.0552266381312663,0.0036673351286757,0.0480386612790619,0.0624146149834707,9.32313582080751e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,42794,-0.0752627762162273,0.00501825413484826,-0.0850985543205299,-0.0654269981119247,1.91987996791338e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,-0.0813163727125806,0.00542138307081125,-0.0919422835313707,-0.0706904618937906,1.94532843861884e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,42754,-0.0488816453521286,0.00326031054338112,-0.0552718540171556,-0.0424914366871016,2.06879339455736e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0576210948847035,0.00384452384334497,-0.0651563616176596,-0.0500858281517473,2.27152946829133e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.104553384768325,0.00697821381386301,-0.118230683843497,-0.0908760856931537,2.43485578637933e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,42638,-0.0773039661857895,0.0052214837854242,-0.0875380744052209,-0.067069857966358,3.3186112462837e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,40511,-0.122878972294465,0.0083253073191972,-0.139196574640092,-0.106561369948839,7.57468677590255e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,42611,0.0396058123754786,0.00269050267056115,0.0343324271411787,0.0448791976097784,1.13894072254579e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,-0.032592266728421,0.0022145183074149,-0.0369327226109542,-0.0282518108458878,1.18557902146407e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,-0.134529085664566,0.00914412271790976,-0.152451566191669,-0.116606605137463,1.31082037203867e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,42676,0.061408048895408,0.00419048022987938,0.0531947076448444,0.0696213901459716,2.97581138573714e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,42754,-0.0640716720652674,0.00439267373437077,-0.0726813125846341,-0.0554620315459007,7.93343833878316e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,-0.0574424276122326,0.00393994042871177,-0.0651647108525077,-0.0497201443719575,8.80490242498514e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.0505078176748915,0.00346657556913551,-0.0573023057903971,-0.0437133295593859,1.00768068545412e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,40283,-0.0917231666283774,0.00629054382156081,-0.104052632518637,-0.0793937007381182,1.02279364783623e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,42611,0.0552885767135019,0.00380290347820831,0.0478348858962136,0.0627422675307902,1.58662991651116e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,-0.0749571375109345,0.00515369119973365,-0.0850583722624125,-0.0648559027594566,1.70819672032929e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,0.0712219896920815,0.00491210699614899,0.0615942599796294,0.0808497194045335,3.24331886771832e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,-0.116814337109144,0.00806694236515364,-0.132625544144845,-0.101003130073443,3.70205760470581e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,-0.0719593391337994,0.00497070216499007,-0.0817019153771799,-0.0622167628904188,3.85770911159463e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,-0.0513565185422095,0.00358527366389972,-0.058383654923453,-0.0443293821609661,3.38434246618813e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,42689,-0.0790366765614151,0.00553247066099022,-0.0898803190569559,-0.0681930340658743,5.78945905406756e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,40223,-0.0795202647405102,0.00557027279675941,-0.0904379994221587,-0.0686025300588618,7.91866446263559e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,-0.105017296347533,0.00736375435625521,-0.119450254885794,-0.0905843378092731,9.47943998004701e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,40482,-0.0635732372135278,0.00447055060261172,-0.0723355163946467,-0.0548109580324088,1.68919454678556e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,-0.14621498221581,0.0103342756566745,-0.166470162502892,-0.125959801928728,4.02830831933758e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,-0.0500628147978864,0.00354485290196303,-0.057010726485734,-0.0431149031100389,5.82551648163751e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.060702999578592,0.0043072343396624,-0.0691451788843302,-0.0522608202728537,8.703005315695e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,-0.0695526684030378,0.00494034998914357,-0.0792357543817592,-0.0598695824243164,1.24666498703728e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,0.0848111446929992,0.00602720273673763,0.0729978273289935,0.096624462057005,1.38241157730433e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,-0.0767425034595164,0.00547056570927466,-0.0874648122496947,-0.0660201946693381,2.19791599972601e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,42636,-0.0819536526589495,0.00584323676971685,-0.0934063967275945,-0.0705009085903045,2.23962393283536e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,42721,0.0227850081911057,0.00162481861284841,0.0196003637099228,0.0259696526722886,2.30128419956626e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,40527,0.0536588556143663,0.00383187224726855,0.04614838600972,0.0611693252190127,3.47138846852413e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,40449,-0.154923589968285,0.0110748700308873,-0.176630335228824,-0.133216844707746,4.26960961694022e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,-0.130214961499795,0.00935973058511491,-0.148560033446621,-0.11186988955297,1.07277052869978e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,42613,-0.0429392595722508,0.00309030738138725,-0.0489962620397698,-0.0368822571047318,1.364405894973e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,42488,0.0383610286324894,0.00276341848957219,0.0329447283929279,0.0437773288720509,1.64425703314281e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.0808515938316631,0.00582803566803889,-0.0922745437410193,-0.0694286439223069,1.8565351420738e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,42188,-0.0547755930799315,0.0039517133359597,-0.0625209512184125,-0.0470302349414505,2.21437281664877e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,42613,-0.05892341472856,0.00427506932085986,-0.0673025505974453,-0.0505442788596746,6.32078130980453e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,42611,-0.0753028096925001,0.00548392886178543,-0.0860513102615996,-0.0645543091234007,1.27568750294043e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,-0.0780194739086862,0.00567757343903182,-0.0891475178491886,-0.0668914299681839,1.28106779529033e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,-0.110314957945035,0.00804048223701617,-0.126074303129586,-0.0945556127604831,1.51365938510385e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,40516,-0.0382260419351978,0.00279413150259311,-0.0437025396802803,-0.0327495441901153,2.86396770855024e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,42721,-0.0362095816558374,0.0026599238706824,-0.041423032442375,-0.0309961308692999,6.32861373919766e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,-0.101451268439122,0.00747134100870267,-0.11609509681618,-0.0868074400620651,1.1369352367267e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,40424,-0.034010006305687,0.00251203989215162,-0.0389336044943041,-0.0290864081170698,1.94974082926938e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,42794,0.0218640183091205,0.00161717707708255,0.0186943512380388,0.0250336853802023,2.20918956476408e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,0.0456657268220641,0.0033800566891099,0.0390408157114086,0.0522906379327195,2.51007729125761e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,-0.0366981215764965,0.00271947174593927,-0.0420282861985374,-0.0313679569544555,3.12850539143642e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.0407690861476212,0.00302775804901412,0.0348346803715535,0.0467034919236888,4.62410684657663e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.0330799574656606,0.00246402510197793,0.0282504682657839,0.0379094466655374,7.83402425256343e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,40283,-0.0378984964806011,0.00282378313145844,-0.0434331114182597,-0.0323638815429426,9.44586686381083e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,42794,-0.0830126052730199,0.0061901924427303,-0.0951453824607713,-0.0708798280852685,9.54394048123706e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,42613,-0.041764593329576,0.00313438403159853,-0.0479079860315091,-0.0356212006276429,2.99785545682284e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,-0.112895999654644,0.00856319787653465,-0.129679867492652,-0.0961121318166362,1.91328002515093e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,-0.0584364992382365,0.00443097235279237,-0.0671212050497096,-0.0497517934267635,2.04163568680971e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,0.0352885759823847,0.00269593689781176,0.0300045396626736,0.0405726123020957,6.54125389302461e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,-0.0978351255675733,0.00748360680287381,-0.112502994901206,-0.0831672562339406,8.07401321832264e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,-0.0397489005628216,0.00305936458452129,-0.0457452551484833,-0.0337525459771598,2.2915049941285e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,42594,-0.0644801825745416,0.00496366622413436,-0.0742089683738449,-0.0547513967752382,2.36268481768254e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,40283,-0.0349261738894868,0.00268717998859921,-0.0401930466671412,-0.0296593011118323,2.41326532243316e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,42611,-0.0397956979177842,0.00308832667410634,-0.0458488181990326,-0.0337425776365358,9.05706876116694e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,-0.16132368984464,0.0125147513446122,-0.18585260248008,-0.1367947772092,9.52245500193568e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,42749,-0.03531079861683,0.00274205070497485,-0.0406852179985808,-0.0299363792350793,1.00239210338884e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,42658,-0.0849549826039119,0.00661329064066464,-0.0979170322596146,-0.0719929329482092,1.50283598138186e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,42475,-0.0432669011201529,0.00336842505786647,-0.0498690142335712,-0.0366647880067346,1.53768412521349e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,42544,-0.0295205229089887,0.00230131427920766,-0.0340310988962358,-0.0250099469217417,1.90905424268273e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,40283,0.0296110959463359,0.00231179707508366,0.0250799736791719,0.0341422182134999,2.69303421871113e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,-0.0581411844564884,0.00457307605334379,-0.0671044135210423,-0.0491779553919346,8.15391100662624e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,42594,0.0427588705874427,0.00336493618068189,0.0361635956733062,0.0493541455015792,8.79199242692741e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,42636,-0.0799591860554338,0.00631025557137988,-0.0923272869753384,-0.0675910851355292,1.38042552734677e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,42668,0.0486957495016994,0.00386120353648839,0.0411277905701822,0.0562637084332167,2.92259062935865e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,-0.0470140757435958,0.00372790822552676,-0.0543207758656282,-0.0397073756215633,2.9623645767397e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,40511,0.043982612375242,0.00348625028395886,0.0371495618186826,0.0508156629318014,3.02073639921877e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,0.0446992237779378,0.00354586806493733,0.0377493223706606,0.0516491251852149,3.13472194900605e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.0864904463770597,0.00688178615244899,-0.0999787472358597,-0.0730021455182597,5.05298859837346e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,40511,-0.0458595064644183,0.0036499595501259,-0.0530134271826651,-0.0387055857461715,5.75811707498616e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,-0.0484696253248109,0.00386236082590369,-0.0560398525435821,-0.0408993981060397,6.39043575677622e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,42636,-0.0867066133462035,0.00692107127308123,-0.100271913041443,-0.0731413136509643,8.32330291090904e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.0426939938999875,0.00341004874648792,-0.0493776894431038,-0.0360102983568712,1.00686753468686e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,40509,0.0931693353064867,0.00744366554093663,0.0785797508462509,0.107758919766722,1.04391694803627e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,40488,0.0242924099539393,0.00194110272113247,0.0204878486205197,0.028096971287359,1.06920611157808e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,42671,-0.0382472419292855,0.00307502917946245,-0.0442742991210319,-0.0322201847375391,2.53911383600993e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,-0.0913763987188363,0.00734473158691679,-0.105772072629193,-0.0769807248084794,2.65992747993141e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,42659,-0.0372566896718877,0.00299811269694203,-0.0431329905578941,-0.0313803887858813,2.92100934467585e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,40482,-0.0541758714975559,0.00438551404285448,-0.0627714790215507,-0.0455802639735612,7.84065816855649e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,40223,-0.0723955623620378,0.00586705485677744,-0.0838949898813216,-0.060896134842754,9.42501698589671e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,42711,-0.0447738494205647,0.00364380693662299,-0.0519157110163457,-0.0376319878247836,1.61250826483409e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,-0.0808125144137034,0.00657857012303434,-0.0937065118548507,-0.0679185169725561,1.68226775926496e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,42752,0.043540546289526,0.00354885416753756,0.0365847921211524,0.0504963004578996,2.02535810612804e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,-0.0500796082131422,0.0040826549488618,-0.0580816119129113,-0.0420776045133731,2.09147300027103e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,42721,-0.0562982812549631,0.00459200298519199,-0.0652986071059394,-0.0472979554039868,2.25812203546699e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,-0.0417381061129267,0.0034140930963093,-0.0484297285816929,-0.0350464836441604,3.45237599026848e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0485762119492168,0.00398594386532276,-0.0563886619252495,-0.0407637619731842,5.52010177726753e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,0.0536305901173399,0.00440943492908938,0.0449880976563247,0.0622730825783551,7.38508385187241e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,42611,-0.046749105666331,0.00385465016595913,-0.0543042199916109,-0.0391939913410511,1.12642182954481e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,42302,-0.042009201603843,0.00347035147801813,-0.0488110905007585,-0.0352073127069274,1.49723909661076e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,40527,0.0725604274219332,0.00600029794043604,0.0607998434586785,0.0843210113851878,1.85213059875878e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,-0.0526923682915934,0.00436446396638616,-0.0612467176657103,-0.0441380189174766,2.18520653159627e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.082435930000072,0.00682652726584071,-0.0958159234411198,-0.0690559365590242,2.30305911277751e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,40527,-0.0468023639665501,0.00387642680606669,-0.0544001605064408,-0.0392045674266594,2.33304483562004e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,-0.0613254494622303,0.0050852880289777,-0.0712926139990265,-0.051358284925434,2.55959750630826e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,-0.080202248673019,0.00666556462542882,-0.0932667553388595,-0.0671377420071785,3.82722893338893e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,42495,0.0413453338992716,0.00343870320772101,0.0346054756121384,0.0480851921864048,3.96953111097016e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,42588,0.0460724799667806,0.0038349664701148,0.0385559456853556,0.0535890142482056,4.4480755636792e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0297611587564209,0.00248507018431808,0.0248904211951574,0.0346318963176843,6.98831350474395e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,42636,-0.0322163858850509,0.00269684765303146,-0.0375022072849926,-0.0269305644851093,9.9824415170121e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,42636,-0.0787157985624874,0.00659266794572266,-0.0916374277361039,-0.065794169388871,1.0726521999255e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,-0.0376170490971209,0.00316260709205908,-0.0438157589975567,-0.0314183391966851,1.84294172316967e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,42679,-0.0467837092591495,0.00393735162960637,-0.054500918453178,-0.0390665000651211,2.12942008450331e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0446253702746214,0.003764558527665,-0.0520039049888448,-0.037246835560398,2.97045502261601e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,42495,-0.0610801686026507,0.0051666579635386,-0.0712068182111863,-0.050953518994115,4.34933782830972e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,40283,-0.0604378991591203,0.00511808194144145,-0.0704693397643455,-0.050406458553895,5.47017362209796e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.037762384629864,0.0032084572464265,-0.0440509608328599,-0.0314738084268681,8.02319384158895e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,42721,0.0401976645072986,0.00342718755772959,0.0334803768941486,0.0469149521204486,1.28692884315267e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,42611,-0.0268751789853722,0.00229164736561473,-0.0313668078219771,-0.0223835501487673,1.31505232600561e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,0.0721132500156078,0.00614972914945886,0.0600597808826685,0.0841667191485472,1.32812370958179e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.068926252906297,0.00588882720675816,-0.080468354231543,-0.057384151581051,1.71880309800752e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,-0.0494977164882193,0.00424484971700745,-0.0578176219335539,-0.0411778110428848,2.85967189774966e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,42711,0.0440074543333071,0.00377490372376736,0.0366086430347231,0.0514062656318911,2.950976454688e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,42676,-0.0418848219287803,0.00361250456177818,-0.0489653308698656,-0.0348043129876951,6.16755262556787e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,42651,-0.0690206338413117,0.00596653455523258,-0.0807150415695676,-0.0573262261130559,8.37568848234643e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,42676,-0.0481478204545815,0.00416633615012613,-0.0563138393088287,-0.0399818016003343,9.56501914183404e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,-0.0855804903135,0.00741936236072727,-0.100122440540525,-0.0710385400864745,1.31740687908255e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,-0.0267904765324286,0.00232912894974215,-0.0313555692739232,-0.022225383790934,1.89383325922621e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,-0.0226963537996864,0.00197831122448785,-0.0265738437996826,-0.0188188637996902,2.50931873126979e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,40169,-0.0334951595969073,0.00292465074128762,-0.039227475049831,-0.0277628441439836,3.38228999264263e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,-0.0431410234666666,0.00377111828933428,-0.0505324153137618,-0.0357496316195715,3.63571096940838e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,-0.034142173570625,0.0029930358445845,-0.0400085238260106,-0.0282758233152394,5.28340189408858e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,42794,-0.066326732387565,0.00582540000553408,-0.0777445163984118,-0.0549089483767182,6.72287190070048e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,42594,-0.0999507446597061,0.00879352125185875,-0.117186046313349,-0.082715443006063,8.41566437138538e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0493663796207534,0.00435062529166909,-0.0578936051924248,-0.040839154049082,1.04914928228076e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,40449,-0.111514415925992,0.00983596788401482,-0.130792912978661,-0.0922359188733227,1.23968464674112e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,42370,-0.0509114953851824,0.00449798053957234,-0.0597275372427442,-0.0420954535276206,1.45106813453234e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,40482,-0.061822788484485,0.00547376116136669,-0.0725513603607637,-0.0510942166082063,2.0114640980074e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,-0.069786913265698,0.00619192269289418,-0.0819230817437706,-0.0576507447876254,2.6271706891719e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,-0.0405949044972661,0.00360390050068972,-0.0476585494786179,-0.0335312595159142,2.85939974365458e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,40483,-0.163356301133136,0.0145064401389825,-0.191788923805542,-0.134923678460731,2.92890565894328e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,42721,-0.0627005828803986,0.00557456005477208,-0.0736267205877519,-0.0517744451730454,3.20682609686101e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,-0.0715534736413853,0.00636850179077172,-0.0840357371512979,-0.0590712101314727,3.6837014669969e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,42311,-0.0569988868368148,0.00507984006742147,-0.0669553733689609,-0.0470424003046687,4.3823303994907e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,-0.0568664448893484,0.00506888715122389,-0.0668014637057472,-0.0469314260729496,4.47211625326933e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,-0.0757657560143675,0.00675059116310188,-0.0889969146940471,-0.0625345973346878,4.50518784969204e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,42495,-0.040662511863669,0.00362903643023467,-0.047775423266929,-0.0335496004604091,5.21059591949503e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,42594,-0.0620248111507033,0.00555857093415119,-0.0729196101816396,-0.051130012119767,8.72430549644524e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.0737133465208956,0.00661133904404789,-0.0866715710472295,-0.0607551219945617,1.01757037257541e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,42754,-0.0625503628200983,0.00563446763105789,-0.0735939193769718,-0.0515068062632248,1.63901350907285e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,40199,-0.0495595638785746,0.00446510141151342,-0.0583111626451409,-0.0408079651120083,1.78984243654789e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,42574,-0.037301350319064,0.00336926848568305,-0.0439051165510028,-0.0306975840871252,2.30179185941506e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,-0.0633396404104384,0.00572568155441489,-0.0745619762570916,-0.0521173045637852,2.66878516617371e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,-0.0304504676483091,0.00275849317107833,-0.0358571142636226,-0.0250438210329956,3.28556358123705e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,42587,-0.0893818851705341,0.0081494237806969,-0.1053547557807,-0.0734090145603682,7.16540562222816e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,42760,-0.0547891188564157,0.00501133759624949,-0.0646113405450647,-0.0449668971677667,1.04555486827964e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,42721,-0.041074477864913,0.00375789528029839,-0.0484399526142979,-0.0337090031155282,1.07946040215973e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,-0.0407149128151012,0.00372979844259562,-0.0480253177625886,-0.0334045078676138,1.26071734967502e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,-0.0296960423430795,0.00272296956125689,-0.035033062683143,-0.024359022003016,1.41199614859496e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,-0.0318806199129221,0.00292356367262128,-0.0376108047112598,-0.0261504351145844,1.50279489212188e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,42594,-0.0429038199820033,0.00393885553765661,-0.0506239768358102,-0.0351836631281964,1.6328545749257e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,-0.0471383450335653,0.00432779457557264,-0.0556208224016876,-0.0386558676654429,1.64122219998312e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,-0.0411229337971409,0.0037756997058114,-0.0485233052205312,-0.0337225623737505,1.64406081575397e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,40449,-0.110956112151779,0.0102325941774193,-0.131011996739521,-0.0909002275640371,2.92294885844901e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,42476,-0.0677841973369998,0.00627037399281104,-0.0800741303629095,-0.0554942643110902,3.99278128454336e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,40199,-0.0503721260926539,0.0046668852593056,-0.0595192212008929,-0.0412250309844149,5.04302712804961e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,42477,-0.0496471310451548,0.00460540216638677,-0.0586737192912729,-0.0406205427990368,5.52134705049082e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,42754,-0.0817247737152291,0.00758627170560183,-0.0965938662582087,-0.0668556811722496,5.95333501435245e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,40527,-0.0797198561266464,0.00739794026310699,-0.0942198190423361,-0.0652198932109567,6.03869072540895e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,0.0467268832707941,0.00435533548894529,0.0381904257124613,0.0552633408291269,9.57399528425546e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0320473160690251,0.0029879801468578,-0.0379037571568664,-0.0261908749811838,9.92518643871135e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,-0.0587649923481676,0.00551042382890705,-0.0695654230528254,-0.0479645616435098,1.91639097255278e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,42754,-0.0507214824240868,0.00476245324976095,-0.0600558907936182,-0.0413870740545553,2.20993443179813e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,40449,-0.113173388780121,0.0106605674063384,-0.134068100896544,-0.0922786766636975,3.33695935619528e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,42346,-0.0498458877285312,0.00471469602439431,-0.059086691936344,-0.0406050835207183,5.08571465873049e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,-0.0725953420603941,0.00687200174209765,-0.0860644654749055,-0.0591262186458827,5.56264900817047e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,42587,-0.118513202221435,0.0112375136941204,-0.140538729061911,-0.0964876753809587,6.68136878153873e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,40379,0.11482876129089,0.0108922549025864,0.0934799416818209,0.136177580899959,7.29367079450534e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,-0.0767068595080531,0.00729270411929997,-0.0910005595818811,-0.0624131594342252,8.98337694923134e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,42620,-0.0337052665962634,0.00320678649845019,-0.0399905681332258,-0.027419965059301,9.71685222113589e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,42594,-0.0576472862738666,0.00549286284310274,-0.0684132974463479,-0.0468812751013852,1.14604761554529e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,0.0205377307778514,0.00195901448536438,0.0166980623865372,0.0243773991691655,1.2896923933332e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,40223,-0.0341775298273456,0.00326188901675683,-0.0405708323001889,-0.0277842273545022,1.43980067278926e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,40468,-0.0356981290402966,0.00341055121487696,-0.0423828094214554,-0.0290134486591377,1.60358652562804e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,42754,-0.0368506712310335,0.00352840590470186,-0.0437663468042491,-0.0299349956578179,1.94925722814177e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,42716,-0.060523089727276,0.00580839215523067,-0.0719075383515281,-0.0491386411030239,2.50758578548713e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,40449,-0.0892766234310162,0.00857046879084357,-0.10607474226107,-0.0724785046009628,2.70871131426955e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,42495,-0.0903584970803621,0.00868166708643862,-0.107374564569782,-0.0733424295909424,2.85126124999718e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,40342,-0.0250289716753578,0.00240650007243974,-0.0297457118173397,-0.0203122315333759,3.21406792999977e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,42618,-0.0346555005238516,0.00333664871803084,-0.041195332011192,-0.0281156690365112,3.5644737139304e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.0406819769878866,0.00392365362553582,-0.0483723380939368,-0.0329916158818364,4.50669083453781e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,42721,0.0484694233477742,0.00469237842486115,0.0392723616350463,0.057666485060502,6.42182408677595e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,40223,-0.0529669037003638,0.00513057009008522,-0.0630228210769309,-0.0429109863237968,7.1390018791085e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,42357,-0.0558905106736191,0.00542714159866014,-0.0665277082069929,-0.0452533131402452,8.90209975711987e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,-0.0228147128375634,0.00221743688876187,-0.0271608891395367,-0.0184685365355901,1.01683262227287e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0428408251650365,0.00417680135346807,-0.051027355817834,-0.0346542945122391,1.41302503832097e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,40283,-0.0464157682178444,0.00453766096063482,-0.0553095837006886,-0.0375219527350001,1.88766463595633e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,42640,0.0387219817832674,0.0037872352954004,0.0312990006042827,0.0461449629622522,1.89564324834859e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,42711,-0.0634987507712095,0.00621720042865778,-0.0756844636113787,-0.0513130379310402,2.11799501225614e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,42654,-0.0591207754719775,0.00580159673291866,-0.070491905068498,-0.0477496458754569,2.68059275342313e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,-0.0671744858300903,0.00659397367728934,-0.0800986742375774,-0.0542502974226032,2.76659853661669e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,-0.0390045386172918,0.00382961408332489,-0.0465105822206086,-0.0314984950139751,2.95870607887753e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,-0.0833499882411817,0.00818403868585746,-0.0993907040654623,-0.0673092724169011,2.96164250685118e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,42679,-0.0531235516791482,0.00521929166898169,-0.0633533633503523,-0.0428937400079441,3.0324339096373e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,-0.0295985837746062,0.00291081701382607,-0.0353037851217053,-0.0238933824275071,3.36085060226711e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,-0.0673433144097924,0.00663023218185039,-0.0803385694862192,-0.0543480593333657,3.77233731333116e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,-0.0642199025054044,0.00634648126706959,-0.0766590057888608,-0.0517807992219481,5.57097775558846e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,-0.0598901326015372,0.00591944871146097,-0.0714922520760007,-0.0482880131270737,5.65191413086807e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,42594,0.0461040316286404,0.00455989279856574,0.0371666417434516,0.0550414215138293,6.0316468907945e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,42613,0.172385786062923,0.0170804081632589,0.138908186062935,0.20586338606291,7.24730895585655e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,-0.123441307146313,0.012236864689791,-0.147425561938304,-0.0994570523543229,7.62177181912306e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,-0.0860466653892857,0.00852893991611504,-0.102763387624871,-0.0693299431537002,7.81413388572742e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.0373142653224418,0.0037001571518939,-0.0445665733401539,-0.0300619573047298,8.20355052061616e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,40223,-0.0601458696639575,0.00596948571005355,-0.0718460616556625,-0.0484456776722526,8.97888593551934e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,-0.0304707324551433,0.00302577935745611,-0.0364012599957572,-0.0245402049145293,9.41536628395212e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,42692,-0.0623237927310132,0.00619575412572121,-0.0744674708174268,-0.0501801146445996,1.01517647100105e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,40483,-0.0378730723359366,0.00376416613584528,-0.0452508379621934,-0.0304953067096799,1.02910486476123e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,40451,-0.0452692840713439,0.00451331604023031,-0.0541153835101953,-0.0364231846324925,1.410830827103e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,40511,-0.0558367114332909,0.00557734190786927,-0.0667683015727147,-0.0449051212938671,1.70175266647273e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,40527,0.0406314989385836,0.00407056913122724,0.0326531834413782,0.048609814435789,2.28708895770899e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,42648,-0.0318033918534142,0.00320416296837483,-0.0380835512714289,-0.0255232324353995,3.8671162546681e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,42594,-0.0717079777639502,0.00722940633177728,-0.0858776141742337,-0.0575383413536667,4.13738911330601e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,-0.066840701954301,0.00673935961647911,-0.0800498468026001,-0.053631557106002,4.1918786839217e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,42611,-0.0571408862019461,0.00576376384061324,-0.068437863329548,-0.0458439090743441,4.35226399044761e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,40199,-0.0812463809049654,0.00819662538492183,-0.0973117666594122,-0.0651809951505187,4.60337420783206e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,40539,-0.0193450942507832,0.00195338283557433,-0.0231737246085089,-0.0155164638930575,4.98983073568605e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,-0.0943159924762682,0.00954974773569795,-0.113033498038236,-0.0755984869143002,6.31748532085832e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,-0.0678133749313548,0.00690350955376921,-0.0813442536567424,-0.0542824962059671,1.10532775948797e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,-0.0941506086463191,0.00962077810324018,-0.11300733372867,-0.0752938835639683,1.53612733858229e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,-0.0478972928991446,0.00489722497000879,-0.0574958538403618,-0.0382987319579274,1.62344929708831e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,-0.10235750922828,0.0104683723766481,-0.12287551908651,-0.08183949937005,1.66774761377932e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,42480,-0.0359767751309585,0.00368238693911011,-0.0431942535316143,-0.0287592967303027,1.80340325074736e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,42754,0.00848305868610189,0.000869309245710873,0.00677921256450858,0.0101869048076952,2.01277222942494e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,-0.0462330252563545,0.00473684699751921,-0.0555172453714921,-0.0369488051412168,2.04392372070889e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,-0.0317595141289739,0.0032557975637166,-0.0381408773538584,-0.0253781509040894,2.09088793469289e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,40456,-0.105375302481876,0.0108170659302318,-0.126576751705131,-0.084173853258622,2.45516922365728e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,-0.0516986412221289,0.00531807474435307,-0.0621220677210609,-0.0412752147231969,2.89695321013157e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,42711,-0.0584964318798481,0.00601797180058974,-0.070291656609004,-0.0467012071506922,2.92220771539014e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,42311,-0.0614725578021297,0.00632923636836858,-0.0738778610841321,-0.0490672545201273,3.16956696670189e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,40511,0.0272937577009564,0.00281112465095306,0.0217839533850884,0.0328035620168244,3.36283939633485e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,40283,0.0504632229961175,0.00520531979912053,0.0402607961898412,0.0606656498023937,3.89321679384692e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,42594,-0.0552602187579222,0.00570474153047727,-0.0664415121576576,-0.0440789253581867,4.05789389317627e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,42441,0.0271933446094429,0.00280884119662296,0.0216880158640619,0.0326986733548239,4.28379389952883e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,42594,-0.0317869293360675,0.00329938409595346,-0.0382537221641363,-0.0253201365079987,6.75157504261548e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,-0.0275652913566224,0.0028647413578963,-0.0331801844180992,-0.0219503982951457,7.60371654684199e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,0.0358422544835828,0.00372906495696567,0.02853328716793,0.0431512217992355,8.38955368563395e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,-0.0811705396288648,0.00844544194565628,-0.0977236058423511,-0.0646174734153784,8.43379064560654e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,42594,-0.0864340555852145,0.00900493927079748,-0.104083736555978,-0.0687843746144514,9.52757417883072e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,42663,-0.0306159793178447,0.00319559353386617,-0.0368793426442224,-0.024352615991467,1.13022183271794e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,-0.0772886923326981,0.00807384696231695,-0.0931134323788393,-0.0614639522865568,1.22087422950747e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,40539,0.022863595187416,0.00238861444831496,0.0181819108687187,0.0275452795061133,1.26658457777532e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,40532,-0.0253794571623272,0.00265176942637121,-0.0305769252380148,-0.0201819890866397,1.2807105339473e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,40515,-0.0533238703312082,0.00558131437725698,-0.0642632465106319,-0.0423844941517846,1.50444245069244e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,0.0226027922975325,0.0023670524929761,0.0179633694112993,0.0272422151837656,1.53469250546387e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,42676,-0.0398904937353118,0.00420596612985576,-0.0481341873498291,-0.0316468001207945,2.84364322045876e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,42636,-0.0334850900079432,0.00353741067597551,-0.0404184149328552,-0.0265517650830312,3.38524220518131e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,0.0323658924710901,0.00342181137067319,0.0256591421845707,0.0390726427576096,3.62870282210325e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0321898065149129,0.00340628746819223,0.0255134830772561,0.0388661299525697,3.93607044358001e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,-0.0480795098366665,0.00508967565998565,-0.0580552741302383,-0.0381037455430946,4.08952191867598e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,42495,-0.0374875710578899,0.00397622537741024,-0.0452809727976139,-0.0296941693181658,4.86515160434096e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,-0.0587333165412899,0.00623719481829143,-0.0709582183851411,-0.0465084146974387,5.42369606536874e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,-0.0288382944688683,0.00306508229422545,-0.0348458557655502,-0.0228307331721864,5.83075161302213e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,-0.074397948159055,0.00793863497572508,-0.0899576727114761,-0.0588382236066338,8.53576493921279e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,-0.0549658758366772,0.00588737861156268,-0.06650513791534,-0.0434266137580143,1.15345447845473e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,-0.0257112452111686,0.00275434845579348,-0.0311097681845238,-0.0203127222378133,1.16851914858174e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,42711,-0.0220292930154235,0.0023695909277104,-0.0266736912337359,-0.0173848947971111,1.66820947372044e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,42754,-0.0338480367817704,0.0036460940911174,-0.0409943812003605,-0.0267016923631803,1.88784543167388e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,42679,-0.0331876394789202,0.00357576827919621,-0.0401961453061447,-0.0261791336516956,1.92681828235211e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.0217043321431577,0.00234714767523502,-0.0263047415866183,-0.017103922699697,2.65312798634651e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,-0.0214736095747245,0.00232250287500729,-0.0260257152097388,-0.0169215039397103,2.75891208999652e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,-0.0266900447144173,0.00288980238777062,-0.0323540573944477,-0.0210260320343869,3.01816414453051e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,-0.0794675854591675,0.0086099858946973,-0.0963431578127742,-0.0625920131055608,3.11407584853385e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,40511,-0.0419144738126517,0.00454495688048623,-0.0508225892984047,-0.0330063583268987,3.42517294874184e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,-0.0664395855460293,0.00722314679697632,-0.0805969532681028,-0.0522822178239557,4.17689202185427e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,40539,-0.0281252131724868,0.00306303663318652,-0.0341287649735323,-0.0221216613714412,4.95740357973551e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,42679,0.0367622521398839,0.00401320859451025,0.0288963632946438,0.044628140985124,5.91121319120515e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,42571,-0.0281092216949503,0.00307051936188659,-0.034127439644248,-0.0220910037456526,6.24008568106416e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,42618,-0.0255284263663983,0.00278952728665327,-0.0309958998482388,-0.0200609528845579,6.41326327819419e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,40346,-0.0255146769479818,0.00278874527185779,-0.0309806176808231,-0.0200487362151406,6.73345216281782e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,-0.0186710880562713,0.00204280412516156,-0.022674984141588,-0.0146671919709547,7.13739917127696e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,42136,-0.0830342214642507,0.00909967783750844,-0.100869590025767,-0.0651988529027341,8.22598164940694e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,42370,-0.042589754885127,0.00467850533463689,-0.0517596253410153,-0.0334198844292387,1.00096829521662e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,42689,-0.0268844980712721,0.00295385419851684,-0.0326740523003651,-0.0210949438421791,1.01427333662961e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,42594,-0.0278717431187423,0.00306398105145967,-0.0338771459796032,-0.0218663402578813,1.06194671710935e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,-0.0948855236051857,0.010433407601899,-0.115335002504908,-0.0744360447054636,1.08362296959538e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,42706,-0.0326123803383466,0.0035871720066425,-0.0396432374713659,-0.0255815232053273,1.11234971713862e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.0737567255766566,0.00811326122754328,-0.0896587175826414,-0.0578547335706718,1.15167183930217e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,-0.0798534393068582,0.00881847939490218,-0.0971376589208665,-0.0625692196928499,1.55048164810356e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,42449,0.0248345598476731,0.00274581525060197,0.0194527619564932,0.0302163577388529,1.70992303443713e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,-0.0374535053404738,0.00414048146503482,-0.045568849011942,-0.0293381616690055,1.73462138943972e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,-0.022931342688781,0.0025367862233727,-0.0279034436865914,-0.0179592416909705,1.78720689897685e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,-0.044418600884745,0.00491609505174901,-0.0540541471861731,-0.0347830545833169,1.90853012677859e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,-0.0477547898805937,0.00529916353141015,-0.0581411504021576,-0.0373684293590298,2.29918043303165e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,42476,-0.0339086741383254,0.00376389044692683,-0.041285899414302,-0.0265314488623488,2.36110685901569e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.0248228040113952,0.0027563936780333,-0.0302253356203404,-0.0194202724024499,2.43057213517789e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,42575,-0.0467870085113557,0.00520617540025127,-0.0569911122958481,-0.0365829047268632,2.88165515041115e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,40383,-0.0241348047738704,0.00268551105943572,-0.0293984064503644,-0.0188712030973764,2.94667395492781e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,42683,-0.0329174547553093,0.00366820561780648,-0.04010713776621,-0.0257277717444086,3.2407412772566e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,-0.0587262770939154,0.00654476574917371,-0.0715540179622958,-0.0458985362255349,3.33789439364793e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,0.0214276032385112,0.0023891177679989,0.0167449324132334,0.0261102740637891,3.38825217801311e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,42654,0.0438823018191808,0.00489440739223552,0.0342892633303992,0.0534753403079625,3.48165547403754e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,-0.0358353366869033,0.00401885489909086,-0.0437122922891214,-0.0279583810846853,5.40966633412351e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,-0.0970398672536452,0.0109072474482012,-0.118418072252119,-0.0756616622551709,6.48979158833813e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,-0.0746955038343307,0.00842289494859013,-0.0912043779335673,-0.058186629735094,8.5835689385626e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,42587,-0.0620656687071508,0.00702090848483948,-0.0758266493374362,-0.0483046880768654,1.07424966806588e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,42611,0.0226928412097463,0.00257012316514721,0.0176553998060578,0.0277302826134348,1.18065560601619e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,42594,-0.0827159459535618,0.00937518241915285,-0.101091303495101,-0.0643405884120222,1.25229556803142e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,-0.0244361486490233,0.00277518825991421,-0.0298755176384552,-0.0189967796595915,1.46347544991113e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0212564162073206,0.0024142898200207,0.01652440816008,0.0259884242545612,1.47397055323346e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0335609998187443,0.0038137319269493,-0.0410359143955649,-0.0260860852419237,1.53307134471608e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,-0.0173084895714471,0.00196761229065876,-0.0211650096611383,-0.0134519694817559,1.58430510007052e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,-0.0628441956687803,0.00715158064150036,-0.076861293726121,-0.0488270976114396,1.71770062492419e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,-0.0394080922602488,0.00448826691312781,-0.0482050954099793,-0.0306110891105183,1.82762242080759e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,42365,-0.0347329439138859,0.00395979053352373,-0.0424941333595924,-0.0269717544681794,1.97911027838266e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,42495,-0.059997787326262,0.00684122794864128,-0.0734065941055989,-0.0465889805469251,2.00109401463201e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0271295065888455,0.00309387023003742,-0.0331934922397189,-0.0210655209379722,2.06511811174491e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,-0.0793157298077985,0.00905717774702505,-0.0970677981919676,-0.0615636614236294,2.2370975215393e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,42636,-0.0325232417822016,0.00371820922050001,-0.0398109318543816,-0.0252355517100216,2.44851506323043e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,42711,-0.039243178124716,0.00448941045823056,-0.0480424226228479,-0.0304439336265841,2.57390110122944e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,42563,-0.0317006357796985,0.00362676613820437,-0.0388090974105791,-0.024592174148818,2.58913484086704e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,40527,-0.0993394126769334,0.0114058604154504,-0.121694899091216,-0.0769839262626507,3.47461844952778e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,0.0238953784548672,0.00274389341075972,0.0185173473697782,0.0292734095399563,3.50314649306841e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,-0.0502803260970034,0.00577512798599604,-0.0615995769495556,-0.0389610752444512,3.50833186329091e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.0185910177499489,0.0021359205767038,0.0144046134196094,0.0227774220802883,3.58209366094323e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0242823766544223,0.0028022178992326,0.0187900295719264,0.0297747237369182,5.00341312601921e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,42754,-0.0349074479525127,0.00403397812915308,-0.0428140450856528,-0.0270008508193727,5.55838701337174e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,42721,-0.0553082634450369,0.00641426361501098,-0.0678802201304584,-0.0427363067596153,7.25991401587445e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,42594,-0.0406126317116474,0.00471421364707266,-0.0498524904599098,-0.031372772963385,7.77409568477326e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,-0.0337663279017099,0.00392216409533194,-0.0414537695285605,-0.0260788862748593,8.17200880841251e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,42587,-0.0274694647202078,0.00319584780221059,-0.0337333264125406,-0.0212056030278751,9.21236695159816e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,42679,-0.0379519545886974,0.00441656765549568,-0.0466084271934689,-0.0292954819839258,9.3888267178863e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,40511,-0.0276546440450763,0.00321989369661911,-0.0339656356904498,-0.0213436523997029,9.9477817001849e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,42495,-0.0455266795233592,0.00531824400697628,-0.0559504377770327,-0.0351029212696857,1.24638399256094e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,40451,-0.0841569029185711,0.00983679008633636,-0.10343701148779,-0.0648767943493519,1.32749989769485e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0548356764762822,0.00641316588935928,-0.0674054816194264,-0.0422658713331381,1.383484294543e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,40483,-0.0327276900623354,0.0038324326652154,-0.0402392580861576,-0.0252161220385132,1.51845527529325e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,40527,-0.023759277505563,0.00278245774259632,-0.0292128946810518,-0.0183056603300742,1.52705695489864e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,-0.0488698595739564,0.0057286270262227,-0.0600979685453529,-0.0376417506025599,1.60787069549375e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,42679,-0.0225809218521538,0.00264871827059319,-0.0277724096625164,-0.0173894340417911,1.68593656572805e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,42754,-0.0349643048305707,0.00410255976394631,-0.0430053219679055,-0.026923287693236,1.7240734156015e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,-0.0383935762427339,0.00450505944902544,-0.0472234927628238,-0.029563659722644,1.76776782411465e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0238788418013539,0.00280323579989354,-0.0293731839691453,-0.0183844996335626,1.79083361033167e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,42590,-0.0775140048382672,0.00910655752444564,-0.0953628575861806,-0.0596651520903537,1.89175194603882e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,-0.0525683280128947,0.00618931402623765,-0.0646993835043204,-0.0404372725214689,2.21649804053382e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.0244973776885549,0.0028858529373865,0.0188411059312773,0.0301536494458324,2.30253681976421e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,-0.0267048249196109,0.00315043387609811,-0.0328796753167632,-0.0205299745224586,2.61012340271206e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,42556,-0.069971764467757,0.00825860293813344,-0.0861586262264985,-0.0537849027090154,2.64898142024286e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.023840490911113,0.00281869400314414,-0.0293651311572755,-0.0183158506649505,2.99787002021232e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,-0.0249354493299458,0.00294760848425512,-0.0307127619590859,-0.0191581367008058,3.01355225931396e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,-0.0709663090330601,0.00839446264764037,-0.0874194558224353,-0.054513162243685,3.10515680537694e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,42125,-0.0284670658976446,0.00337020155017645,-0.0350726609359904,-0.0218614708592988,3.31440941648972e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,-0.0504850993912275,0.00598198845364392,-0.0622097967603696,-0.0387604020220854,3.51727895037802e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,-0.0351915355630806,0.00418274690252099,-0.0433897194920218,-0.0269933516341395,4.37957970096573e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,-0.0862206894388379,0.0102636468895049,-0.106337437342268,-0.0661039415354083,4.88609773939443e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.0235752930151423,0.00280959644284978,-0.0290821020431278,-0.0180684839871567,5.2967400847773e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,42754,-0.0626706998791712,0.00747128245965718,-0.0773144135000993,-0.0480269862582431,5.41987394641994e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,42317,-0.0413195181995277,0.00492780870983295,-0.0509780232708003,-0.0316610131282551,5.587938917786e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,-0.0433528893830588,0.00517096847999648,-0.0534879876038519,-0.0332177911622657,5.72916599010909e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,-0.0614964159844502,0.00734692579461447,-0.0758963905418946,-0.0470964414270058,6.44468301667026e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,42676,-0.0564150717642615,0.00675652689728229,-0.0696578644829348,-0.0431722790455882,7.50508941817798e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,42679,-0.0682632124590297,0.00817672151232943,-0.0842895866231954,-0.052236838294864,7.58325473883619e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,39872,-0.020335151866887,0.00243635011710036,-0.0251103980964037,-0.0155599056373703,7.89503568686338e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,40511,-0.076036715339206,0.00911400419278147,-0.0939001635570577,-0.0581732671213543,8.09278341880641e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,-0.0249639813700597,0.00300068378476946,-0.0308453215882078,-0.0190826411519116,9.87275853325278e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,40116,-0.0645951947329604,0.00777341533620994,-0.0798310887919319,-0.0493593006739889,1.07243286041054e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,-0.070062627897566,0.00844972897782494,-0.0866240966941028,-0.0535011591010291,1.22157131344811e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,42594,-0.0747853430710565,0.00902670228479533,-0.0924776795492554,-0.0570930065928577,1.29356329719899e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,42346,-0.0523777273294789,0.00633785117755317,-0.0647999156374831,-0.0399555390214747,1.53929573989025e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,-0.0191193014079919,0.00231597239312489,-0.0236586072985167,-0.0145799955174672,1.6543431742657e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,-0.0661976915195568,0.00802112678164271,-0.0819191000115766,-0.0504762830275371,1.71769892853638e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,-0.0424505473748351,0.00514599315038145,-0.0525366939495827,-0.0323644008000874,1.7403907427323e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,42646,-0.0375200026915371,0.00455928569702526,-0.0464562026577066,-0.0285838027253675,2.05416028270673e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,-0.0499017926785949,0.00606624405360301,-0.0617916310236568,-0.038011954333533,2.11024728575697e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0324100990078223,0.00395085807060454,0.0246664171894374,0.0401537808262072,2.55418471214749e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,-0.0564789168408752,0.0068885617663768,-0.0699804979029737,-0.0429773357787767,2.6872231890034e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,42495,0.0209918099479078,0.0025637618737706,0.0159668366753174,0.0260167832204982,2.89911777329486e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,42721,-0.0326119025602237,0.00398592969299108,-0.0404243247584862,-0.0247994803619612,3.04554764669214e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,-0.0343120688990228,0.00420061979456696,-0.0425452836963741,-0.0260788541016716,3.40295522440804e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,0.0246146828481266,0.0030148283284635,0.0187056193243381,0.030523746371915,3.51114176814285e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,42437,-0.0345800968495076,0.00423742565807798,-0.0428854511393404,-0.0262747425596747,3.63165002153231e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,40223,-0.0326933259960132,0.00400641114907507,-0.0405458918482003,-0.024840760143826,3.70633435051436e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,0.0237708069288664,0.00292095121413187,0.018045742549168,0.0294958713085649,4.36718391099504e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0252132702457229,0.00309769132283636,-0.0312847452384821,-0.0191417952529636,4.3899025311734e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,40539,-0.0294149642055225,0.0036155758085422,-0.0365014927902652,-0.0223284356207798,4.52495812216452e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,0.0505729105408285,0.00622289278515749,0.0383760406819199,0.0627697803997372,4.78799576901098e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.0263403256840288,0.00324578342719851,-0.0327020612013379,-0.0199785901667197,5.36267541682723e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,0.0332141803077374,0.00410599245482984,0.025166435096271,0.0412619255192039,6.51880595831052e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,0.0282799428294532,0.00349710352317238,0.0214256199240353,0.035134265734871,6.65510632817294e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,-0.0479811336270473,0.00593318713072096,-0.0596101804032604,-0.0363520868508343,6.74670637829928e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0368503452169438,0.00455864069166303,-0.0457852809726033,-0.0279154094612843,6.93865490119331e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,-0.0794709030154379,0.00985869044284205,-0.0987939362834083,-0.0601478697474675,8.20403618359993e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,-0.0289201197767542,0.00358897561712494,-0.0359545119863191,-0.0218857275671893,8.40280959076256e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,-0.0278608410815515,0.00346028252617995,-0.0346429948328642,-0.0210786873302388,8.85451713888707e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,42638,0.0171266018522716,0.00213248854198852,0.0129469243099741,0.0213062793945691,1.04446492805313e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,42794,0.0222364408861816,0.00277491922134154,0.0167975992123522,0.0276752825600111,1.20653794544356e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,-0.054810013800663,0.00684615752066085,-0.0682284825411583,-0.0413915450601678,1.30442853641302e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,42311,-0.0492397159962559,0.00616162456957035,-0.0613165001526138,-0.037162931839898,1.44566018579558e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,-0.0462769099616474,0.00579181602231426,-0.0576288693653833,-0.0349249505579114,1.45798955530639e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,0.0121659776850784,0.00152251187255799,0.00918185441486477,0.0151501009552921,1.47158857430555e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,42587,-0.0559335452986478,0.0070103721078459,-0.0696738746300258,-0.0421932159672699,1.59861488713389e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,40116,-0.0541678953485997,0.00678894473390314,-0.0674742270270498,-0.0408615636701495,1.62485459635306e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,40539,-0.0250953168229834,0.00314557027720801,-0.0312606345663111,-0.0189299990796557,1.63026762918977e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,42326,0.038913447827537,0.00488050436202751,0.0293476592779631,0.0484792363771109,1.6728451998062e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,42255,-0.0547666855451477,0.00687208871516605,-0.0682359794268732,-0.0412973916634223,1.72564324819599e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,-0.0351832564185629,0.00441947447552904,-0.0438454263905999,-0.026521086446526,1.87344876193286e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,-0.0256688082634081,0.00322986063503901,-0.0319993351080845,-0.0193382814187316,2.0570924638649e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,-0.0769776031954223,0.00969581291169038,-0.0959813965023354,-0.0579738098885092,2.22636687419696e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,-0.0390833314462747,0.00492596407265945,-0.0487382210286873,-0.0294284418638622,2.2901332687935e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,-0.0171689504785519,0.0021652237103657,-0.0214127889508686,-0.0129251120062351,2.41307671474217e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,42594,-0.0652371519265179,0.00826178095024719,-0.0814302425890024,-0.0490440612640334,3.09665557896695e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,-0.05003481460774,0.00633769923984209,-0.0624567051178305,-0.0376129240976495,3.17693114486786e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,-0.04498406584888,0.0057046245305666,-0.0561651299287906,-0.0338030017689695,3.37833389022881e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,-0.0660886435630462,0.00839322886444712,-0.0825393721373626,-0.0496379149887299,3.75544290073468e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,-0.0453397124154023,0.00577654398956275,-0.0566617386349452,-0.0340176861958593,4.51304463876375e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,40511,-0.0532019210251401,0.00677882173671232,-0.0664884116290962,-0.039915430421184,4.59845442712886e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,-0.0619171958271271,0.00789110626536674,-0.077383764107246,-0.0464506275470083,4.66674327772062e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,42346,-0.0314967453183711,0.00401886405750186,-0.0393737188710747,-0.0236197717656674,4.9588947989519e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0469306961482373,0.00598984803853574,0.0351905939927073,0.0586707983037674,5.03868257163471e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,40430,-0.0335038748630503,0.00427874211193544,-0.0418902094024438,-0.0251175403236569,5.30400024039484e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,-0.0351681274723393,0.00449428505625687,-0.0439769261826027,-0.0263593287620758,5.45172555906496e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,42441,-0.0281146694061733,0.00359430470802333,-0.035159506633899,-0.0210698321784476,5.59098796586122e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,42594,-0.0657646974585526,0.00840884528301257,-0.0822460342132572,-0.0492833607038479,5.63561468734899e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,-0.0517318670165158,0.00661368346211249,-0.0646946866022562,-0.0387690474307753,5.67307709094717e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,-0.0297402273098217,0.00380809175004197,-0.037204087139904,-0.0222763674797395,6.15476246846815e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,42333,-0.0393115268567543,0.00503631393952451,-0.0491827021782223,-0.0294403515352862,6.36779534561821e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,-0.0847762610894916,0.0108659353805823,-0.106073494435433,-0.0634790277435504,6.63278604584241e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,42754,-0.072307772686537,0.0092891727822767,-0.0905145513397994,-0.0541009940332747,7.52844589285204e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,42754,-0.0709380566114254,0.00912608939571184,-0.0888251918270206,-0.0530509213958302,8.20815553450955e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,40539,0.0236646760986416,0.0030439431508401,0.017698547522995,0.0296308046742882,8.23872514461547e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,-0.0492047606816713,0.00633675950865904,-0.061624809318643,-0.0367847120446996,8.89651964716734e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,-0.0148934620709653,0.00192092127676831,-0.0186584677734312,-0.0111284563684994,9.58982802582067e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,42587,0.0228346499921832,0.00294586949731892,0.0170607457774381,0.0286085542069283,9.7407553165704e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,-0.0412502790726756,0.00532358340668666,-0.0516845025497814,-0.0308160555955697,1.01088659740026e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0309816494283112,0.00402243347034275,-0.038865619030183,-0.0230976798264394,1.44904529455323e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,0.0402827592996095,0.0052414181245484,0.0300095797754946,0.0505559388237243,1.62999693131039e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,42538,-0.0548634988181208,0.00715190480593344,-0.0688812322377503,-0.0408457653984912,1.82217289928987e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,42678,-0.0514822369877875,0.00671194264756396,-0.0646376445770129,-0.0383268293985622,1.83409284765866e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,42594,-0.0612549768727756,0.00799367259665997,-0.0769225751622292,-0.0455873785833221,1.94194151250278e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,-0.0595038831132041,0.007764216885256,-0.0747217482083059,-0.0442860180181024,1.95161200494943e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,40199,-0.0263997565427487,0.00344679285852,-0.0331554705454479,-0.0196440425400495,2.02750012596072e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,-0.0615955621423159,0.00805096003145208,-0.077375443803962,-0.0458156804806699,2.13355533980271e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,42336,-0.0302657936269992,0.00395890098621754,-0.0380252395599855,-0.0225063476940128,2.23424273684113e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,42611,0.021860132558098,0.0028600237046329,0.0162544860970175,0.0274657790191785,2.2600140032441e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,-0.0543368746446739,0.00713251841704341,-0.068316610742079,-0.0403571385472688,2.77878266864187e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,-0.0633657435734156,0.00832642647575416,-0.0796855394658938,-0.0470459476809375,2.95863289591174e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,-0.0648243253893354,0.00852485655397218,-0.0815330442351209,-0.0481156065435499,3.06436569676088e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,42636,-0.0819312116944653,0.0107935256024461,-0.10308652187526,-0.0607759015136709,3.38914327728628e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0515979170210066,0.00680558059225184,-0.0649368549818202,-0.0382589790601929,3.63451237042221e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.037062052145426,0.00489426144983942,-0.0466548045871112,-0.0274692997037407,3.90315748316511e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,42636,0.0389887328196963,0.0051515933796484,0.0288916097955855,0.0490858558438072,4.02754439774527e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,42689,-0.0243488726438654,0.00322410214153271,-0.0306681128412695,-0.0180296324464613,4.55632806443517e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,-0.0400019387291486,0.00529591956734915,-0.050381941081153,-0.0296219363771443,4.56941718505028e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,42587,-0.0402090386333712,0.00533057686846044,-0.0506569692955537,-0.0297611079711887,4.88485904493323e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,-0.0634081228858126,0.00841379942558762,-0.0798991697599643,-0.0469170760116609,5.15535042446732e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,-0.0633961665788781,0.00842263130873117,-0.0799045239439912,-0.046887809213765,5.53367186913999e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.0336272626707673,0.00446810655278253,0.0248697738273135,0.042384751514221,5.56202797028368e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,40483,-0.0474301037358969,0.00630163852618549,-0.0597813152472205,-0.0350788922245734,5.60272647644685e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,40451,-0.0158974685377989,0.00211343489376611,-0.0200398009295805,-0.0117551361460173,5.80058162224616e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,-0.0572464791312362,0.00761825075659963,-0.0721782506141715,-0.0423147076483009,6.08015383927955e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,42611,0.0220640750531544,0.00293650932236462,0.0163085167813198,0.0278196333249891,6.11093011718596e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,-0.0430981781059312,0.00573710029633294,-0.0543428946867437,-0.0318534615251186,6.19067261477297e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,42711,-0.0212693427286603,0.0028326611300147,-0.0268213585434891,-0.0157173269138315,6.3498441748244e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,40269,0.0158185829425968,0.00210637245874206,0.0116900929234624,0.0199470729617313,6.37370268607091e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,-0.0259719877936478,0.00347225144390392,-0.0327776006236995,-0.0191663749635962,7.89763184667063e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,42676,-0.0341108997761254,0.00456118877639331,-0.0430508297778563,-0.0251709697743945,7.98094298000129e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,-0.0382806352230174,0.00512328109020544,-0.0483222661598201,-0.0282390042862148,8.40469837048299e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0245289635958413,0.00329146142272197,0.0180776992073062,0.0309802279843763,9.86058979356084e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.0325222143531798,0.00436620569931021,-0.0410799775238278,-0.0239644511825318,1.00385270224596e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,-0.0537441793567008,0.00722466212558473,-0.0679045171228469,-0.0395838415905547,1.08997258607066e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,42346,-0.0552209169563778,0.00743383529239177,-0.0697912341294657,-0.0406505997832899,1.16761449591666e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,-0.0355913127058112,0.0047916508540911,-0.0449829483798298,-0.0261996770317927,1.18422865113432e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.0207498596323216,0.00279754857856071,-0.0262330548463006,-0.0152666644183426,1.2680448181391e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,-0.0296263573504507,0.0039944412295115,-0.0374554621602933,-0.0217972525406082,1.27073540640975e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,40494,-0.0347762224857298,0.00469204116232848,-0.0439726231638937,-0.025579821807566,1.33544422386894e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,40382,0.0314197089236652,0.00424429439480931,0.023100891909839,0.0397385259374915,1.42900991020135e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,40283,-0.0326180783264796,0.00444334017798399,-0.0413270250753282,-0.023909131577631,2.270290018867e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,42594,0.0322775181382697,0.00440303450892063,0.0236475705007853,0.0409074657757542,2.41994204880266e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,-0.0543629476639908,0.0074316003731614,-0.0689288843953871,-0.0397970109325944,2.75025499134746e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,-0.0283336213930409,0.00387560681976354,-0.0359298107597774,-0.0207374320263044,2.80958471330428e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,-0.0827905317181269,0.0113417520854474,-0.105020365805604,-0.06056069763065,3.08013233099224e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,-0.0441029001518536,0.00604321780546083,-0.0559476070505568,-0.0322581932531503,3.09068174551415e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,40116,-0.0563539608258536,0.00772767096296303,-0.0715001959132611,-0.041207725738446,3.25342758463116e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,42794,-0.0399341669951436,0.00547801272321839,-0.0506710719326516,-0.0291972620576355,3.2730098316619e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.0197807720533271,0.00271699261995374,0.0144554665182177,0.0251060775884364,3.54883889185888e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,40283,-0.0369410274857661,0.00507879164973132,-0.0468954591192395,-0.0269865958522927,3.73676069404425e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,-0.0810158522739653,0.0111656152154055,-0.10290045809616,-0.0591312464517704,4.25803009796834e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0265446833542256,0.00366094260092684,-0.0337201308520422,-0.019369235856409,4.37072217794341e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-0.020649090948513,0.00285297156877256,-0.0262409152233072,-0.0150572666737188,4.80679843335697e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,-0.0561615915752202,0.00776511546800812,-0.0713812178925161,-0.0409419652579243,5.00299124030232e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,42594,-0.027636618756359,0.00382292296215618,-0.0351295477621852,-0.0201436897505329,5.12220977041305e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,-0.0575914237098991,0.00796803411093237,-0.0732087705673266,-0.0419740768524717,5.23340525646301e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,0.0421134707981713,0.00583192673892073,0.0306828943898866,0.0535440472064559,5.42857468903735e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,42689,0.0347741562758745,0.00481883672064101,0.0253292363034182,0.0442190762483309,5.62748365154891e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,0.0172500241009338,0.00239540855578952,0.0125550233315863,0.0219450248702812,6.28075646426185e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,-0.0278612174155781,0.00387283892209554,-0.0354519817028854,-0.0202704531282709,6.62561842436938e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,42613,-0.0264710065333898,0.00368085720912132,-0.0336854866632676,-0.019256526403512,6.74612233412781e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0341045319388465,0.00474527285656856,-0.0434052667377208,-0.0248037971399721,6.97020832036426e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,-0.0471570319648773,0.00656278314499017,-0.060020086929058,-0.0342939770006965,7.04362785797434e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,0.0235812031256029,0.00328281674395642,0.0171468823074484,0.0300155239437575,7.16278693869397e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,40462,-0.0523795769900195,0.00729251022183607,-0.0666728970248182,-0.0380862569552208,7.26814455246465e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,-0.0604686272250625,0.00842192261750974,-0.0769755955553816,-0.0439616588947434,7.41547978678757e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,42721,-0.0282110390235668,0.00393100766681109,-0.0359158140505165,-0.020506263996617,7.52216440694825e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,-0.0697190811085888,0.00972864252335172,-0.0887872204543581,-0.0506509417628194,8.09898722177896e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,42644,0.0197838727209569,0.0027613228802453,0.0143716798756761,0.0251960655662377,8.20532697464158e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,40482,-0.0739784992358978,0.0103483986446296,-0.0942613605793719,-0.0536956378924237,9.29531303264006e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,-0.0370289474411027,0.00518085888941498,-0.047183430864356,-0.0268744640178493,9.30668741215774e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,-0.0479654202734494,0.0067193008527098,-0.0611352499447606,-0.0347955906021382,9.92579131530687e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,-0.0674829115030823,0.00945393559376098,-0.0860126252668538,-0.0489531977393107,9.94750594237387e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,42439,-0.0340483775840089,0.00477063288219449,-0.0433988180331101,-0.0246979371349077,1.0029935174365e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,-0.0403802689079846,0.0056707551751468,-0.0514949490512723,-0.0292655887646969,1.12884197998881e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,39870,-0.0881202487588081,0.0123753040251757,-0.112375844648153,-0.0638646528694637,1.1432860241972e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,40223,-0.0216562101930202,0.00304344002017631,-0.0276213526325657,-0.0156910677534746,1.18254809261163e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0286027152329732,0.00402397854694088,-0.0364897131849774,-0.0207157172809691,1.23565677176228e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,40283,-0.0236408173736858,0.00333933264297569,-0.0301859093539181,-0.0170957253934534,1.5341772280833e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,42311,-0.0245833847301619,0.00347900605638928,-0.0314022366006849,-0.0177645328596389,1.6726640938242e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,42488,-0.0249066988281181,0.00352888841546629,-0.031823320122432,-0.0179900775338042,1.77363974803194e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,-0.0309341710158163,0.00438747078945238,-0.039533613763143,-0.0223347282684896,1.88864576687398e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,-0.0845089688458926,0.012040248427518,-0.108107855763828,-0.0609100819279572,2.36849429167608e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,42581,-0.029689973912956,0.00423132309087568,-0.0379833671710724,-0.0213965806548397,2.38076174745528e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,-0.0658660027920162,0.00939220781180078,-0.0842747301031457,-0.0474572754808867,2.44939507153869e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,42587,-0.0972368568645239,0.0138684027464301,-0.124418926247527,-0.0700547874815209,2.47261811176878e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,-0.0965858279179373,0.0138019207708053,-0.123637592628716,-0.0695340632071588,2.74398053551796e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,0.0312608274119593,0.00447092537248977,0.0224978136818794,0.0400238411420393,2.83722002866316e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0333787674024646,0.00477631935802365,-0.0427403533441909,-0.0240171814607382,2.91052536477959e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,-0.035018870294534,0.00501723225943633,-0.0448526455230292,-0.0251850950660388,3.0966725292835e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,-0.0431616095951867,0.00618520227575845,-0.0552846060556732,-0.0310386131347001,3.16296766944105e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,42754,-0.0240646405702305,0.00345073482780845,-0.030828080832735,-0.0173012003077259,3.22843664613849e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,-0.0451335168002106,0.00648158619944561,-0.057837425751124,-0.0324296078492972,3.51073770568427e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,42711,-0.0159643471254989,0.00229448372033799,-0.0204615352173614,-0.0114671590336365,3.61777003489766e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,-0.0310245614480031,0.0044625137580356,-0.0397710884137529,-0.0222780344822533,3.79371995117772e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,-0.0369664333420228,0.00531965661973723,-0.0473929603167078,-0.0265399063673378,3.88884368789274e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,-0.0455444283504916,0.0065595034542688,-0.0584010551208584,-0.0326878015801247,4.01104080198765e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,40457,-0.0401046513341111,0.00578392676182209,-0.0514411477872824,-0.0287681548809398,4.32068483154025e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,-0.0264487238843892,0.00381727712761643,-0.0339305870545174,-0.018966860714261,4.47945145372727e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,40283,-0.0227197772895044,0.00328580083640729,-0.0291599469288627,-0.0162796076501461,4.95214735088458e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,42636,0.0215013318312737,0.00311101181141098,0.0154037486809082,0.0275989149816392,5.01658173938841e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,42357,-0.0399459832523562,0.00578078534801355,-0.0512763225344627,-0.0286156439702496,5.06490800108582e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,40223,-0.0501765672945222,0.00726341545882467,-0.0644128615938186,-0.0359402729952259,5.18157081630495e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,-0.0298151645454937,0.00431850899898181,-0.0382794421834981,-0.0213508869074894,5.32553238559202e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,40532,-0.0195328913828325,0.00284602318337511,-0.0251110968222477,-0.0139546859434173,7.0835490669833e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,42754,-0.03941141354499,0.00574410064931777,-0.0506698508176528,-0.0281529762723272,7.1248628807567e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,40136,-0.0275275932400538,0.00401278729674298,-0.03539265634167,-0.0196625301384376,7.25942345362464e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,-0.0522077213608731,0.00761281633319467,-0.0671288413739347,-0.0372866013478116,7.29636844027636e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,40199,-0.064269581389656,0.00937813605501072,-0.082650728057477,-0.045888434721835,7.61138319605455e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0293962270251567,0.00429042024106682,-0.0378054506976477,-0.0209870033526657,7.62162466225976e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,42346,-0.0444413732761369,0.00648618331935939,-0.0571542925820813,-0.0317284539701925,7.62272810805395e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.022393641895981,0.00326799235361735,-0.028798906909071,-0.015988376882891,7.64630843633307e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,-0.0183446180187464,0.00267803359352612,-0.0235935638620576,-0.0130956721754352,7.76615865010422e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,-0.0288423598986863,0.00421204387096487,-0.0370979658857775,-0.0205867539115952,7.84359997214627e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,-0.0663595000592029,0.00969615477824253,-0.0853639634245583,-0.0473550366938476,8.11547396885651e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,42594,-0.0556206520601747,0.00812914526211945,-0.0715537767739288,-0.0396875273464206,8.14146280956984e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,-0.0394770189964418,0.00577820322980857,-0.0508022973268666,-0.028151740666017,8.80903000457927e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,42587,-0.0372772928714806,0.00546502284183731,-0.0479887376414817,-0.0265658481014794,9.42454286323224e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,0.0281476595963049,0.00413816647113573,0.0200368533128789,0.0362584658797309,1.0758334521535e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,42534,-0.0473958456544396,0.00696914280427008,-0.061055365550809,-0.0337363257580702,1.08460471832127e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,-0.0360385352802773,0.00530244559894386,-0.0464313286542073,-0.0256457419063474,1.11691442949365e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,42638,-0.0345278457364551,0.00508632658141073,-0.0444970458360202,-0.0245586456368901,1.18168309104806e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0342694407228147,0.00505888392855556,-0.0441848532227836,-0.0243540282228458,1.30498502310627e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,40483,-0.0194368663273382,0.00286980589385908,-0.0250616858793019,-0.0138120467753744,1.32510117272237e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,0.0256787040313929,0.00379512598944822,0.0182402570920744,0.0331171509707115,1.37736473137896e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,40511,-0.0501088142990847,0.00740827584791612,-0.0646290349610003,-0.0355885936371691,1.40949466069459e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,-0.053560681654446,0.00792772567049677,-0.0690990239686197,-0.0380223393402724,1.48726925087772e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,42711,-0.0401202058405605,0.00594238756909627,-0.0517672854759892,-0.0284731262051318,1.52266586267819e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,40342,-0.0732980195421976,0.0108741486559492,-0.094611350907858,-0.0519846881765372,1.6554817718235e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,42754,-0.0315184692000411,0.00468697542697305,-0.0407049410369083,-0.0223319973631739,1.83010644568108e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,40302,-0.0864554373028959,0.0128823314039871,-0.111704806854711,-0.0612060677510812,2.02478084708615e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,42346,-0.064866313904905,0.00967530612737863,-0.0838299139145671,-0.0459027138952429,2.1061063027952e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,42679,-0.0379733666841636,0.0056646806444162,-0.0490761407472193,-0.0268705926211078,2.11532815820873e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,40223,-0.0453561405461781,0.00676473303501198,-0.0586150172948015,-0.0320972637975546,2.11544464263593e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,42677,-0.0288422851478602,0.00430954885131812,-0.0372890008964437,-0.0203955693992767,2.27832771163796e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,-0.0266704792329744,0.00398590810242145,-0.0344828591137204,-0.0188580993522283,2.31833663845609e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,40451,-0.0264569745463016,0.0039542972894403,-0.0342073972336045,-0.0187065518589986,2.32659986678719e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,40527,0.0333435521934424,0.00498812742680287,0.0235668224369088,0.043120281949976,2.42455039034539e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,42495,-0.0397101798375504,0.00595462192284616,-0.0513812388063288,-0.0280391208687719,2.68092872672091e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,42475,-0.0337432829589454,0.00507181337232184,-0.0436840371686962,-0.0238025287491946,2.98231050745671e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,-0.0319920032145206,0.00480952951523515,-0.0414186810643815,-0.0225653253646597,3.00772674308369e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,42636,-0.0363051347158655,0.00545927203673993,-0.0470053079078757,-0.0256049615238552,3.04051865898127e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,-0.0244751574343498,0.00368105610662653,-0.0316900274033378,-0.0172602874653618,3.09277763805276e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,40451,-0.0549776049224667,0.00827338158664443,-0.0711934328322898,-0.0387617770126436,3.16958573075966e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,40449,-0.0690569334541973,0.0103991361343516,-0.0894392402775264,-0.0486746266308683,3.2670284676207e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,42636,-0.0278913798192619,0.00420180601080994,-0.0361269196004494,-0.0196558400380744,3.30278894041014e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,40527,-0.0275144635993375,0.00415161498098187,-0.035651628962062,-0.019377298236613,3.57119336536739e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,-0.048331203273023,0.00729669607639627,-0.0626327275827597,-0.0340296789632863,3.63617852251054e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,42711,-0.0198869986828885,0.00300282961890133,-0.0257725447359351,-0.0140014526298419,3.65898997779328e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,40199,-0.0242861154749685,0.00366721027378372,-0.0314738476115846,-0.0170983833383524,3.69622413657332e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,42676,-0.0445692478866614,0.00673814697613067,-0.0577760159598775,-0.0313624798134453,3.8695812900059e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,-0.0230850584447648,0.00349339164995502,-0.0299321060786766,-0.016238010810853,4.0646739463389e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,42495,-0.0271714983740978,0.00411268952955213,-0.03523236985202,-0.0191106268961756,4.0780952976981e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,-0.028606695679931,0.00433244034860112,-0.0370982787631892,-0.0201151125966728,4.18485294404332e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,42587,-0.066794373051626,0.0101313745243465,-0.0866518671193452,-0.0469368789839069,4.47710411209533e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0270368447686318,0.00410138128705098,-0.0350755520912518,-0.0189981374460119,4.49635183959628e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,40199,-0.0360332286474254,0.00546688707514902,-0.0467483273147175,-0.0253181299801334,4.56302083516211e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,-0.0190185868680679,0.00288612511307012,-0.0246753920896854,-0.0133617816464505,4.57165283170916e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,-0.0513798840054379,0.00781449656651168,-0.0666962972758007,-0.036063470735075,5.08579863180195e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,40199,-0.0371005052525797,0.00564365204197784,-0.0481620632548563,-0.0260389472503031,5.12502451244089e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,0.0345043180785974,0.0052538384584372,0.0242067947000604,0.0448018414571343,5.30725106083643e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,42600,-0.0198810120985052,0.00302726772929253,-0.0258144568479186,-0.0139475673490918,5.31204121078923e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,-0.0670555881131787,0.0102165916098131,-0.0870801076684123,-0.0470310685579451,5.45202912112611e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.0220000799853928,0.00335892029057979,-0.0285835637549292,-0.0154165962158564,6.02043604670442e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,40449,-0.045627732821146,0.00696758682076643,-0.0592842029898482,-0.0319712626524438,6.06203029479201e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,39956,-0.0150561019630835,0.00230196888415534,-0.019567960976028,-0.0105442429501391,6.40808869781209e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,42511,0.0219560693497403,0.00336311182078078,0.01536437018101,0.0285477685184706,6.88408381883571e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,-0.0321968736823775,0.00493252537248246,-0.0418646234124431,-0.0225291239523119,6.9895850728938e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.0228705701501322,0.00351447796618081,-0.0297589469638466,-0.0159821933364178,7.91138329120089e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,-0.0178447696323804,0.00275028859352114,-0.0232353352756819,-0.012454203989079,9.05315749692175e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,-0.0379350107357427,0.00584898897679389,-0.0493990291302587,-0.0264709923412267,9.20759618628734e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,-0.0278497198036977,0.00429545844386903,-0.036268818353681,-0.0194306212537144,9.27976760547235e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,42636,-0.0775465122782729,0.0119701131268643,-0.101007934006927,-0.0540850905496189,9.59643123083864e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,42476,0.0322039236708552,0.00497437280730653,0.0224541529685345,0.041953694373176,9.88192935426075e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,-0.0880832592029187,0.0136090897760325,-0.114757075163942,-0.0614094432418949,9.98282372290885e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,-0.0596425495365873,0.00921582534053733,-0.0777055672040405,-0.0415795318691342,1.00304544908211e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,40482,0.0312752658716652,0.00483591298157812,0.0217968764277721,0.0407536553155583,1.03895835425959e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,-0.0245574375185322,0.00379785363641013,-0.0320012306458961,-0.0171136443911684,1.04090872885423e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,42794,0.0192459923774893,0.00298094590557564,0.013403338402561,0.0250886463524175,1.10909528374174e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,40451,-0.0306713925875847,0.00475168920297227,-0.0399847034254103,-0.0213580817497591,1.12786956536732e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,-0.0407153754138023,0.00631166420684187,-0.0530862372592124,-0.0283445135683922,1.15788026411791e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,-0.0537562197904519,0.00834346635903632,-0.0701094138541631,-0.0374030257267407,1.21211298839651e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,-0.0211877559711521,0.00328957377148779,-0.0276353205632681,-0.014740191379036,1.2291437242816e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,42636,-0.0159499766957745,0.00247778851611615,-0.0208064421873622,-0.0110935112041869,1.25844476951577e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,42587,-0.0600513074560036,0.00933118519456725,-0.0783404304373555,-0.0417621844746518,1.27215961074046e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,-0.0490365781106314,0.00761962606534618,-0.06397104519871,-0.0341021110225529,1.28119486570212e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,-0.0263424635636484,0.00409753290800107,-0.0343736280633305,-0.0183112990639663,1.32856855735457e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,40483,-0.0148983204554758,0.00231717539516178,-0.0194399842299928,-0.0103566566809587,1.33175053702534e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,40483,-0.0451077076051432,0.00701695085892462,-0.0588609312886354,-0.0313544839216509,1.34161677245852e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,42721,-0.0310377934361528,0.00483526952922396,-0.0405149217134317,-0.0215606651588738,1.4171081045987e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,-0.0529036853217972,0.00824730723806707,-0.0690684075084087,-0.0367389631351858,1.46796500139147e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,-0.0457892024011459,0.007141092297259,-0.0597857433037735,-0.0317926614985183,1.48405543030383e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,-0.022110875140802,0.0034530558403793,-0.0288788645879454,-0.0153428856936586,1.57088468881512e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,40257,-0.0320460493139307,0.00500708328088693,-0.0418599325444691,-0.0222321660833923,1.61510327556176e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,-0.0565250769138733,0.00884638657964491,-0.0738639946099773,-0.0391861592177693,1.72841447279287e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,-0.0432068234469732,0.00676411561578655,-0.0564644900539149,-0.0299491568400316,1.74111886768651e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,42624,-0.0477815618743282,0.0074974857370536,-0.0624766339189533,-0.0330864898297032,1.91406099201491e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,42642,-0.0433902219021011,0.00682082868424735,-0.0567590461232259,-0.0300213976809763,2.063573291864e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,-0.0700847862425784,0.0110191716559866,-0.0916823626883121,-0.0484872097968446,2.08014041903223e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,-0.0468256994253403,0.00736504832835238,-0.061261194148911,-0.0323902047017697,2.12505728392809e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,40283,-0.0452344351865477,0.00711996305994487,-0.0591895627840397,-0.0312793075890558,2.19167817621575e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,40511,-0.0521556167180067,0.0082231985936183,-0.0682730859614986,-0.0360381474745148,2.34689437798853e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,42370,-0.0472573452116075,0.00745398864064986,-0.0618671629472812,-0.0326475274759338,2.37454740905266e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,40511,-0.0297132277258757,0.00468915778581267,-0.0389039769860685,-0.0205224784656828,2.43843690814478e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,40451,-0.0256658407182212,0.00405211527441519,-0.033607986656075,-0.0177236947803675,2.48096234502395e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,42566,-0.0292496924975724,0.00462547316167283,-0.0383156198944511,-0.0201837651006936,2.63648463963213e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,-0.0309597201755544,0.00489853408438098,-0.0405608469809411,-0.0213585933701676,2.71327808595885e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.0407797817095239,0.00645251957535728,-0.0534267200772242,-0.0281328433418236,2.71734205771955e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,-0.0775779127175463,0.0122882832322138,-0.101662947852685,-0.0534928775824072,2.81960501464076e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,42611,0.0181640610107522,0.00287724359598927,0.0125246635626132,0.0238034584588912,2.82281658146662e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,40449,-0.0441396495389225,0.00699192844335885,-0.0578438292879058,-0.0304354697899391,2.84081342477279e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,0.0157934903551111,0.00250228435190824,0.010889013025371,0.0206979676848513,2.8468255653648e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,40223,-0.0380916222057609,0.00603476766727252,-0.0499197668336151,-0.0262634775779068,2.85977391559517e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,40451,-0.0226943881311447,0.00359862732211334,-0.0297476976824868,-0.0156410785798025,2.96300606272307e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,0.0158233196610425,0.00251439903429462,0.010895097553825,0.0207515417682599,3.20852657040839e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,-0.0249572951589239,0.00396901609898055,-0.0327365667129258,-0.0171780236049221,3.31688834854863e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,-0.0209104635520965,0.00332744176377934,-0.027432249409104,-0.014388677695089,3.39523158820953e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.0168711361586591,0.00268574319891504,0.0116070794887856,0.0221351928285326,3.47126480769633e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,40539,-0.0134208136397636,0.0021368016636281,-0.0176089449004747,-0.00923268237905253,3.49168568362263e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,42611,-0.0278065277787233,0.00443030757937603,-0.0364899306343003,-0.0191231249231463,3.57089973137949e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.0133368097291674,0.00212612924115087,0.0091695964165117,0.0175040230418231,3.67504612331892e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,42794,-0.0165108687702579,0.00263368752079177,-0.0216728963110098,-0.011348841229506,3.74096186491717e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,42311,-0.041980694768578,0.00669680139542046,-0.0551064255036021,-0.0288549640335539,3.75319045041363e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,42711,-0.0319423967391689,0.0050964209398987,-0.0419313817813703,-0.0219534116969674,3.77759018040403e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,-0.0196451737283716,0.00314636112706195,-0.025812041537413,-0.0134783059193302,4.39911161761017e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,42581,0.0388688646073701,0.00622861425491421,0.0266607806677382,0.0510769485470019,4.49694499702263e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.0165560917089326,0.00265391454106974,0.0113544192084359,0.0217577642094293,4.55470929216413e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,42370,0.0249934723664179,0.00401130661786992,0.0171313113953929,0.032855633337443,4.78324794956629e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,-0.0292111628403979,0.00469386110779232,-0.0384111306116708,-0.020011195069125,5.04212907768348e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,-0.0397661654805522,0.00639173776601812,-0.0522939715019477,-0.0272383594591567,5.09929647042901e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,-0.0352105589801788,0.00566000533402903,-0.0463041694348757,-0.0241169485254819,5.11963858268966e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,-0.0471617643706319,0.0075817558043983,-0.0620220057472525,-0.0323015229940112,5.13398933334847e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,40499,-0.0273166418159662,0.00439732279494343,-0.0359353944940554,-0.0186978891378771,5.41160816243723e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,-0.0401238345987871,0.00646746419681632,-0.0528000644245471,-0.0274476047730271,5.66689637896811e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,40482,-0.0484682196752993,0.0078194519185031,-0.0637943454355654,-0.0331420939150332,5.90241996554112e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,-0.0662665095765288,0.0106966226721576,-0.0872318900139576,-0.0453011291391,6.02809548938938e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,42587,-0.0200553717404225,0.00323878248257698,-0.0264033854062734,-0.0137073580745716,6.10422716002583e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,-0.0580501835882136,0.00940609360214358,-0.076486127048415,-0.0396142401280122,6.9587407821125e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-0.0659419204703718,0.0106886067005484,-0.0868915896034467,-0.044992251337297,7.05531268325648e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,-0.0248901130782749,0.00403950148613808,-0.0328075359911056,-0.0169726901654443,7.44752261925949e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,42611,-0.0153217139896044,0.00249060698309171,-0.0202033036764641,-0.0104401243027447,7.87865302850212e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,40116,-0.0298548100853593,0.00486186293088158,-0.0393840614298872,-0.0203255587408314,8.50624192619011e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,-0.0316710328174154,0.00516109399211486,-0.0417867770419605,-0.0215552885928703,8.67283626061668e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,40470,-0.019929637468425,0.00324826608260678,-0.0262962389903342,-0.0135630359465157,8.77564387464634e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,42495,0.0210383954139872,0.00343147411708948,0.0143127061444918,0.0277640846834826,8.9794893425501e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.0276745975120018,0.00451620259836517,-0.0365263546047975,-0.0188228404192061,9.15916620776907e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,0.0287674921015268,0.00469614593205754,0.019563046074694,0.0379719381283596,9.27521142187933e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,-0.0205131146822762,0.00334883024742804,-0.0270768219672352,-0.0139494073973173,9.35619126120041e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,42711,-0.0188078864930924,0.00307384799171382,-0.0248326285568514,-0.0127831444293333,9.69606323595802e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,-0.0146965163204558,0.00240568916165146,-0.0194116670772926,-0.00998136556361889,1.02990128094833e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,-0.0543245090927873,0.00889589698439422,-0.0717604671822,-0.0368885510033747,1.05149801326589e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,-0.0349418801333532,0.00572922458161762,-0.0461711603133238,-0.0237125999533827,1.09817039412835e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,42339,-0.0234229794722262,0.00384091871251813,-0.0309511801487617,-0.0158947787956906,1.10225054112658e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,42261,-0.044102689168672,0.00724028996634503,-0.0582936575027082,-0.0299117208346357,1.15150996992951e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,-0.0383422999158334,0.00629514353525268,-0.0506807812449286,-0.0260038185867381,1.15430686715468e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,-0.0145071209583599,0.00238149942524259,-0.0191748598318354,-0.00983938208488441,1.1552188903597e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,-0.040408118380689,0.00663571325024643,-0.053414116351172,-0.027402120410206,1.16329886413529e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,-0.0324324840582982,0.00532812380049691,-0.0428756067072721,-0.0219893614093242,1.18129632550073e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,42618,-0.0244544466805084,0.0040251812345136,-0.032343801900155,-0.0165650914608617,1.27050974788068e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,40054,-0.0441915824105385,0.00727403045731791,-0.0584486821068816,-0.0299344827141954,1.27940576487961e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,42676,-0.0631596494608165,0.0103993547667645,-0.0835423848036748,-0.0427769141179582,1.28581423364077e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,42754,-0.0296984743040751,0.00489179958765683,-0.0392864014958825,-0.0201105471122678,1.30449673355832e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.0332530308234132,0.005479839858601,-0.0439935169462711,-0.0225125447005552,1.32864784469725e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,-0.0657288061349309,0.0108566678340542,-0.0870078750896771,-0.0444497371801847,1.45585772372089e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,-0.047967219137522,0.00793788060776929,-0.0635254651287498,-0.0324089731462942,1.56217609310839e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,-0.0461232978766189,0.00763318027545475,-0.0610843312165102,-0.0311622645367276,1.56569982078178e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,-0.060763327656951,0.0100648484775472,-0.0804904306729436,-0.0410362246409584,1.60974676057615e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,42711,-0.0344939771753433,0.00571924722510737,-0.0457037017365538,-0.0232842526141329,1.66983341011443e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,42346,-0.034107565893822,0.00565714996142054,-0.0451955798182063,-0.0230195519694377,1.69283849614273e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,42370,-0.0321252940793213,0.00533019793359552,-0.0425724820291685,-0.0216781061294741,1.71452997124717e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,-0.0204128808493995,0.00339251504320393,-0.0270622103340793,-0.0137635513647198,1.82276125059669e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,42754,-0.0364734698449567,0.00608109291025718,-0.0483924119490608,-0.0245545277408526,2.05037575808583e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0159318154645921,0.00265625353451689,0.010725558536939,0.0211380723922452,2.05044910276692e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,40223,-0.0182973816941105,0.00305230584111185,-0.0242799011426897,-0.0123148622455313,2.10358533835166e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,42578,-0.0494105580991189,0.00824563292009235,-0.0655719986224999,-0.0332491175757378,2.12169095005643e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,-0.0684403246794394,0.0114298597506673,-0.0908428497907473,-0.0460377995681315,2.18131101117297e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,40482,-0.0328658584754419,0.00549615502297704,-0.0436383223204769,-0.0220933946304069,2.30187347142918e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,40451,-0.0365951548166803,0.00612726611623569,-0.0486045964045022,-0.0245857132288583,2.4068955435723e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,0.0353413224386013,0.00592548604136811,0.0237273697975198,0.0469552750796828,2.51828945514708e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,-0.025073150670056,0.00420344551739464,-0.0333119038841495,-0.0168343974559625,2.52247766424065e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,-0.0194247270663284,0.00325725381397561,-0.0258089445417206,-0.0130405095909362,2.54239600721039e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,-0.0577635480200403,0.00970312052823234,-0.0767816642553757,-0.0387454317847049,2.69697439792788e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,42669,-0.017749892842057,0.00298192638078117,-0.0235944685483881,-0.0119053171357259,2.70653510500581e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,-0.019258835202427,0.00323667727258598,-0.0256027226566955,-0.0129149477481585,2.744208596135e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,42711,-0.0212632685626928,0.0035825891237601,-0.0282851432452626,-0.014241393880123,3.00734166021583e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,40482,-0.0388436131239249,0.00654405328854068,-0.0516699575694646,-0.0260172686783852,3.01175191100148e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,0.0180473291784223,0.00304423844720749,0.0120806218218956,0.0240140365349489,3.14961005956485e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,0.0196635586027574,0.0033184548270545,0.0131593871417306,0.0261677300637843,3.20371590465613e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,40539,0.0163793856772513,0.00276861390182374,0.0109529024296768,0.0218058689248258,3.39190566414157e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.0207816061540578,0.0035210890490991,-0.0276829406902921,-0.0138802716178236,3.67717783385825e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,40479,-0.0182602079215877,0.00309656096608233,-0.024329467415109,-0.0121909484280663,3.80935674880633e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.0227362485174078,0.00385642160067742,-0.0302948348547355,-0.01517766218008,3.82128493854318e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.0224626463448385,0.00381930940344296,-0.0299484927755867,-0.0149767999140903,4.16877710774747e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,42587,0.0271406239515461,0.00462879955030995,0.0180681768329386,0.0362130710701536,4.64097725776393e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,42711,-0.0219157375704825,0.00373899780558044,-0.0292441732694201,-0.0145873018715448,4.69700490101293e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,-0.0233493542067617,0.00399121232771749,-0.031172130369088,-0.0155265780444355,5.0468176073939e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,42711,0.0178173475775751,0.0030481141923418,0.0118430437605852,0.023791651394565,5.17109782440774e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,42594,-0.0401801828436817,0.00689348536176866,-0.0536914141527483,-0.0266689515346151,5.71399588987317e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,-0.0282090494099758,0.00484188614105851,-0.0376991462464504,-0.0187189525735011,5.83064132492607e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,40539,-0.00991915219037433,0.00170306104690836,-0.0132571518423147,-0.00658115253843395,5.89064232735252e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,42494,-0.0404283485956457,0.00694892449507328,-0.0540482406059894,-0.0268084565853021,6.09525544643354e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,40532,-0.0471681625581738,0.00811765525371447,-0.0630787668554541,-0.0312575582608934,6.3937858564023e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,-0.0384911523674005,0.00663078877308852,-0.051487498362654,-0.025494806372147,6.58893277549866e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0337892181122234,0.0058230396560598,-0.0452023758381007,-0.0223760603863462,6.67352986653477e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,-0.0194802107256806,0.00335745296499283,-0.0260608185370666,-0.0128996029142947,6.69782416387136e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.0161596455035277,0.00278903670583927,-0.0216261574469726,-0.0106931335600827,7.06216673216933e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,-0.0550496120385809,0.0095049844469968,-0.0736793815546946,-0.0364198425224671,7.12492587282294e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,42689,-0.0327239279126029,0.00565978669883957,-0.0438171098423285,-0.0216307459828774,7.55274879601481e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.0179700637191724,0.00311115089975567,-0.0240679194826935,-0.0118722079556513,7.81693387123719e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,42711,-0.0336849901021066,0.00583244494947175,-0.0451165822030712,-0.022253398001142,7.84364750198789e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,-0.0518024808135723,0.00896970569695101,-0.0693831039795963,-0.0342218576475483,7.885665729424e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,40449,-0.0323832576469042,0.00561152310183888,-0.0433818429265084,-0.0213846723673,8.09540016843249e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,-0.0273977687265873,0.00474978227390754,-0.0367073419834461,-0.0180881954697285,8.19182473205177e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,-0.0489130832542748,0.00849437748966806,-0.0655620631340242,-0.0322641033745254,8.72306449329214e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0220272894128498,0.00382707084634484,0.0145262305540139,0.0295283482716857,8.8233656418212e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,40440,-0.0166906306174924,0.00290022198704182,-0.0223750657120944,-0.0110061955228905,8.89319127714069e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,-0.0282986753915924,0.00492376782997148,-0.0379492603383365,-0.0186480904448483,9.30005178008416e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,42585,-0.0501022741437642,0.00871902797427055,-0.0671915689733345,-0.0330129793141939,9.31956017816354e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,-0.0398724823298536,0.00694522550472519,-0.053485124319115,-0.0262598403405923,9.66170328096445e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,-0.0631934159898881,0.011022748034167,-0.0847980021368554,-0.0415888298429209,1.00796892672904e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,-0.0108037168578737,0.00189123561576167,-0.0145105386647666,-0.00709689505098087,1.13684819933454e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,-0.0274209991443905,0.00480153179094128,-0.0368320014546354,-0.0180099968341456,1.15227678260956e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,40527,-0.0159628066144114,0.0028022829384645,-0.0214552811738018,-0.0104703320550209,1.25441291592986e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.0170367181503298,0.00299120182252408,-0.022899473722477,-0.0111739625781826,1.25564190256923e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,42357,0.0133395833877825,0.00234339076829232,0.00874653748192959,0.0179326292936355,1.27919165337787e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,-0.0183443748097154,0.00322804506044222,-0.0246713431281822,-0.0120174064912487,1.35778725715606e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,42357,-0.0201660963241671,0.00354976828381292,-0.0271236421604405,-0.0132085504878938,1.36776642142054e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,-0.0443078625789207,0.00781967736288935,-0.0596344302101838,-0.0289812949476575,1.49004648661642e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,42794,0.0170266445192423,0.00300616313443145,0.0111345647757566,0.0229187242627279,1.5095673436466e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,42592,-0.0316464336051668,0.00558935323651535,-0.0426015659487368,-0.0206913012615967,1.52768137763362e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,-0.0295492712710716,0.00522256790963398,-0.0397855043739542,-0.019313038168189,1.56345521630335e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,-0.0297546397550453,0.00526011515749156,-0.0400644654637288,-0.0194448140463619,1.58098921388764e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,-0.0379810876300653,0.00672152713340587,-0.0511552808115408,-0.0248068944485898,1.63832026086687e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,42734,0.0203180842882475,0.00359724092276917,0.01326749207962,0.0273686764968751,1.65359784779585e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,42689,-0.0313772940113633,0.00556809709123257,-0.0422907643101792,-0.0204638237125475,1.78362791637984e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0371855293700403,0.0066129462818618,0.0242241546575911,0.0501469040824894,1.91265610995306e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0226524199343726,0.00402849331496826,-0.0305482668317104,-0.0147565730370348,1.91466661353002e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,-0.0317967129883802,0.00565802221356991,-0.0428864365269773,-0.0207069894497832,1.958635523063e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,-0.0119023031346357,0.00212013466999988,-0.0160577670878355,-0.00774683918143593,2.01703073594449e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,-0.0346225922528254,0.00618140795944109,-0.0467381518533299,-0.0225070326523209,2.17997976517226e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,-0.0136375662321728,0.00244103726569855,-0.0184219992729419,-0.00885313319140362,2.35814749671044e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,42346,-0.0526983842600486,0.00945082275911186,-0.0712219968679079,-0.0341747716521894,2.50870469031763e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,42679,-0.0385132767419479,0.00692702915294778,-0.0520902538817256,-0.0249362996021703,2.75128085932892e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,-0.0368463312972655,0.00664424796596921,-0.0498690573105651,-0.0238236052839658,2.98446630395505e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,-0.021154875714261,0.0038147444965379,-0.0286317749274752,-0.0136779765010467,2.98689468796152e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,0.0179341829555197,0.00324012705391749,0.0115835339298415,0.024284831981198,3.16996002819003e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,42357,-0.0314281119288629,0.00568153813694876,-0.0425639266772824,-0.0202922971804433,3.23340124350466e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,40116,-0.0362880685565792,0.00656461623757186,-0.04915471638222,-0.0234214207309384,3.31667728398318e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,-0.0332611002582492,0.00602448296312159,-0.0450690868659675,-0.0214531136505309,3.44532835151121e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,-0.0291203668321093,0.00527594572902741,-0.039461220461003,-0.0187795132032156,3.4767848772532e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,40482,-0.026607374193704,0.00482089181730497,-0.0360563221556217,-0.0171584262317862,3.48104774739312e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,42311,-0.0176374520224236,0.00320147311884778,-0.0239123393353652,-0.0113625647094819,3.67329065745296e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,42311,-0.0289147083566594,0.00524857206696241,-0.0392019096079058,-0.0186275071054131,3.67549214834925e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,-0.0157173944727582,0.00285270250676745,-0.0213086913860224,-0.010126097559494,3.67699734480728e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,-0.0343283237641373,0.00623295392683035,-0.0465449134607247,-0.0221117340675498,3.70686945017485e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,-0.0217897257165812,0.00395793531250164,-0.0295472789290844,-0.014032172504078,3.75198930924208e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,40116,-0.0361718233492512,0.00658005389392024,-0.0490687289813348,-0.0232749177171675,3.94558598527477e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.0183797904472345,0.00335125981905183,-0.024948259692576,-0.0118113212018929,4.22429735323069e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,0.0329691201134038,0.00601380786521412,0.0211820566975841,0.0447561835292235,4.27508575671301e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,42616,-0.0240377300350764,0.00439661597515267,-0.0326550973463756,-0.0154203627237772,4.65042943785475e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,-0.0424578915514999,0.00777328323377042,-0.05769352668969,-0.0272222564133099,4.79306192737855e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,40532,-0.0256767535784534,0.00470748211806238,-0.0349034185298556,-0.0164500886270511,5.01542671457946e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,40449,-0.0366258191239821,0.00672300881586789,-0.0498029164030832,-0.023448721844881,5.20608602140891e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,-0.0233119079565207,0.00430030528951562,-0.0317405063239713,-0.0148833095890701,6.04902679169053e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,-0.0418902073914657,0.00772920309014132,-0.0570394454481426,-0.0267409693347887,6.09161084856971e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,42292,-0.025450439700865,0.00469807233606976,-0.0346586614795617,-0.0162422179221683,6.16063329086809e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,-0.0537911492617861,0.0099657143844963,-0.0733239494553988,-0.0342583490681733,6.86802170499975e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,42594,-0.0189846195198318,0.0035181400217819,-0.0258801739625243,-0.0120890650771393,6.92213713777306e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,-0.0366437986128426,0.00679127011361633,-0.0499546880355306,-0.0233329091901546,6.94058140867615e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,-0.0555156800861236,0.0103034352099136,-0.0757104130975543,-0.035320947074693,7.24206977279432e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,-0.0521535660238706,0.009682646508067,-0.0711315531796819,-0.0331755788680592,7.34072214177722e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,-0.038716831980794,0.00718873153336558,-0.0528067457861905,-0.0246269181753974,7.35839848629403e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,42689,-0.0533358204666636,0.00990810725012654,-0.0727557106769116,-0.0339159302564156,7.44600375800224e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,42636,-0.0253952545798548,0.00471945161034242,-0.0346453797361259,-0.0161451294235837,7.53256112266649e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0152124776225967,0.00282943995988502,-0.0207581799439713,-0.00966677530122201,7.72269361517318e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,40283,0.0155174902415522,0.00288955782664678,0.00985395690132451,0.0211810235817799,8.02401352065882e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,42370,-0.0602791499050005,0.0112705007856304,-0.0823693314448361,-0.038188968365165,9.02178747154292e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,42311,-0.0381080909446377,0.0071256195052245,-0.0520743051748778,-0.0241418767143977,9.04044580851361e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,42134,-0.0323010600066069,0.00605070334769278,-0.0441604385680847,-0.020441681445129,9.53558403758492e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,40539,-0.0221717442888327,0.00415843298933071,-0.0303222729479209,-0.0140212156297445,9.91353236283789e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,42587,-0.0158871203188184,0.0029810907089429,-0.0217300581083465,-0.0100441825292903,1.00191436319725e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0323342361016688,0.00606753362231784,-0.0442266020014118,-0.0204418702019259,1.00303937300508e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,-0.0338352603542944,0.0063497121036519,-0.0462806960774521,-0.0213898246311367,1.00594198970447e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0201566769922969,0.00379158588434861,0.0127251686589736,0.0275881853256201,1.07677582851342e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,-0.0307344927238883,0.00578588409232324,-0.0420748255448418,-0.0193941599029347,1.1020905329997e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,-0.0258090688065926,0.00485883895257125,-0.0353323931536322,-0.0162857444595529,1.10619993323211e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,40532,-0.0143033123504967,0.00270136965498994,-0.0195979968742769,-0.00900862782671638,1.21349215057953e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,40482,-0.0303818518450146,0.00573804516676317,-0.0416284203718704,-0.0191352833181588,1.21377945269042e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,42562,-0.0401318615794086,0.00758861372594612,-0.055005544482263,-0.0252581786765542,1.25314294068893e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,42794,-0.0220305309990186,0.00416673128306689,-0.0301973243138297,-0.0138637376842075,1.26093761660299e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,-0.0368318500183284,0.00696663867101254,-0.050486461813513,-0.0231772382231439,1.26358213407608e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,-0.0301629948507979,0.00571131009613002,-0.0413571626392127,-0.018968827062383,1.30309992589215e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,-0.054000868638248,0.0102329660610213,-0.0740574821178496,-0.0339442551586463,1.33699621597986e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,40223,-0.0280414438010465,0.00531547410254552,-0.0384597730420357,-0.0176231145600573,1.34950105979911e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,-0.0181585971881942,0.00344331126579829,-0.0249074872691588,-0.0114097071072295,1.36263355038377e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,-0.0346515036702487,0.00658126926531625,-0.0475507914302685,-0.0217522159102288,1.42632145792147e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,42760,-0.0149509962990912,0.00284127322178761,-0.0205198918137949,-0.0093821007843875,1.44607010793957e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,40483,-0.0392567708013152,0.00747002998108904,-0.0538980295642497,-0.0246155120383807,1.50530099136096e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,42711,-0.0686044041926794,0.0130614022095043,-0.0942047525233079,-0.0430040558620509,1.52364450827711e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,40235,0.0183483902224623,0.00349681456879715,0.0114946336676199,0.0252021467773047,1.57313562990301e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,42677,0.021913733603037,0.00417712580713684,0.0137265670210488,0.0301009001850252,1.57681977839088e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,42594,-0.0308141395981807,0.00588243086378381,-0.0423437040911969,-0.0192845751051644,1.64487231519057e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,-0.0410572465740525,0.00783825318917971,-0.0564202228248447,-0.0256942703232603,1.64722948386957e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,42562,-0.0187548438342886,0.00358387457235243,-0.0257792379960994,-0.0117304496724778,1.6919442373066e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0134035518317069,0.00256673253750729,0.00837275605819264,0.0184343476052212,1.80105416105668e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,40418,-0.023894695935109,0.00457612656736203,-0.0328639040071386,-0.0149254878630794,1.80557734705871e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,-0.0272374911479522,0.00522147565554191,-0.0374715834328143,-0.01700339886309,1.85112896008485e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,40451,-0.0169338888046258,0.00324747361222225,-0.0232989370845814,-0.0105688405246702,1.87602453562068e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,40182,-0.0236775490300406,0.00454590395204227,-0.0325875207760435,-0.0147675772840378,1.93770267585247e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,40269,-0.0306140929043017,0.00587872570635438,-0.0421363952887563,-0.0190917905198471,1.94723152976832e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,-0.0255486091542889,0.00490651773538763,-0.0351653839156486,-0.0159318343929291,1.95294369148145e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,-0.0151286468732006,0.00290693587723747,-0.020826241192586,-0.00943105255381513,1.97567143326857e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,-0.0310058322928107,0.00595941309938166,-0.0426862819675988,-0.0193253826180227,1.99745403187263e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,-0.0533058137004333,0.0102565621662314,-0.0734086755462468,-0.0332029518546199,2.05811754559448e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,-0.0336244747773341,0.00647294333694576,-0.0463114437177478,-0.0209375058369204,2.08204800052438e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,-0.0367458485320789,0.00707513392713563,-0.0506131110292648,-0.0228785860348931,2.09219866461625e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,40482,-0.0337635238279344,0.00651264204712467,-0.0465283022402987,-0.02099874541557,2.20571225387323e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,42598,-0.0223908818736732,0.00431967333785399,-0.030857441615867,-0.0139243221314794,2.20965778696377e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,-0.0181031469725077,0.00349405000541338,-0.0249514849831179,-0.0112548089618975,2.24442370479857e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,42311,-0.0446961005047673,0.00862859394463187,-0.0616081446362457,-0.0277840563732888,2.2517636953667e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,42611,-0.0228742616986105,0.00442103015007455,-0.0315394807927566,-0.0142090426044644,2.3248083564759e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,0.0408356618375677,0.0079079283001972,0.0253361223691812,0.0563352013059542,2.45326612258521e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,-0.0218645845032032,0.00423462211187978,-0.0301644438424875,-0.0135647251639188,2.4612153697353e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,-0.0348966491342488,0.00676091076311022,-0.0481480342299448,-0.0216452640385527,2.49113920125942e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,40199,-0.022559286322307,0.00437613032371425,-0.0311365017567869,-0.0139820708878271,2.57927411468083e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,-0.0181594223891629,0.00352661109755828,-0.0250715801403772,-0.0112472646379487,2.66040867845079e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,-0.0156365797075946,0.00303954323673166,-0.0215940844515887,-0.00967907496360059,2.72891309980028e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0771110094936961,0.0150369936090257,-0.106583516967387,-0.0476385020200056,2.96783844773152e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,-0.0389711540092769,0.00760345228880862,-0.0538739204953418,-0.024068387523212,3.01856745590515e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,42495,-0.0178654029027359,0.00348788358433825,-0.0247016547280389,-0.0110291510774329,3.06324956209095e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,-0.0155169851748055,0.0030301149641051,-0.0214560105044515,-0.00957795984515954,3.09083410995645e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,-0.0330300469801333,0.00645264518772577,-0.0456772315480758,-0.0203828624121908,3.12602885612168e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,40223,-0.0242755803843123,0.00474859488952159,-0.0335828263677746,-0.0149683344008499,3.23833376244613e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,42611,-0.0376150847248667,0.00736592278283291,-0.0520522933792192,-0.0231778760705142,3.3243940652926e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,42311,-0.0176265042485071,0.00345244812279135,-0.0243933025691782,-0.010859705927836,3.34526937930832e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,40483,-0.041793837577973,0.0082130491867985,-0.0578914139840981,-0.025696261171848,3.66302869855112e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,-0.016726748119296,0.00328983793436626,-0.0231748304706539,-0.0102786657679382,3.73796084747661e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,-0.0152162771205849,0.00299300623314106,-0.0210825693375413,-0.00934998490362839,3.74655727366422e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,42509,-0.0268732512293721,0.00529028475360404,-0.037242209346436,-0.0165042931123082,3.83072979628857e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,42624,-0.0278770200290478,0.00549253244207857,-0.0386423836155218,-0.0171116564425738,3.91768514385155e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,40223,-0.0317116855907379,0.00624814783157771,-0.0439580553406302,-0.0194653158408456,3.9303811963519e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,40483,-0.0540571099360203,0.0106639773627388,-0.0749585055669884,-0.0331557143050522,4.05965787351798e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,-0.036017139777157,0.00710519238040523,-0.0499433168427513,-0.0220909627115628,4.06086416679204e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,40482,-0.0278031460928177,0.00548694786927122,-0.0385575639165893,-0.0170487282690461,4.10221540804345e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,40182,-0.0655689180275456,0.0129556746325565,-0.0909620403073563,-0.0401757957477349,4.23768743095632e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0176084793474284,0.00348109954527044,-0.0244314344561584,-0.0107855242386983,4.28564767896804e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,42580,-0.0145777963670501,0.00288759522742384,-0.0202374830128008,-0.00891810972129936,4.51329529535798e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,42346,-0.0143486878123494,0.00284372722128534,-0.0199223931660687,-0.00877498245863013,4.57815846276873e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,42705,0.0139165727198806,0.00276700425856246,0.0084932443730982,0.0193399010666631,4.98139303126943e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,42495,-0.0478101441421942,0.00950697508810289,-0.0664438153148759,-0.0291764729695125,4.99585671392097e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,42636,0.0180054821067428,0.00358349285831348,0.0109818361044484,0.0250291281090373,5.11064206515201e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,42642,-0.0470092227448884,0.00936596892216239,-0.0653665218323267,-0.0286519236574501,5.25636308863396e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,42476,-0.0314609401016662,0.00627160299863625,-0.0437532819789932,-0.0191685982243391,5.33257025707366e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,-0.0285313683148449,0.00569399773569175,-0.0396916038768007,-0.017371132752889,5.50524188792392e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,42613,-0.0194567558344824,0.00388805458150419,-0.0270773428142306,-0.0118361688547342,5.67934170086933e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,42130,-0.0124880658555669,0.00249728760606089,-0.0173827495634463,-0.00759338214768759,5.7885622832705e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,-0.0151428060961589,0.00302852065665791,-0.0210787065832084,-0.00920690560910943,5.80404456961913e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,42721,-0.0109478950477315,0.00219200631871169,-0.0152442274324064,-0.00665156266305653,5.97353513484181e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,40511,-0.0270105577055181,0.00540813269533356,-0.0376104977883719,-0.0164106176226644,5.98891814292325e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,-0.0192421199322957,0.0038542749504447,-0.0267964988351673,-0.0116877410294241,6.03804548168284e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,40166,-0.0223712196001429,0.00448529780449617,-0.0311624032969554,-0.0135800359033304,6.20450590838758e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,-0.026380916711333,0.00529190116654882,-0.0367530429977687,-0.0160087904248974,6.2701059435534e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,-0.0253494257479638,0.00508988928957875,-0.0353256087555382,-0.0153732427403895,6.42599595827921e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,-0.03859593811978,0.00775345583786055,-0.0537927115619867,-0.0233991646775733,6.50822135290943e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,40511,-0.0318911281004874,0.00642153829589559,-0.0444773431604428,-0.019304913040532,6.92471684430712e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,-0.0514368467152207,0.0103661561433111,-0.0717545127561106,-0.0311191806743309,7.06228838484875e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,-0.0469713069161593,0.00948036412055987,-0.0655528205924566,-0.0283897932398619,7.33679446037486e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,-0.0356302897142693,0.00722730632128432,-0.0497958101039866,-0.021464769324552,8.32275532855481e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0159043740293389,0.00322580473323233,0.00958179675220355,0.0222269513064743,8.32435777292672e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0260341850584275,0.00528264157248117,-0.0363881625404906,-0.0156802075763644,8.39558361465164e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,42746,-0.0106591744215449,0.00216745384339102,-0.0149073839545913,-0.0064109648884985,8.8533731221621e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,-0.0293788011882413,0.00597482032667287,-0.0410894490285201,-0.0176681533479624,8.88934082198942e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,40182,-0.0246548869540847,0.00501452979595525,-0.034483365354157,-0.0148264085540124,8.92928171439429e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,42456,-0.0201639829037663,0.00410235838171681,-0.0282046053319312,-0.0121233604756013,8.97443645560452e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,-0.0115502340680974,0.0023506644396845,-0.016157536369879,-0.00694293176631581,9.04742975311431e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,-0.0210169060919163,0.00427712706718964,-0.029400075143608,-0.0126337370402246,9.06267420167288e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0293141515320485,0.00596839454198261,0.0176160982297626,0.0410122048343344,9.14313693784838e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,40483,-0.02747972293567,0.00559641489685353,-0.0384486961335029,-0.0165107497378371,9.2240182073776e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,-0.014384341223107,0.00293093597063176,-0.0201289757255453,-0.00863970672066875,9.32024316988379e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,-0.0326275033919024,0.00665021960998422,-0.0456619338274715,-0.0195930729563334,9.3958370139188e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,42754,-0.0240933618737734,0.00491128332235628,-0.0337194771855917,-0.0144672465619551,9.41673462900586e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,40080,-0.0259345427537588,0.00528888297055992,-0.0363007533760563,-0.0155683321314614,9.54576731632794e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,-0.0368250206989588,0.00751202234945615,-0.0515485845038929,-0.0221014568940248,9.61149930306065e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,-0.0294516996229816,0.00601234825634462,-0.041235902205417,-0.0176674970405461,9.77026412620706e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,-0.0234494582606786,0.00478719822936554,-0.0328323667902351,-0.0140665497311221,9.79805427624457e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,-0.0271754552001999,0.00554856688179164,-0.0380506462885115,-0.0163002641118883,9.8095511052737e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,-0.0353220395977456,0.00721473071668676,-0.0494629118024517,-0.0211811673930396,9.90568923464934e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,40182,-0.0228192663897072,0.00466364951691365,-0.0319600194428579,-0.0136785133365564,1.00716757552538e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,-0.0263982874009655,0.00539999085048489,-0.0369822694679158,-0.0158143053340151,1.02763969047725e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,-0.0240254019729278,0.00491515143569936,-0.0336590987868985,-0.014391705158957,1.03274904553116e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.0138143095785094,0.00283187363918475,-0.0193647819113115,-0.00826383724570725,1.08307467667284e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,42214,-0.0403538773523759,0.00828592172282218,-0.0565942839291074,-0.0241134707756444,1.12810723119882e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,40511,-0.0477442235156783,0.00980917846411202,-0.0669702133053379,-0.0285182337260188,1.14660036949699e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,42587,-0.0435190381059614,0.00894772229319665,-0.0610565738006268,-0.0259815024112959,1.16520887314777e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,-0.011439804587827,0.00235367733293946,-0.0160530121603883,-0.00682659701526561,1.18458717768987e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,40408,-0.045507498809947,0.00936262659135931,-0.0638582469290113,-0.0271567506908828,1.18647499680385e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,40532,-0.0321021014478782,0.00660706582272722,-0.0450519504604236,-0.0191522524353328,1.19708352012804e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,-0.021041580932709,0.00434365099475028,-0.0295551368824195,-0.0125280249829984,1.28561661356674e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,42594,0.01324730289094,0.00273649110353958,0.00788378032800243,0.0186108254538776,1.30640732431784e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,-0.040494646074948,0.00836969258453709,-0.0568992435406407,-0.0240900486092554,1.32768577898615e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,42461,0.0326592077976728,0.00675312823201882,0.0194230764629159,0.0458953391324297,1.33857341715864e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,40116,-0.0191182192018584,0.00395475041821588,-0.0268695300215615,-0.0113669083821552,1.35475474152684e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,42746,-0.0253803757371197,0.00525204179532884,-0.0356743776559643,-0.0150863738182752,1.36321410150572e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,42636,-0.050269820793161,0.0104104797704565,-0.0706743611432556,-0.0298652804430664,1.38891359391642e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,42779,-0.0170918923028068,0.00354295420143957,-0.0240360825376284,-0.0101477020679852,1.42097901375406e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,42475,-0.0255446556701863,0.0052969091027474,-0.0359265975115712,-0.0151627138288014,1.43300234733299e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,40223,-0.0252549584857005,0.00523813693721457,-0.035521706882641,-0.0149882100887599,1.44485043924642e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,42357,-0.0681898408895282,0.0141594441611757,-0.0959423514454325,-0.0404373303336238,1.48201930156515e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,42543,-0.015716370842547,0.00327085995420374,-0.0221272563527863,-0.0093054853323077,1.56461834180991e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,-0.0127827611705186,0.00266132195422452,-0.0179989522007986,-0.00756657014023851,1.57884754127444e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,42611,-0.0130858206380176,0.00272498893654383,-0.0184267989536435,-0.00774484232239174,1.58662020966876e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,-0.0362269268683016,0.00754432611550627,-0.0510138060546939,-0.0214400476819093,1.58876997328137e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,42587,-0.0283985543662798,0.00591991874298605,-0.0400015951025325,-0.0167955136300272,1.62698591117354e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,40483,-0.0297668622506031,0.006217329669428,-0.041952828402682,-0.0175808960985242,1.70824844662437e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,-0.0319029964905967,0.00666344831849707,-0.0449633551948509,-0.0188426377863424,1.70866465864509e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,40283,-0.032273761711403,0.00674243804125449,-0.0454889402722618,-0.0190585831505442,1.7176982612606e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,0.0128198056022242,0.00268058510751031,0.00756585879150397,0.0180737524129444,1.75336763034292e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0203365581498525,0.00425323616578548,-0.028672901034792,-0.012000215264913,1.75882574919457e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,42663,-0.0109103012065672,0.00228531499666612,-0.0153895186000327,-0.00643108381310157,1.82419642362873e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,42636,-0.0601995823903813,0.0126524563206318,-0.0849983967788196,-0.035400768001943,1.97616545697009e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,40511,-0.013549866425345,0.0028617269311439,-0.019158851210387,-0.00794088164030295,2.21870144362204e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,40199,-0.0212374092146003,0.00448555291368032,-0.0300290929254137,-0.0124457255037869,2.22199326264912e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,42587,-0.0156561581993891,0.00330875808266801,-0.0221413240414184,-0.00917099235735976,2.24886740344046e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,42594,-0.0321909883266908,0.00680665540221576,-0.0455320329150337,-0.0188499437383479,2.27547168154353e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,-0.0285327378390145,0.00603411253159695,-0.0403595984009445,-0.0167058772770844,2.28393090865005e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,42462,0.0289449844839204,0.00612453345693635,0.0169408989083252,0.0409490700595157,2.31255481099724e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0285587401026381,0.00604913723171225,-0.0404150490767941,-0.0167024311284821,2.36958058388937e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,42587,-0.0215058262524345,0.00455904213054037,-0.0304415488282936,-0.0125701036765753,2.41550217166842e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,-0.0425495017228981,0.00902516288424995,-0.060238820976028,-0.0248601824697682,2.44742328180695e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.0140469785049325,0.00298066026080608,-0.0198890726161124,-0.00820488439375259,2.47376733012063e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,42563,-0.0179419577099564,0.00380962678926114,-0.0254088262169083,-0.0104750892030046,2.50654182296276e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,42771,0.0221990562305566,0.00471754402000074,0.0129526699513551,0.0314454425097581,2.55570162576467e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,-0.0189150075013766,0.00402087415970952,-0.0267959208544073,-0.011034094148346,2.57875866454058e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,-0.0216836691600195,0.00461482085502681,-0.030728718035872,-0.0126386202841669,2.64921355451987e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,40223,0.0200740882990553,0.00427793167915621,0.0116893422079091,0.0284588343902014,2.7316591951348e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,-0.0336663927214594,0.00718208726613457,-0.0477432837630832,-0.0195895016798357,2.79819963781961e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,-0.0204668255796686,0.00437083572346345,-0.0290336635976569,-0.0118999875616802,2.86654348451986e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,42594,-0.0385562152442749,0.00824725792057158,-0.0547208407685952,-0.0223915897199546,2.96770024129737e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,42654,-0.0144886885065993,0.00309960543093532,-0.0205639151512326,-0.00841346186196609,2.97724604789493e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,0.00827565439484293,0.00177352323903801,0.00479954884632842,0.0117517599433574,3.09755618128214e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,-0.0263162399074241,0.0056475188937072,-0.0373853769390902,-0.0152471028757579,3.19577414236715e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,-0.0266876558626659,0.00572940182119847,-0.0379172834322149,-0.0154580282931169,3.22361191350963e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,42689,-0.0143169519236196,0.00307749501987592,-0.0203488421625764,-0.00828506168466281,3.31621484366213e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,42636,0.0327473048307236,0.00704710251627329,0.018934983898828,0.0465596257626193,3.40131469053799e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,-0.0254159037432017,0.00546975895397884,-0.0361366312930002,-0.0146951761934031,3.40589827718968e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,-0.0293940312029568,0.00633070418398819,-0.0418022114035736,-0.0169858510023399,3.47119778226097e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,40223,-0.0410240307033113,0.00884916602412174,-0.0583683961105899,-0.0236796652960327,3.59431446285732e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,-0.0183209427381641,0.00395518337966517,-0.0260731021623078,-0.0105687833140203,3.65321940101663e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,42594,-0.0323250074925758,0.00698620525120798,-0.0460179697849434,-0.0186320452002081,3.74519414532749e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,0.0146814993730049,0.0031736750748086,0.00846109622638007,0.0209019025196298,3.76720771101125e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,42587,0.00705547871948429,0.00152621695818549,0.00406409348144073,0.0100468639575278,3.82031822940325e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,42216,-0.0351532255345639,0.00761062752630848,-0.0500700554861285,-0.0202363955829992,3.89352401205747e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,-0.0429766196484263,0.00930404095515899,-0.061212539920538,-0.0247406993763147,3.89604779266329e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,42446,-0.026189914463007,0.00567196825162824,-0.0373069722361983,-0.0150728566898156,3.92174557398298e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,40080,-0.0166985657131865,0.00361654028782333,-0.0237869846773202,-0.00961014674905279,3.93261746335066e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,-0.015803366942586,0.0034303598255667,-0.0225268722006968,-0.00907986168447531,4.12460283256144e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,-0.0354398128924058,0.00769285632285815,-0.0505178112852077,-0.0203618144996038,4.12658714851668e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,40223,-0.0418741479729167,0.00909614078453494,-0.0597025839106052,-0.0240457120352282,4.20076703896711e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,-0.0167758692243453,0.00365782916971187,-0.0239452143969806,-0.00960652405171005,4.56169164508577e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.0396482024454926,0.00865046118117505,-0.0566031063605957,-0.0226932985303895,4.61691079942327e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,-0.043470793880952,0.0094845447162039,-0.0620605015247117,-0.0248810862371924,4.61801441063351e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,-0.0237236744881755,0.00517665517072615,-0.0338699186227988,-0.0135774303535523,4.63697770342704e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,-0.0210252055929159,0.00459327448333457,-0.0300280235802516,-0.0120223876055801,4.75010524689006e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,42594,-0.0217470740094532,0.00475334359182769,-0.0310636274494355,-0.012430520569471,4.80238520891397e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.0224807645504296,0.00491615375176901,0.0128451031969623,0.0321164259038968,4.85457033651239e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,42754,-0.0281363261488955,0.00616259882667259,-0.0402150198491737,-0.0160576324486172,5.02306963297906e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,40182,-0.021982785047204,0.00483532454316814,-0.0314600211518135,-0.0125055489425944,5.51834683449092e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,-0.0470642837892843,0.0103739260057806,-0.0673971787606144,-0.0267313888179543,5.77179907802279e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,40136,-0.0245568880816251,0.00542639049637388,-0.0351926134545179,-0.0139211627087323,6.0901078146111e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,-0.0123206359879846,0.00272345900982818,-0.0176586156472478,-0.00698265632872131,6.12308566828938e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,39042,-0.0500093304947345,0.0110610977580942,-0.0716890821005992,-0.0283295788888698,6.22109762307017e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,-0.0243409266485852,0.00539390702873297,-0.0349129844249019,-0.0137688688722686,6.46751957775696e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,-0.0289904104759718,0.00642497772651362,-0.0415833668199385,-0.0163974541320051,6.47225549487931e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,42664,-0.0193153196284207,0.00428593614881373,-0.0277157544800956,-0.0109148847767458,6.64062060016009e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,-0.0235543758289192,0.00523045600931045,-0.0338060696071677,-0.0133026820506708,6.75893298971895e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,42597,-0.0209993600472834,0.00466937607665808,-0.0301513371575332,-0.0118473829370336,6.94155447784678e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,42261,-0.013819946335287,0.00307382745793297,-0.0198446481528356,-0.00779524451773838,6.98376883315362e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,-0.0232452703261118,0.00517183543864197,-0.0333820677858501,-0.0131084728663735,7.04005445649435e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,40302,-0.0237378810487499,0.00528480066636824,-0.0340960903548316,-0.0133796717426681,7.13609859770351e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,42711,-0.0289421894164548,0.00644607299009916,-0.0415764924770492,-0.0163078863558605,7.18480216985973e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,40516,-0.0159894357875089,0.00357692231671984,-0.0230002035282798,-0.00897866804673798,7.89186448209005e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,42654,-0.0381684326329337,0.00854132438702518,-0.0549094284315031,-0.0214274368343644,7.93465749247341e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,42292,-0.0271269407476294,0.00607765174720239,-0.0390391381721461,-0.0152147433231128,8.13458589684824e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,42141,0.0143764011371105,0.00322301598294698,0.00805928981053446,0.0206935124636866,8.24410950751439e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,42636,0.0209864624797884,0.00470752476714326,0.0117597139361876,0.0302132110233892,8.33715658988298e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,42611,0.0106812225747383,0.00239963061683614,0.00597794656573945,0.0153844985837371,8.60826076887846e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,-0.0292901960856734,0.00658171299990003,-0.0421903535654775,-0.0163900386058694,8.66101172151545e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,42495,-0.0353726034188139,0.00796424564044541,-0.0509825248740869,-0.0197626819635409,9.00857787829009e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.018254476629349,0.00411346153286284,-0.0263168612337601,-0.0101920920249378,9.17663270974204e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.014085290545687,0.00318548773987857,-0.020328846515849,-0.00784173457552504,9.86958147756847e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,40223,-0.0339002021994415,0.00766688365101817,-0.0489272941554371,-0.0188731102434459,9.88917489020072e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,42654,-0.0246045938062957,0.00557487119815964,-0.0355313413546886,-0.0136778462579028,1.02512617930539e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.0251179889717173,0.0056917423944751,0.0139621738785461,0.0362738040648885,1.02716498368303e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,40199,-0.0177046207954526,0.00401618569406405,-0.0255763447558182,-0.00983289683508711,1.05164435836914e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,40302,-0.0240777190366764,0.005470739324546,-0.0348003681127866,-0.0133550699605663,1.0866767365777e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,40483,-0.0292955649390361,0.00666101120814814,-0.0423511469070065,-0.0162399829710658,1.10220199429358e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,42679,-0.0138310412413324,0.00314514152118366,-0.0199955186228524,-0.00766656385981245,1.10298175095637e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,-0.0170546009842166,0.0038804117498499,-0.0246602080139225,-0.00944899395451084,1.11759219597869e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,42590,-0.0132869474208689,0.00302346395702369,-0.0192129367766354,-0.00736095806510251,1.11824813257435e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,-0.0166861421699367,0.00379987778198824,-0.0241339026226337,-0.00923838171723976,1.13739064818247e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,-0.0384804368327511,0.00876513558009451,-0.0556601025697363,-0.0213007710957658,1.14295105319701e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,-0.0154422081287079,0.00352421968191654,-0.0223496787052644,-0.00853473755215152,1.18827750427203e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,42771,-0.0134921681639544,0.00308053964297996,-0.0195300258641951,-0.00745431046371367,1.19674365188178e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,42594,0.0189067883320565,0.00431700148763223,0.0104454654162974,0.0273681112478157,1.19793382191401e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,42552,-0.0107208038083597,0.00244810749373382,-0.015519094496078,-0.00592251312064143,1.20010617822281e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,42587,-0.0336077762219305,0.00768521892440177,-0.0486708053137579,-0.018544747130103,1.23452716627721e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,42638,-0.0148090800509334,0.00338815054033216,-0.0214498551099844,-0.00816830499188234,1.24695699719146e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,-0.0163969329325495,0.00375180030554738,-0.0237504615314223,-0.00904340433367659,1.25155312042413e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",40539,-0.0073136979129296,0.00167920442450799,-0.0106049385849653,-0.00402245724089393,1.33957125898216e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,-0.0300528659751316,0.00690774143755931,-0.0435920391927478,-0.0165136927575153,1.36994342312339e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,42495,-0.02354544638725,0.00541357320080081,-0.0341560498608196,-0.0129348429136804,1.37567194462117e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,-0.0326716379841647,0.0075121409959183,-0.0473954343361645,-0.0179478416321648,1.37676638025868e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,42346,-0.0254589482739564,0.00586287425360499,-0.0369501818110222,-0.0139677147368906,1.41988950974601e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,-0.0177733726277291,0.00409940507697678,-0.0258082065786036,-0.0097385386768546,1.46628504804501e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,40116,-0.0187941091015271,0.00433578207261547,-0.0272922419638535,-0.0102959762392008,1.47297808379119e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,-0.0251944607282353,0.00581418602531933,-0.0365902653378611,-0.0137986561186094,1.48179335437091e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,42292,-0.0384008876245017,0.00887207649580434,-0.0557901575562782,-0.0210116176927252,1.51389224994141e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,-0.0348777150041404,0.00806168676497578,-0.050678621063493,-0.0190768089447879,1.52936859012709e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,40451,-0.0182136640385182,0.00421252688630976,-0.0264702167356853,-0.00995711134135105,1.54760429026764e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,-0.0503904328295515,0.0116583762002411,-0.073240850182024,-0.0275400154770791,1.55768524598455e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,0.0260450003452185,0.00602694495360174,0.0142321882361591,0.0378578124542779,1.56350941999814e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,-0.0269055674255055,0.00622800818534546,-0.0391124634687826,-0.0146986713822284,1.57107665850814e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.00932596544207564,0.00215988373904862,-0.0135593375706109,-0.00509259331354035,1.58934735161624e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,42476,-0.0345051727682188,0.00799346714291249,-0.0501723683683273,-0.0188379771681103,1.59546872195376e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,-0.0450700438094187,0.0104539631394923,-0.0655598115628237,-0.0245802760560138,1.63687913573208e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,42346,-0.0166842955112386,0.00387395926299709,-0.0242772556667129,-0.00909133535576428,1.66848346216569e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,42711,-0.0342207310178808,0.00794867796577373,-0.0498001398307973,-0.0186413222049643,1.68002415949237e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,40451,-0.017410774262906,0.00404829734368017,-0.0253454370565191,-0.00947611146929288,1.71644691126763e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,42676,-0.039133035022002,0.00911864726527261,-0.0570055836619363,-0.0212604863820677,1.78676803299763e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,40182,-0.0346244482915389,0.00807284093474153,-0.0504472165236323,-0.0188016800594455,1.81010111628024e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,0.0207743509374823,0.00484621645191243,0.0112757666917339,0.0302729351832306,1.82601996466583e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,40532,0.0250620388197664,0.00584891007577103,0.0135981750712552,0.0365259025682776,1.84323938484629e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,0.0117633141717636,0.00274978030304865,0.00637374477778822,0.0171528835657389,1.90215863864455e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.0174927726038536,0.00409066391350079,-0.0255104738743152,-0.00947507133339208,1.91609360204389e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,-0.0189075866964534,0.00442229970562613,-0.0275752941194806,-0.0102398792734261,1.92020795651219e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,40182,-0.0291274830035243,0.00681473097362529,-0.0424843557118299,-0.0157706102952187,1.93448010500645e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,-0.0621154534365957,0.0145532596892232,-0.0906398424274732,-0.0335910644457183,1.98717634797185e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,40302,-0.0147183620412908,0.00345089064339105,-0.0214821077023372,-0.00795461638024431,2.01474654710913e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,42721,-0.0462165190974915,0.0108440654149655,-0.0674708873108238,-0.0249621508841592,2.04052484100904e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,-0.026732750541161,0.00627431194103475,-0.0390304019455891,-0.0144350991367329,2.05240368812141e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,0.0218372556469832,0.00512587312766136,0.0117905443167669,0.0318839669771994,2.0590301974534e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,-0.0145324823820353,0.00341637286744508,-0.0212285732022277,-0.00783639156184298,2.11609615000744e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,40483,-0.0301353442720125,0.00709433486619275,-0.0440402406097503,-0.0162304479342747,2.17606933668264e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,40483,0.015888832984746,0.0037416273849434,0.00855524331025689,0.023222422659235,2.18871477223435e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,-0.0293099469058811,0.00690285181772065,-0.0428395364686136,-0.0157803573431486,2.19332142188976e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,40283,-0.0312284724002449,0.00735866507236932,-0.0456514559420887,-0.016805488858401,2.21584575583181e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,-0.0183301417717034,0.00432605586941287,-0.0268092112757526,-0.00985107226765415,2.2789336485685e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.0137722105994651,0.00325186526712769,-0.0201458665230354,-0.00739855467589487,2.29898540652965e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,0.0367375284991986,0.00868386608887898,0.0197171509649958,0.0537579060334014,2.34663490640159e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,-0.012049820458421,0.00284949700633815,-0.0176348345908438,-0.00646480632599823,2.36837060879433e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,40451,-0.0168393321737032,0.00398833557898532,-0.0246564699085145,-0.00902219443889203,2.43889299093485e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,-0.0168311123052682,0.00398662491726609,-0.0246448971431097,-0.00901732746742665,2.4415467213742e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,-0.0449427367735634,0.0106611827058794,-0.0658386548770871,-0.0240468186700398,2.51107095084142e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,40199,-0.0240850532332991,0.0057142429075755,-0.0352849693321471,-0.0128851371344511,2.51866458729372e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,-0.0192737905184122,0.00457664780591354,-0.0282440202180027,-0.0103035608188217,2.55557423275762e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,40223,-0.0127694478395013,0.00303454644666573,-0.0187171588749661,-0.00682173680403647,2.59651880677272e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,-0.0348658065512768,0.00829284592218836,-0.051119784558766,-0.0186118285437876,2.63564676617061e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,-0.018104851023334,0.00430863145684348,-0.0265497686787472,-0.00965993336792078,2.66315197766786e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,-0.0229983503158064,0.00547656750278457,-0.0337324226212642,-0.0122642780103487,2.6934221496323e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,42370,-0.0201943071583221,0.00482651802788314,-0.029654282492973,-0.0107343318236711,2.88239652167478e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,-0.0203090260899139,0.00485731023910955,-0.0298293541585686,-0.0107886980212592,2.9231864672996e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,40283,-0.0320716973771554,0.00767081729935475,-0.0471064992838907,-0.0170368954704201,2.9245815667468e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,42594,-0.0149471763426981,0.00357776194286701,-0.0219595897507174,-0.00793476293467873,2.96206597470671e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,-0.0219849212293445,0.00526202168586861,-0.0322984837336469,-0.011671358725042,2.96248972781963e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,-0.0387331803626734,0.00927503237368336,-0.0569122438150928,-0.020554116910254,2.98479640082623e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,0.00657990093076389,0.00157668853990386,0.00348959139255232,0.00967021046897546,3.02536509777906e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,-0.0160064885736607,0.00384605460456629,-0.0235447555986106,-0.00846822154871076,3.17762018802538e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.0122623286524642,0.00294730107975124,-0.0180390387687766,-0.00648561853615177,3.19855411863279e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.017173341155641,0.00414709938164568,0.00904502636761548,0.0253016559436666,3.47861193755462e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,-0.0352275018088068,0.00850950869178162,-0.0519061388446988,-0.0185488647729148,3.49752215400467e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,40102,-0.0225782674975038,0.00545365264442867,-0.033267426680584,-0.0118891083144236,3.49878127343781e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,-0.0238919206088285,0.0057877968710139,-0.0352360024760157,-0.0125478387416412,3.68218292361749e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,-0.0155077916460214,0.00376102613943711,-0.0228794028793181,-0.00813618041272461,3.75747531372467e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,-0.0276106246348908,0.00670350630646714,-0.0407494969955664,-0.0144717522742152,3.83510277143259e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,42638,-0.0100719010865141,0.00244973561359418,-0.0148733828891587,-0.00527041928386955,3.95563528721285e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,-0.0311496992695436,0.00759264049629314,-0.0460312746422781,-0.016268123896809,4.10915027085284e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,-0.027440817568867,0.00669054281281626,-0.0405542814819868,-0.0143273536557471,4.13478585491353e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,-0.0179067704645502,0.0043685741935624,-0.0264691758839325,-0.00934436504516789,4.17437039572044e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,0.0178404167921731,0.00435243031798058,0.00930965336893114,0.026371180215415,4.17976350384636e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,40283,-0.0128359461522171,0.00313194250132679,-0.0189745534548176,-0.00669733884961655,4.18982470288621e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,-0.034425258796868,0.00841013166706356,-0.0509091168643126,-0.0179414007294234,4.27802612568883e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,40532,0.0108914000539839,0.00266077847528144,0.00567627424243226,0.0161065258655355,4.2820008931935e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.0147828212619482,0.00361226926495298,-0.0218628690212561,-0.00770277350264041,4.29489930290448e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,42676,-0.0176567225235887,0.0043176080090282,-0.0261192342212839,-0.00919421082589339,4.34872906207676e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,42495,0.017287528571923,0.0042285382863704,0.008999593530637,0.025575463613209,4.37102647038411e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,40451,0.0472583369773374,0.0115743357533436,0.0245726389007839,0.069944035053891,4.4760058685188e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,40449,-0.0238945712401019,0.00585368843618734,-0.0353678005750291,-0.0124213419051747,4.49644187827063e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,-0.0253022244494673,0.00622216801463778,-0.0374976737581573,-0.0131067751407772,4.80667823470482e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,-0.0133172328889029,0.00327689865832998,-0.0197399542592296,-0.00689451151857609,4.85700691374401e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,0.00820231702276166,0.00201847239017595,0.0042461111380168,0.0121585229075065,4.85894721159184e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,42681,-0.0295781549581287,0.00728298438196218,-0.0438528043467746,-0.0153035055694829,4.90827255679872e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,-0.0118243780732771,0.00291292845568771,-0.017533717846425,-0.00611503830012914,4.95048400265242e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,42611,0.0127950679562815,0.0031560860563146,0.00660913928590484,0.0189809966266581,5.06131866544773e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,42554,-0.033860698016886,0.00835554958432719,-0.0502375752021673,-0.0174838208316047,5.09644032130175e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,42592,-0.0267703873818469,0.00661044598792888,-0.0397268615181875,-0.0138139132455063,5.15699011859754e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,42370,-0.0316657682360972,0.00782109525770067,-0.0469951149411905,-0.0163364215310039,5.17833510034092e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,42357,-0.0199993193579321,0.00494526557156798,-0.0296920398782053,-0.0103065988376589,5.28161271273907e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,-0.0457973162497724,0.0113384576773028,-0.068020693297286,-0.0235739392022588,5.39522187951374e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,-0.0219304679691073,0.00543532966429472,-0.0325837141111249,-0.0112772218270896,5.50183381973563e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,-0.0336826175191374,0.00835424761433221,-0.0500569428432285,-0.0173082921950462,5.5716179996226e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,-0.0364536037591687,0.00904211572943751,-0.0541761505888662,-0.0187310569294712,5.57770064360444e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,42311,-0.0246977823127213,0.00612718833043845,-0.0367070714403807,-0.012688493185062,5.5889276184096e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,40449,-0.0125301877744018,0.0031092426373512,-0.0186243033436101,-0.00643607220519341,5.61485314692371e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,42261,0.0358985434234195,0.00891253006758744,0.0184299844909482,0.0533671023558909,5.66019182627593e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,-0.0120396202189059,0.00299783089760217,-0.0179153687782061,-0.00616387165960562,5.94871012797568e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,40483,-0.0229554124144627,0.00572487771377378,-0.0341761727334593,-0.0117346520954661,6.11705272351325e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.0150802297190339,0.00376421055925897,-0.0224580824151815,-0.00770237702288631,6.20329114338867e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,40223,-0.0116715201242674,0.00291464133201787,-0.0173842171350224,-0.00595882311351242,6.25708631366686e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,-0.0167869642199099,0.00420341012227742,-0.0250256480595737,-0.00854828038024619,6.54906440920612e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,42594,-0.0266684514589232,0.00668729660335022,-0.0397755528014896,-0.0135613501163567,6.70070498069833e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,40251,-0.0131873389987167,0.00330723794651082,-0.0196695253738779,-0.00670515262355553,6.72261726247947e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,40223,-0.0205937822593928,0.00516661517236516,-0.0307203479972285,-0.0104672165215571,6.76484418708887e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,-0.010856341784262,0.00272775331691066,-0.0162027382854069,-0.00550994528311713,6.93570749772536e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,-0.0208261653787424,0.00523486241053782,-0.0310864957033965,-0.0105658350540882,6.97533724778978e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,42679,-0.0277091194645309,0.00697348734527092,-0.0413771546612619,-0.0140410842677999,7.11941405721079e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,40449,-0.0173667454422707,0.00437051933408065,-0.0259329633370687,-0.00880052754747258,7.12326476076157e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,40116,-0.0231775066656056,0.00583963767782867,-0.0346231965141498,-0.0117318168170614,7.26376527877443e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,40199,-0.0106769850531919,0.00269071913220682,-0.0159507945523172,-0.00540317555406648,7.29142872391077e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0132071592510628,0.00332917081436675,-0.0197323340472217,-0.00668198445490401,7.31301767857476e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,-0.0129158173996187,0.00326343133572442,-0.0193121428176386,-0.00651949198159887,7.61253353054186e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,40199,0.0175139467729905,0.00442927281571544,0.00883257205418824,0.0261953214917928,7.72927809868588e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0140775252905032,0.00356318622890585,-0.0210613702991586,-0.00709368028184769,7.83576347870134e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,-0.0136712061703793,0.00346163980446222,-0.0204560201871253,-0.00688639215363336,7.87708594284236e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,42346,-0.016933955850318,0.00428903721185496,-0.0253404687855538,-0.00852744291508232,7.91527554074484e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,40267,-0.0403188975149728,0.0102118408604586,-0.0603341056014717,-0.020303689428474,7.92119048224825e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,-0.0181195393130643,0.00458962779517709,-0.0271152097916113,-0.00912386883451716,7.92285118552897e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,-0.0267304202342476,0.00678224562391943,-0.0400236216571297,-0.0134372188113655,8.1560102523047e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,-0.0232782161961063,0.00591774360232222,-0.0348769936566578,-0.0116794387355547,8.41021735287644e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.0204020831664494,0.0051894856814201,0.010230691230866,0.0305734751020328,8.48711507176709e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,40483,-0.0274708238613403,0.00699520857491195,-0.0411814326681677,-0.0137602150545129,8.64907049381629e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,-0.0345784384366635,0.00880797180563045,-0.0518420631756992,-0.0173148136976278,8.69645555294151e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,42370,-0.025769372451846,0.00657068628743614,-0.0386479175752208,-0.0128908273284711,8.83100691236901e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,40511,-0.0117571177919543,0.0030021360099213,-0.0176413043714,-0.00587293121250853,9.04647264344259e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,42311,-0.017844554496832,0.00455927941513707,-0.0267807421505007,-0.00890836684316338,9.1276912769853e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,40199,-0.0175147322877476,0.00447643794084045,-0.0262885506517948,-0.00874091392370028,9.18383403946544e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,-0.0317111907970574,0.00810571589606756,-0.0475983939533498,-0.015823987640765,9.20075975152134e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,-0.0168268593017072,0.00430288093351019,-0.0252605059313872,-0.00839321267202722,9.26197272090868e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),40324,0.0713899603151786,0.0182774079709284,0.0355662406921589,0.107213679938198,9.44252565899655e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,40449,-0.0139478689482871,0.00357239962947688,-0.0209497722220617,-0.00694596567451236,9.50336256541661e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,40483,-0.0529240125116583,0.0135610345032787,-0.0795036401380845,-0.026344384885232,9.569675009564e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,42594,-0.0233887962519117,0.00599407689381311,-0.0351371869637854,-0.011640405540038,9.58736670372474e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,40511,-0.020870591361471,0.00535074660697965,-0.0313580547111511,-0.0103831280117909,9.65490155393988e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.0199728104894266,0.00512398366456994,-0.0300158184719837,-0.0099298025068695,9.75905235864218e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,40451,-0.0190525024126021,0.00489420817949224,-0.0286451504444069,-0.0094598543807973,9.9638070489139e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,-0.0152682290891724,0.00392392753705051,-0.0229591270617914,-0.00757733111655336,0.000100400741415165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,42572,-0.0172592285941571,0.00443790181939048,-0.0259575161601625,-0.00856094102815181,0.000101123477152023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,-0.00914090139630082,0.00235137771400834,-0.0137496017157572,-0.00453220107684447,0.000101781333785318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,40483,-0.0180173413181018,0.00464541659402248,-0.0271223578423858,-0.0089123247938177,0.000105690222099414
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,-0.0327574681404564,0.00844842526791618,-0.0493163816655721,-0.0161985546153407,0.000106211480279009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,40532,-0.0283311736177475,0.00731327127638143,-0.0426651853194552,-0.0139971619160399,0.000107692165042928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,-0.026188656426783,0.00677462399921003,-0.0394669194652347,-0.0129103933883314,0.000111392284089121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,-0.0159078132541084,0.00412380862665524,-0.0239904781623527,-0.00782514834586412,0.000115164272721593
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,-0.0245226102356042,0.00635800804913691,-0.0369843060119126,-0.0120609144592959,0.000115439292720023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,40527,-0.0319396719938321,0.008281788476418,-0.0481719774076114,-0.0157073665800528,0.000115603964085025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.0121065984583658,0.00314033026653207,-0.0182616457807686,-0.00595155113596291,0.000116167689318008
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,-0.0227717153035472,0.00590989671824577,-0.0343551128713089,-0.0111883177357855,0.000117255474511295
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.0187411425033588,0.00486434511715531,-0.0282752589329832,-0.00920702607373436,0.000117339294790242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,40532,-0.00926076234798114,0.00240471009776507,-0.0139739941396007,-0.00454753055636161,0.000118238596454923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,42370,-0.0113126780403609,0.00294358813367168,-0.0170821107823574,-0.00554324529836441,0.000122030851723088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,-0.00963253399950322,0.00251095310038216,-0.0145540020762523,-0.00471106592275418,0.000125518885626177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,42778,-0.00913676891032136,0.00238231916896103,-0.013806114481485,-0.00446742333915774,0.000126007876904711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,40539,0.00856059340978887,0.00223590317570392,0.00417822318540919,0.0129429636341685,0.000129516749234456
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,40539,-0.00789329645997128,0.00206382363954952,-0.0119383907934883,-0.00384820212645423,0.000131686940540472
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,40284,0.0118786135051256,0.00311106344049542,0.00578092916175458,0.0179762978484966,0.00013516939734931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,42495,-0.0135981774837595,0.00356267402306436,-0.0205810185689657,-0.00661533639855337,0.000135781128888757
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,-0.0416622897430283,0.0109196337928367,-0.0630647719769883,-0.0202598075090683,0.000136608588244565
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",42311,-0.0207065980801415,0.00542810903260099,-0.0313456917840395,-0.0100675043762436,0.000136974694637983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,-0.0372263002329784,0.00977027159278868,-0.0563760325548442,-0.0180765679111126,0.000139509063742518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.112876096351253,0.0296507965721751,-0.170991657632717,-0.0547605350697903,0.000141374563061615
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,40199,-0.0161662319586844,0.00424805232556725,-0.0244924145167962,-0.00784004940057258,0.000142248406731414
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,40527,-0.016809393085891,0.00441834293921518,-0.0254693452467528,-0.00814944092502925,0.000142862802438279
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,40109,0.0239820163716539,0.00630928402258044,0.0116158196873963,0.0363482130559116,0.000144857430783017
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,40527,-0.020989604197459,0.00553115994211472,-0.0318306776840039,-0.0101485307109142,0.000148536138815183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,-0.0234843460124302,0.00619305540582757,-0.0356227346078523,-0.0113459574170082,0.000150190394965732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,42311,-0.0273504644757463,0.00722119895568308,-0.0415040144288852,-0.0131969145226075,0.000152835163970831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,-0.0205337540349474,0.00542542287505309,-0.0311675828700515,-0.00989992519984336,0.000154691166234786
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,42495,-0.0374237998723601,0.00988885944190357,-0.0568059643784911,-0.0180416353662291,0.000154730827811735
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,0.010581114690721,0.00280543153930682,0.0050824688736796,0.0160797605077623,0.000163012628463347
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0172342932808307,0.004573800595289,-0.0261989424475971,-0.00826964411406421,0.000165226475011928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,-0.0339719352520138,0.00902214670781718,-0.0516553427993354,-0.0162885277046921,0.000167128515391567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,-0.0323971225065686,0.00860477249540064,-0.0492624765975538,-0.0155317684155833,0.000167381989529845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.0123055814996361,0.00327019542220241,-0.0187151645271528,-0.00589599847211935,0.000168648967149355
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,42611,-0.0174254017242212,0.00463621049941742,-0.0265123743030794,-0.00833842914536309,0.000171629416223431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,42663,-0.00939342599111989,0.00250331843288372,-0.014299930119572,-0.0044869218626678,0.00017589210799165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,-0.0343351555237044,0.00916036509448323,-0.0522894711088916,-0.0163808399385173,0.00017899613536562
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,-0.0182953655985455,0.00489576074521522,-0.0278910566591674,-0.00869967453792369,0.000187161377776136
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,40482,-0.00965992148597127,0.00258868826454527,-0.01473375048448,-0.00458609248746255,0.000191208896615591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,40539,0.0118128551344873,0.00316743056144944,0.00560469123404639,0.0180210190349282,0.000192813160694167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,42495,0.0126132172241084,0.00338428789924168,0.00598001294159471,0.0192464215066221,0.000194580623272322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,42546,-0.0208584646949389,0.00559838143725618,-0.031831292311961,-0.00988563707791678,0.000195497162883393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,40283,-0.020246468041473,0.00543744983991842,-0.0309038697277131,-0.00958906635523288,0.000197435258874321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,42711,-0.0232335290042511,0.00625067735713954,-0.0354848566242446,-0.0109822013842575,0.000202446558428767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,40449,-0.02813444483683,0.00757059950970452,-0.0429728198758508,-0.0132960697978091,0.000203159333282649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.00782551720923149,0.00210925960206402,0.00369136838918602,0.011959666029277,0.000208213465667518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,-0.0159716531316078,0.00432009925243111,-0.0244390476663728,-0.00750425859684287,0.000218977358196495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,42370,-0.0121911191832279,0.00330093997746861,-0.0186609615390664,-0.0057212768273894,0.000222321447183947
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,40466,-0.0241823502563382,0.00656559630624954,-0.0370509190165873,-0.0113137814960891,0.000231409006153293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,-0.0114184420835411,0.00310907149254979,-0.0175122222089387,-0.00532466195814354,0.00024121043473471
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,40182,-0.0180052585241302,0.00490337543160162,-0.0276158743700694,-0.00839464267819107,0.000241788921303866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,42454,0.00912038645594052,0.00248419923907151,0.00425135594736037,0.0139894169645207,0.000242211929875445
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,42689,-0.0182456561991444,0.00497514469021336,-0.0279969397919626,-0.00849437260632618,0.000246007560783218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,42594,-0.0340143315379437,0.00927779958677488,-0.0521988187280224,-0.0158298443478649,0.000247126518428876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,-0.0104351358772865,0.00284756133384298,-0.0160163560916188,-0.00485391566295426,0.000248870441553773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,40116,-0.0199380249955105,0.00545093562811597,-0.0306218588266178,-0.00925419116440315,0.000255660291648212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,40302,-0.0110421019844887,0.00302047052290559,-0.0169622242093836,-0.00512197975959369,0.000257608898755057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,40471,-0.0308080103281472,0.00842973632593351,-0.0473302935269769,-0.0142857271293175,0.000258669534064486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,-0.0392499782786442,0.0107474264114855,-0.0603149340451557,-0.0181850225121326,0.000261347247457633
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,42674,-0.021623797396325,0.00592256958373087,-0.0332320337804375,-0.0100155610122124,0.000262124076959229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,42475,0.0119179383587033,0.00326767873538272,0.00551328803735314,0.0183225886800534,0.00026610844899709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,-0.0260314198392307,0.00713882067919008,-0.0400235083704432,-0.0120393313080181,0.000266870763868897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0237871414266703,0.00653371258761906,-0.0365932180984037,-0.010981064754937,0.000272930241846487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00861976168553975,0.00236883200139519,0.00397685096280517,0.0132626724082743,0.000274914403826635
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0176777328598677,0.00486593410245341,0.00814050201905897,0.0272149637006763,0.000281459292843226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0192970027989577,0.00532469448299124,-0.0297334039856206,-0.0088606016122949,0.000291294397881016
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,-0.0241242570583498,0.00666426174148271,-0.0371862100716559,-0.0110623040450437,0.000295748956748958
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,-0.0220296206581935,0.00609531364978366,-0.0339764354117695,-0.0100828059046175,0.000302598920963576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,42754,-0.00986080552791414,0.00273005120945504,-0.015211705898446,-0.00450990515738226,0.000305002153512945
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,42311,-0.0165291853581542,0.00458213812137463,-0.0255101760760485,-0.00754819464025989,0.00031053960881393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,42292,-0.0132001709248549,0.00365971841489987,-0.0203732190180587,-0.00602712283165118,0.000311051831165781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,-0.0413661665063901,0.0114889474124044,-0.0638845034347026,-0.0188478295780775,0.00031873109281612
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,42461,-0.0210360356948814,0.00584440952536945,-0.0324910783646055,-0.00958099302515727,0.000320184397584397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.00921048858923334,0.00255978507203246,0.00419330984804972,0.014227667330417,0.000321640936746048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,42611,0.0236895271755292,0.00659430165757253,0.010764695926687,0.0366143584243713,0.000328788238038165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,42594,-0.0239581283245876,0.00667504947648079,-0.0370412252984899,-0.0108750313506853,0.000332870570027888
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,-0.0300665658767243,0.00838623276464402,-0.0465035820954265,-0.013629549658022,0.000337968401465408
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,40283,0.0196633441500787,0.00548581528423879,0.00891114619297064,0.0304155421071867,0.000339307303796376
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,40223,-0.0158327120897475,0.00441868813268369,-0.0244933408298075,-0.00717208334968743,0.000340971527259647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.0083267202674456,0.00232454978427306,-0.0128828378446208,-0.0037706026902704,0.000342068394230823
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,-0.014743388102988,0.00411920340562631,-0.0228170267780155,-0.0066697494279604,0.000346118024055674
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.0136276043809408,0.00381114605862803,-0.0210974506558518,-0.00615775810602989,0.000350720206370791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.0160026790769743,0.0044827468732675,0.00721649520537002,0.0247888629485786,0.000358444040625668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,-0.0393931726071428,0.0110367200160059,-0.0610251438385145,-0.0177612013757712,0.000359204818883573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,42679,-0.0205335954010059,0.00575436653241343,-0.0318121538045362,-0.00925503699747558,0.000360482825995114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,-0.0103503134087397,0.00290598915185079,-0.0160460521463673,-0.00465457467111215,0.000369729102768346
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,40449,-0.0129485632436374,0.00363756513454405,-0.0200781909073437,-0.00581893557993106,0.000372839112312584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,-0.0136119564757601,0.00382985515999404,-0.0211184725893484,-0.00610544036217176,0.00038074830104233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,40014,-0.0287771156158366,0.00809742778362287,-0.0446480740717374,-0.0129061571599358,0.000381240535742421
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,-0.0278618770777792,0.0078422118850523,-0.0432326123724817,-0.0124911417830767,0.000382461213324577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,40182,-0.0148796331560039,0.00419745833415764,-0.0231066514909529,-0.00665261482105494,0.000394372146346584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.0104518364988388,0.00295734864965322,-0.0162482398521591,-0.00465543314551848,0.000410660875713903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,40199,0.0109015166098958,0.00308905735392892,0.00484696419619512,0.0169560690235965,0.000418716106713406
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,42587,0.0272314875331405,0.00771826238716482,0.0121036932542975,0.0423592818119835,0.000419815026936993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.0122782560432629,0.00348103166995651,-0.0191010781163776,-0.00545543397014813,0.000421393384521088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,-0.0214669385101459,0.00609507586182282,-0.0334132871993186,-0.00952058982097313,0.000429707082992459
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,42370,-0.0298814568662604,0.00848599226858641,-0.0465140017126898,-0.013248912019831,0.000430939240749232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,-0.0197779946515701,0.00562987180865429,-0.0308125433965325,-0.00874344590660765,0.0004447848236925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,42347,-0.015142174858498,0.00431272502287647,-0.0235951159033359,-0.00668923381366014,0.000447842544518021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,42676,0.0225450087061109,0.00642229606498448,0.00995730841874128,0.0351327089934805,0.000448846626162607
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,-0.0146516773923056,0.00417659814027411,-0.0228378097472429,-0.00646554503736838,0.000453217267687656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,-0.00978084315027861,0.00279273362952105,-0.0152546010641399,-0.00430708523641735,0.000462846455823689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,-0.0111948286445095,0.0031969146729238,-0.0174607814034402,-0.00492887588557886,0.000464023746041569
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,40223,-0.00796074673026196,0.00227447382470634,-0.0124187154266864,-0.00350277803383754,0.000467027219586435
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,40199,0.00919637772656173,0.00263001398806104,0.00404155030996209,0.0143512051431614,0.000472903403912423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,0.0119254554200203,0.00341696575236725,0.00522820254538051,0.0186227082946601,0.000484792560848247
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,42636,0.0118613751879428,0.00340080358426006,0.00519580016279307,0.0185269502130925,0.000488541036987089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,-0.0120137654818503,0.00344837319857228,-0.0187725769510519,-0.00525495401264858,0.000496054827336782
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,42611,-0.013414682038737,0.00385228203297519,-0.0209651548233683,-0.00586420925410561,0.000498767144511395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,-0.0196397264027788,0.00564261633964153,-0.0306992544284762,-0.00858019837708141,0.000501870187369983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.0158118405912337,0.00454948385450824,0.00689485223639751,0.0247288289460698,0.000511772286507436
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,-0.0306330606302735,0.00881634097137354,-0.0479130889341656,-0.0133530323263813,0.000513279220844076
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.0108983441473115,0.00314612200297394,0.00473194502148254,0.0170647432731404,0.000534069806018159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,-0.0209832776119295,0.00608700981529538,-0.0329138168499084,-0.00905273837395056,0.00056844101055868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,-0.0165207277581639,0.00479842341200887,-0.0259256376457013,-0.00711581787062651,0.000577495272943373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,42587,-0.0306317700763948,0.00890604071802195,-0.0480876098837178,-0.0131759302690718,0.000584699974328576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,-0.0151060868985113,0.00440087827291384,-0.0237318083134224,-0.00648036548360015,0.000599847159741428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,40199,-0.00745195492500817,0.00217262326205273,-0.0117102965186315,-0.00319361333138481,0.000605942960626844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,42370,-0.0313765451804603,0.00914974824843344,-0.0493100517473898,-0.0134430386135307,0.000607161015527266
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,-0.0274019568675001,0.00799362663978981,-0.0430694650814881,-0.011734448653512,0.000610326896613619
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,42721,-0.0101750982259786,0.00296874879383223,-0.0159938458618898,-0.00435635059006742,0.000611198075259995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,40283,0.00759251777352634,0.00221700655866734,0.00324718491853836,0.0119378506285143,0.000617773510078441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,42666,0.00948269887408329,0.0027729018072186,0.00404781133193483,0.0149175864162317,0.000628588328693942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,42311,-0.0168627448266966,0.0049391023282158,-0.0265433853899996,-0.00718210426339367,0.000641792865275577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,40449,-0.0149856570725145,0.00439851029040704,-0.0236067372417123,-0.0063645769033167,0.00065914677038027
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,40483,-0.0284401763419693,0.00834814580115304,-0.0448025421122292,-0.0120778105717093,0.000659668381571331
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,-0.0194770193357006,0.00573205162504288,-0.0307118405207847,-0.0082421981506166,0.000680975883035629
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,42370,-0.0273971670351857,0.00807065935804322,-0.0432156593769504,-0.011578674693421,0.000689157917082565
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,40482,-0.00933751776096563,0.00275682957903225,-0.0147409037358688,-0.00393413178606243,0.000708898669582112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,-0.0178345708153172,0.00527010365769091,-0.0281639739843914,-0.007505167646243,0.00071655056728495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,42311,-0.0242188415222446,0.00715962031518992,-0.0382516973400169,-0.0101859857044724,0.000719870482045476
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,42597,-0.0345281501352971,0.0102264084431318,-0.0545719106838354,-0.0144843895867589,0.000736574487576299
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,40283,-0.0190772587603837,0.00565280911904871,-0.0301567646337192,-0.00799775288704825,0.000741150806170982
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,40532,-0.0307357675897608,0.00911227430367813,-0.04859582522497,-0.0128757099545517,0.000746008171079901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,40451,-0.0237171371932978,0.00703663012369716,-0.0375089322357443,-0.0099253421508514,0.000752773210728949
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,40483,0.0264127024517923,0.00784322090921221,0.0110399894697364,0.0417854154338483,0.000760833804846195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,42370,-0.016110089887768,0.00478413588693202,-0.0254869962261547,-0.0067331835493812,0.000760982206726442
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,0.0237791522712557,0.00707599737563866,0.00991019741500396,0.0376481071275075,0.000780497376058926
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,-0.0192008341520908,0.00571737163667951,-0.0304068825599826,-0.00799478574419894,0.000786771204252079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,-0.0277431686335879,0.00827279077396846,-0.043957838550566,-0.0115284987166097,0.000800040922948343
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,-0.00736353982196799,0.00219923361781282,-0.0116740377128811,-0.00305304193105487,0.000815517725500901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,42676,-0.0259011005394853,0.00773833561557552,-0.0410682383460133,-0.0107339627329573,0.000818805778325346
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,-0.0360618144337659,0.0107746505522409,-0.0571801295161581,-0.0149434993513736,0.000819845666412943
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,-0.0126883590298641,0.00379276929533918,-0.0201221868487289,-0.00525453121099929,0.00082391632193982
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,40532,-0.0231381298592623,0.00691978026595551,-0.0367008991805351,-0.00957536053798949,0.000829170489326848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,-0.0402395704307636,0.0120464945403812,-0.0638506997299109,-0.0166284411316164,0.000839069045504914
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,42679,-0.0115240506803029,0.0034522427488092,-0.0182904464679689,-0.00475765489263684,0.000845712130582015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,-0.0298136933579576,0.00893630152972536,-0.0473288443562193,-0.0122985423596958,0.000851915878107585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,42357,-0.0147697839850342,0.00443174337663723,-0.0234560010032432,-0.00608356696682523,0.000862368185841213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,40250,-0.0218879133499634,0.00656957488190976,-0.0347642801185066,-0.00901154658142031,0.000865973800955242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0216608762049591,0.00650509035167012,0.00891089911568566,0.0344108532942325,0.000871309481682465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,-0.0186031647620415,0.00558807772012364,-0.0295557970934839,-0.00765053243059922,0.000874185230073238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,40404,-0.0160853075077779,0.00484284898006422,-0.0255772915087038,-0.00659332350685203,0.00089835524251282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,42605,-0.0374938662722577,0.0112891130538806,-0.0596205278578637,-0.0153672046866518,0.000898574619029908
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,-0.0104697073905722,0.00315271887242813,-0.0166490363805313,-0.00429037840061304,0.000899879928795623
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,42357,-0.0225448814269686,0.00679318536869293,-0.0358595247496067,-0.00923023810433043,0.000906668565374495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,42311,-0.0141960026359325,0.00428263359171729,-0.0225899644756984,-0.00580204079616658,0.000919628391407697
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,42587,-0.0181216142554945,0.00547725556667196,-0.0288570351661716,-0.00738619334481749,0.000940375162099438
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,40436,-0.0290875396374136,0.00879860078104591,-0.0463327971682635,-0.0118422821065636,0.000949590076612831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,42563,-0.021429179273932,0.00649536045872472,-0.0341600857730325,-0.0086982727748316,0.000972310035495531
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.0210182069392505,0.0063734948459856,0.00852615704111874,0.0335102568373823,0.000977716305356214
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.0109102742555705,0.00330989835127263,0.00442287348707612,0.0173976750240648,0.000982363907373373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,-0.0271482824425091,0.0082485595788279,-0.0433154592170117,-0.0109811056680064,0.00100045762158622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,40449,-0.0335226257859082,0.0102017308336925,-0.0535180182199455,-0.0135272333518709,0.001019412329157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,42636,-0.021952303152716,0.00668328055727609,-0.0350515330449772,-0.00885307326045487,0.00102366732953725
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,-0.00834810756981139,0.00254407046052471,-0.0133344856724398,-0.00336172946718295,0.00103606383904619
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,-0.01494692280427,0.00455584884030439,-0.0238763865312666,-0.0060174590772734,0.00103770117468431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,42636,0.0122759287821294,0.00375302123457727,0.00492000716235794,0.0196318504019008,0.00107458431213794
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.0377391902546835,0.0115380084315899,-0.0603536867805997,-0.0151246937287672,0.00107491643350437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.0110070349185246,0.00336726816606615,-0.0176068805240143,-0.00440718931303498,0.00108323034250591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,-0.0182131943003358,0.00557481989521942,-0.0291398412949659,-0.00728654730570578,0.00109008522312308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,40463,-0.0320916269982423,0.00983234071803495,-0.0513630148055908,-0.0128202391908938,0.00110223415407608
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,40080,-0.0120865318435717,0.0037076403336955,-0.0193535068976149,-0.00481955678952851,0.00111794363932722
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,40527,0.0172369567745244,0.00529605730763529,0.0068566844515592,0.0276172290974895,0.00113854286707767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,42679,-0.0179956773129121,0.0055321490050353,-0.0288386893627813,-0.0071526652630429,0.00114503757310434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,42311,-0.0117982076257853,0.00362780496307132,-0.0189087053534051,-0.00468770989816551,0.00114820293800427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,40482,-0.0244535630978373,0.00753248163418819,-0.0392172271008462,-0.00968989909482846,0.00117209168207729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,42711,-0.0242418058862982,0.00746980154923305,-0.038882616922795,-0.0096009948498014,0.00117609109556783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,42679,0.00910059136988595,0.00280667337476918,0.00359951155533837,0.0146016711844335,0.00118780930816566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,42676,-0.0115300857525954,0.00356148688796816,-0.018510600053013,-0.00454957145217786,0.00120900540309246
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,40539,-0.00600170260150377,0.00185492644608328,-0.00963735843582701,-0.00236604676718054,0.00121757737419719
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,40449,-0.0197094809266618,0.00610144077446446,-0.0316683048446121,-0.00775065700871148,0.00124015817729292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,-0.0112151138689193,0.00348169215463686,-0.0180392304920076,-0.0043909972458311,0.00127974065301082
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,42594,-0.011641281196552,0.00362398370732391,-0.0187442892629068,-0.00453827313019709,0.0013199322940276
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",40302,-0.0146474395396926,0.00456106334711207,-0.0235871237000323,-0.00570775537935298,0.00132462023893068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,-0.0263725983288051,0.00821326772381937,-0.0424706030674911,-0.0102745935901191,0.00132656971554929
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,0.0227216870000213,0.00709175845795643,0.00882184042242672,0.0366215335776159,0.0013592949292144
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,-0.0221589190518313,0.00691770779237426,-0.0357176263248848,-0.00860021177877771,0.00136291511117665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,42346,-0.0176926647770783,0.00553102100189731,-0.0285334659407971,-0.00685186361335959,0.00138324983632135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,-0.0277998154085647,0.00869107449030788,-0.0448343214095681,-0.0107653094075612,0.00138449056957538
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,42700,-0.029633890460381,0.00926861879871657,-0.0478003833058655,-0.0114673976148966,0.00139074764541446
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,42586,-0.0214971693044962,0.00673135404343059,-0.0346906232296201,-0.00830371537937224,0.00140841821215737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,-0.037715207409948,0.011827676182146,-0.0608974527269541,-0.0145329620929419,0.001432286447865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,42551,-0.0192073743276843,0.00602453106831548,-0.0310154552215826,-0.00739929343378593,0.00143494498708643
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,40080,-0.0177800340168666,0.00558063569315388,-0.0287180799754483,-0.00684198805828503,0.00144650207816721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,40527,-0.0311998878220205,0.00981614459893239,-0.050439531235928,-0.011960244408113,0.00148475000067308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,42292,-0.0228372281534955,0.00719026350795667,-0.0369301446290906,-0.00874431167790043,0.00149598939892723
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0192313986283901,0.00605793498994604,0.00735784604809582,0.0311049512086843,0.00150393247944389
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,40482,-0.009330660003738,0.00293954785514518,-0.0150921737998226,-0.00356914620765344,0.00150662820852036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,0.00582795986274702,0.00183777610864687,0.00222591868979914,0.00943000103569489,0.00152214303647883
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,42543,0.0158761894659543,0.00500794950470236,0.00606060843673764,0.0256917704951709,0.00152679501737026
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,42711,0.00739963869181056,0.00233624221942316,0.00282060394174116,0.01197867344188,0.00154190351467773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,-0.0410541084015185,0.0129739600776,-0.0664830701536145,-0.0156251466494225,0.00155776859370967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,40182,-0.0217999454155155,0.00689071671331813,-0.0353057501736191,-0.008294140657412,0.00156218451225214
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,-0.0174018231711793,0.00550828555173526,-0.0281980628525804,-0.0066055834897782,0.00158629585425683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,-0.00951694371525302,0.0030180951610162,-0.0154324102308448,-0.00360147719966128,0.00161794747162924
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,0.00847334513251136,0.00268749571093972,0.00320585353906951,0.0137408367259532,0.00162020937699302
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,42495,-0.0137766226563268,0.00437559389327801,-0.0223527866871518,-0.00520045862550195,0.00164465182656341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,42524,-0.0136194396453478,0.00432806541737765,-0.022102447863408,-0.00513643142728765,0.00165446508141126
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,42611,-0.00838062510552069,0.00266353108719582,-0.0136011460364245,-0.00316010417461689,0.00165635874535499
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,-0.0170635326721273,0.00542453712379389,-0.0276956254347633,-0.00643143990949128,0.001661655140534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,-0.0283879677632411,0.00902776314815862,-0.046082383533632,-0.0106935519928502,0.0016679313993676
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,-0.0232161698984767,0.00739476720421703,-0.0377099136187421,-0.00872242617821133,0.00169656493986737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,42370,-0.0176906027528823,0.00563943728322285,-0.0287438998279991,-0.00663730567776555,0.00171094261215601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,-0.0303754382912397,0.00970354952635246,-0.0493943953628905,-0.0113564812195889,0.00175047630507903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,-0.0271765472550935,0.00868438123694111,-0.0441979344794981,-0.0101551600306889,0.00175644913762953
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,42311,-0.0141810539267824,0.00453425581974046,-0.0230681953334737,-0.00529391252009107,0.00176663116810364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,42604,-0.0285782246742594,0.00913852395228862,-0.0464897316207451,-0.0106667177277737,0.00176842011732009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.0123074078815484,0.00393701195994601,-0.0200239513230425,-0.00459086444005417,0.00177619035149866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,40283,-0.0214044570800581,0.00685174199218877,-0.0348338713847481,-0.00797504277536807,0.00178904388751437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,42679,-0.0192621498104185,0.00617541941665845,-0.031365971867069,-0.00715832775376789,0.00181746737194056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,42636,-0.0120481427894469,0.00386891387746761,-0.0196312139892834,-0.00446507158961039,0.00184901414405792
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,-0.021396257958508,0.00687497050499785,-0.0348712001483038,-0.00792131576871224,0.00186172136619528
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0080050377704296,0.00257232531942978,0.00296328014434723,0.013046795396512,0.00186223973942912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,42611,0.0138669505985472,0.00446127712244815,0.00512284743854883,0.0226110537585456,0.00188565665510642
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,42679,-0.021524414472893,0.00693622436234733,-0.0351194142230938,-0.00792941472269225,0.00191843246855763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00494107729023033,0.00159315370851269,0.00181849602154546,0.0080636585589152,0.00192973187024472
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,-0.0227382252731761,0.00733210990090348,-0.0371091606789469,-0.00836728986740528,0.00193234376040251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,40527,0.0304870336415828,0.00984866811713665,0.0111836441319949,0.0497904231511706,0.00196928006371011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,-0.034988300497243,0.0113235995706087,-0.057182555655636,-0.0127940453388499,0.00200740002250969
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,40116,-0.0119565174625728,0.00387133512063362,-0.0195443342990147,-0.00436870062613087,0.00201692159890394
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,42636,-0.0200330215038484,0.00649000094846034,-0.0327534233628307,-0.00731261964486617,0.00202768188960418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,-0.0144662419252959,0.0046879993297076,-0.0236547206115228,-0.00527776323906901,0.00203426674978081
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,40539,0.0060105244685612,0.00195075994473811,0.00218703497687451,0.00983401396024789,0.00206717664870343
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,-0.0358683539869716,0.0116909594941149,-0.0587826345954369,-0.0129540733785064,0.00215993998170825
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,42587,0.00853212609993968,0.00278156471235518,0.00308025926372352,0.0139839929361558,0.00216372343384349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,-0.0234107869176998,0.00763889851826134,-0.0383830280134921,-0.00843854582190762,0.00218424839728254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,-0.0254568130096041,0.00831110669989048,-0.0417465821413894,-0.00916704387781878,0.00219571420729263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,42277,-0.0227445280082879,0.00744022995218243,-0.0373273787145655,-0.00816167730201031,0.00224040843675361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,40080,0.0145934648286825,0.00477621816895266,0.00523207721753526,0.0239548524398297,0.00225271785970157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,-0.0110509047200887,0.00362799926119869,-0.0181617832720381,-0.00394002616813925,0.00232438928453021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,42448,-0.020542012822188,0.00675086363165129,-0.0337737055402245,-0.00731032010415144,0.00234790859014359
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0218608196530272,0.00719728390489285,-0.0359674961066172,-0.00775414319943722,0.00239195329330657
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,-0.0127341279401583,0.00419771143858125,-0.0209616423597776,-0.0045066135205391,0.00242127030392966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,40451,0.0169816970541435,0.00560353639908184,0.00599876571194308,0.0279646283963439,0.00244677662946701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,-0.0220400546893893,0.00728537784468494,-0.0363193952649718,-0.00776071411380678,0.00248989257478515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.0151932608620123,0.00502295459318139,-0.0250382518646478,-0.00534826985937679,0.0024938709213846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,40283,0.00967326545123192,0.0032013758387293,0.00339856880732249,0.0159479620951413,0.00252019134004107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0197379456971899,0.00653598230090368,-0.0325484710069611,-0.00692742038741872,0.00253339321675493
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,40482,-0.0189351267021074,0.00628444451598607,-0.0312526379534401,-0.00661761545077474,0.00259239553977393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,-0.0260235346818309,0.00867134178613095,-0.0430193645826476,-0.00902770478101421,0.00269612236775068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,0.0357977930618021,0.0119360768940132,0.0124030823495363,0.059192503774068,0.00271256663473502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,-0.0111611988619677,0.00372461224837427,-0.0184614388687813,-0.00386095885515416,0.00273609826602208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,42480,-0.0141115959528556,0.00471261133324,-0.023348314166006,-0.00487487773970524,0.00275462384985683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,40532,0.0175722268238929,0.00588336217661735,0.00604083695772293,0.0291036166900629,0.00282548185148447
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,42679,-0.00654566991830939,0.00219334169388824,-0.0108446196383303,-0.00224672019828844,0.00284703292143901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,-0.0253262416830958,0.00849327471515498,-0.0419730601247996,-0.00867942324139205,0.00287061055550353
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,40451,-0.0245698434628713,0.00824089646217965,-0.0407220005287435,-0.00841768639699922,0.0028749814139718
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,-0.0204864240198591,0.00687246599322334,-0.0339564573665768,-0.00701639067314132,0.00287996339441162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,0.0122364005082478,0.00410560090137174,0.0041894227415592,0.0202833782749364,0.00288373721686857
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,-0.0271823190885018,0.00912046975598219,-0.0450584398102269,-0.00930619836677676,0.00288535407988167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,40483,-0.0275454608718377,0.00925690884883496,-0.0456890022155543,-0.00940191952812122,0.00292973262963701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,0.0145467377794111,0.00489299297102564,0.00495647155620087,0.0241370040026214,0.00295454723263077
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,-0.0136206928118141,0.0045861544560025,-0.022609555545579,-0.00463183007804916,0.00298486692631971
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,42611,-0.0152865019489297,0.00515295595667265,-0.025386295624008,-0.00518670827385127,0.00301692105934539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,40136,0.0125231224390363,0.00422653093157795,0.0042391218131435,0.0208071230649291,0.00305332994381488
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,40509,0.0107813737757347,0.00363893361889942,0.00364906388269185,0.0179136836687776,0.00305504841641401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,42679,0.00837871126772756,0.00282881315153821,0.00283423749071267,0.0139231850447425,0.00306262751303321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,-0.0210983156709048,0.00713100450262231,-0.0350750844960445,-0.00712154684576504,0.00309515212875713
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,42594,0.0274857428569474,0.00929398400345328,0.00926953421017898,0.0457019515037158,0.00310817683231453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,42434,-0.0222059893132475,0.00751579840322538,-0.0369369541835693,-0.0074750244429258,0.00313651187484598
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,40116,0.0118865900161934,0.00403397083444313,0.00398000718068487,0.0197931728517019,0.00321943721389493
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,42611,-0.02170019508195,0.00736820265932559,-0.0361418722942281,-0.00725851786967182,0.00323390104282909
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,40532,0.00744746816043892,0.00252875934695654,0.0024910998404041,0.0124038364804737,0.00323498302543366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,42311,-0.0151372887172835,0.00514561109844248,-0.0252226864702307,-0.00505189096433621,0.00326895560457039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,-0.0223337145959675,0.00760118457922314,-0.0372320363712448,-0.00743539282069009,0.00330825046880869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,42611,-0.0192391455105677,0.00655774771968899,-0.0320923310411581,-0.0063859599799773,0.00335402513841324
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,-0.00683839800323072,0.00233211019260911,-0.0114093339807446,-0.00226746202571687,0.00337058460750214
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,-0.0209706231693043,0.00715179366888615,-0.0349881387603212,-0.00695310757828744,0.0033711533936466
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,42679,-0.0164991775139268,0.00564764788950588,-0.0275685673773583,-0.00542978765049527,0.00349012459175569
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,42346,-0.015114275369324,0.00519379121835796,-0.0252941061573056,-0.00493444458134237,0.00361958237192877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,42328,0.0349182330035076,0.0120030227574146,0.011392308398975,0.0584441576080403,0.00363055541930294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,-0.00678012221893003,0.00233277834577726,-0.0113523677766535,-0.0022078766612066,0.00366254075766876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,40283,-0.0246626134557957,0.00849078969535113,-0.0413045612586839,-0.00802066565290752,0.00368412193115618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,40460,-0.0267737924270216,0.00922048664520899,-0.0448459462516312,-0.008701638602412,0.0036946352692966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,42346,-0.0167447926413893,0.00577232204800307,-0.0280585438554754,-0.00543104142730332,0.00372737411697282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,40283,-0.0334717651826077,0.0115450328036694,-0.0561000294777997,-0.0108435008874158,0.00374808083572787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,40283,-0.0311217756566537,0.0107351970971326,-0.0521627619670337,-0.0100807893462737,0.00375040199753574
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,-0.0111126748800986,0.00383341741790361,-0.0186261730191897,-0.00359917674100756,0.00375201536749331
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,42794,-0.0250046852341541,0.00863255773602209,-0.0419244983967574,-0.00808487207155082,0.00377884972146877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,40527,0.00742704983085894,0.00256421008194735,0.00240119807024214,0.0124529015914757,0.00378159249723865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,40479,0.0138851434650314,0.00479585115376682,0.00448527520364843,0.0232850117264144,0.00379594617198306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,-0.0109722137934194,0.00379058446758658,-0.0184017593498891,-0.00354266823694969,0.00380386289453823
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,42636,-0.0101407575882593,0.00350475126801436,-0.0170100700735675,-0.00327144510295118,0.00381669639370169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,-0.0163416780298113,0.00565560771144318,-0.0274266691442399,-0.00525668691538263,0.00386660316737518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,0.0102452582696266,0.00354636486759304,0.00329438312914421,0.0171961334101089,0.00387287544923902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,40419,0.00989117497709599,0.00342497974103352,0.00317821468467028,0.0166041352695217,0.00388500747143948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,-0.0140645259370098,0.00487722059139379,-0.0236238782961416,-0.00450517357787797,0.00393771527407511
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,40267,0.0087546433695158,0.00303998306035881,0.00279627657121253,0.0147130101678191,0.00398648839352663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,40283,-0.0165279361506036,0.00574090809618154,-0.0277801160191195,-0.00527575628208784,0.00399731851090255
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,0.0129115778375798,0.00449001224216012,0.00411115384294597,0.0217120018322136,0.00403986731731375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,-0.0251337133227713,0.0087432627149006,-0.0422705082439765,-0.0079969184015661,0.00405128227293184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,-0.0201623746813804,0.00702678840662579,-0.0339348799583669,-0.00638986940439382,0.00412066879985987
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,-0.00831016882346431,0.00289788346812931,-0.0139900204209977,-0.00263031722593087,0.00414276702226821
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,-0.0111440973467877,0.00388696524194216,-0.0187625492209944,-0.00352564547258108,0.00415114181454773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00789208348954882,0.00275343031635425,0.00249536006949449,0.0132888069096031,0.00415978430036656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,42618,-0.00697612491897256,0.00243464832499763,-0.0117480356359679,-0.0022042142019772,0.00417192498172759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.0185062298867765,0.00646475827449142,0.00583530366877333,0.0311771561047797,0.00420934691181284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,-0.0337944420359307,0.0118548026941506,-0.0570298553164658,-0.0105590287553955,0.00437041159643431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,42618,-0.0104609380359198,0.00366988146319327,-0.0176539057037786,-0.003267970368061,0.00437192791879685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,42573,-0.0197280927872523,0.00692183010406968,-0.0332948797912288,-0.00616130578327569,0.00437686045275464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,40539,0.00658781109829287,0.00231268502921656,0.0020549484410284,0.0111206737555573,0.0043997225364805
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,-0.0166825390221407,0.00586423512740411,-0.0281764398718528,-0.00518863817242869,0.00445080511117433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,-0.0252551075421612,0.00888276651587793,-0.042665329913282,-0.0078448851710405,0.00447493766604074
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,-0.0103117601463064,0.00363875305120951,-0.017443716126677,-0.00317980416593577,0.00460570029899944
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,-0.0133299196759804,0.00470488739698661,-0.0225514989740741,-0.0041083403778866,0.00461652329979858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,0.011099517412757,0.00392044012650917,0.00341545476479899,0.0187835800607149,0.00464596764919264
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,42237,0.0198882204893151,0.00702782569720409,0.00611368212279504,0.0336627588558351,0.00466300324032844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,42611,-0.0253982849944334,0.00898075975345384,-0.0430005741112029,-0.00779599587766385,0.0046897847717808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,-0.0194479969827915,0.00688835062512675,-0.03294916420804,-0.00594682975754309,0.00476150378270892
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,-0.0187150150438921,0.00663387147091203,-0.0317174031268797,-0.00571262696090453,0.00479383178787042
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,42311,0.0149840120827464,0.00531931154800858,0.0045581614486496,0.0254098627168432,0.00485608347831147
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,40116,-0.0113329941060896,0.00402474409545871,-0.0192214925331887,-0.00344449567899054,0.00487386259000616
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,40285,-0.00605703822850437,0.00215293014451132,-0.0102767813117466,-0.00183729514526219,0.00491079612185245
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,-0.0253797219973362,0.00902762823952463,-0.0430738733468045,-0.00768557064786796,0.0049423035489321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0156664324044944,0.00557711950253613,0.00473527817952354,0.0265975866294652,0.00497592174139334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,-0.0306613632519722,0.0109152991749622,-0.052055349634898,-0.00926737686904637,0.00497630806402927
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,-0.00584500851917576,0.00208166810707436,-0.00992507800904151,-0.00176493902931001,0.00499614889771928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0139479809337919,0.00496980841873019,-0.023688805434503,-0.00420715643308068,0.00501640425164986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,-0.0064667391627838,0.00230489259193169,-0.0109843286429699,-0.00194914968259769,0.00502853560367084
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,40199,-0.0093669081532854,0.00334655749602807,-0.0159261608455004,-0.00280765546107038,0.00513553981929637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,0.00889745173995508,0.00317985316849852,0.00266493952969798,0.0151299639502122,0.00514984728120425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,0.0192663827069005,0.00689965005309067,0.00574306860284277,0.0327896968109582,0.0052411418580126
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,0.0111111425894733,0.00398024040731471,0.00330987139113648,0.0189124137878101,0.00525422979243361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,0.0133776009660014,0.00479671479421057,0.00397603996934866,0.0227791619626541,0.0052977769216012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,42357,-0.0216055922770622,0.00776743127699383,-0.0368297575799701,-0.00638142697415429,0.00541749389580782
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,-0.0169462022978002,0.00610141917619459,-0.0289049838831416,-0.00498742071245881,0.00548852411791159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,40235,-0.0116025109566936,0.00417977779907964,-0.0197948754428897,-0.00341014647049749,0.00551472618202703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,-0.0222275036049863,0.00802556060453922,-0.0379576023898832,-0.00649740482008944,0.00562221435646517
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,40199,-0.0174629981290946,0.00631011033716526,-0.0298308143899385,-0.00509518186825073,0.00565888087986917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,-0.0212326853967202,0.0076774475057525,-0.0362804825079951,-0.00618488828544533,0.00569122137537125
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00782404904192111,0.00283865735987512,-0.0133878174672764,-0.00226028061656587,0.00585621511438756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,-0.0131988145329982,0.00478881826785334,-0.0225848983379908,-0.00381273072800569,0.00585623867662384
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,-0.0137623632202949,0.00501338677463745,-0.0235886012985843,-0.00393612514200546,0.00605863780306241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,40483,0.0116013567578589,0.00422700054868242,0.00331643568244133,0.0198862778332764,0.00606834750633353
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,-0.0124749578779345,0.00455201555010381,-0.021396908356138,-0.00355300739973107,0.00614205406877527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,42311,-0.0100917683182174,0.00368292911478333,-0.0173103093831927,-0.00287322725324208,0.00614947086855163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,40302,-0.0204093336718391,0.00745039782627133,-0.0350121134113309,-0.00580655393234729,0.00616568446020731
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,40511,-0.00737047988405026,0.00269374146551609,-0.0126502131564618,-0.00209074661163872,0.00622596798796345
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00839895161046426,0.00307523911384853,0.00237148294732115,0.0144264202736074,0.00631970321817549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,-0.0186951381914798,0.00684582823753567,-0.0321129615370497,-0.0052773148459099,0.00632480433918091
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,42249,-0.0282498324926354,0.0103468895875655,-0.0485297360842639,-0.00796992890100696,0.00633667957091966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,42311,-0.0285100890641044,0.010443444481441,-0.0489792402477287,-0.00804093788048007,0.0063428317627399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,42346,-0.0180083369662202,0.00660051260888637,-0.0309453416796375,-0.00507133225280292,0.00637415891812958
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,42311,0.00969873895246714,0.00355819743640531,0.00272467197711272,0.0166728059278215,0.00642416790280769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,42548,-0.0111257836560296,0.00408488068174444,-0.0191321497922487,-0.00311941751981049,0.00646488956536057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0141910581212273,0.0052160916253742,0.00396751853549391,0.0244145977069608,0.00652432012155091
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,-0.0152097986679105,0.00559721448176005,-0.0261803390521602,-0.00423925828366076,0.00658841747032683
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,-0.0143599119530277,0.00528429165326885,-0.0247171235934346,-0.00400270031262074,0.00658855259052396
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,-0.0239743996759514,0.0088229291755919,-0.0412673408601115,-0.00668145849179122,0.00659244375095893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,40451,-0.0143178419633986,0.00527552667488661,-0.0246578742461764,-0.00397780968062087,0.00665750032651484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,-0.0155602654536458,0.00574087725349267,-0.0268123848704914,-0.00430814603680019,0.00672824972075079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,40199,-0.00805285950411121,0.00297236171921542,-0.0138786884737734,-0.00222703053444898,0.00675406647453542
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,-0.00616178653936562,0.00227953816240718,-0.0106296813376837,-0.00169389174104755,0.00688018833954656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,-0.0262283449418528,0.00972710206568047,-0.0452934649905865,-0.00716322489311907,0.00701931040789728
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,40361,-0.0146882209722957,0.0054524512978679,-0.0253750255161168,-0.00400141642847464,0.00707322454806263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,-0.0180454626965528,0.00671067822549852,-0.03119839201853,-0.00489253337457574,0.00717573155000479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,0.0113926006348074,0.00424072498394806,0.00308077966626922,0.0197044216033456,0.00723200207352896
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,40199,-0.0134213167548965,0.00499601936444039,-0.0232135147091997,-0.00362911880059337,0.00723345620212778
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,40483,-0.0077186382606638,0.00288445622893367,-0.0133721724693738,-0.0020651040519538,0.00746270455764365
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,42721,-0.0115205434034275,0.00430967050905079,-0.019967497601167,-0.00307358920568791,0.00752251333440533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,39989,-0.012662231702935,0.00473978689245235,-0.0219522140121416,-0.00337224939372838,0.00756315566796507
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,40199,-0.0103987262288939,0.00389317714536608,-0.0180293534338115,-0.00276809902397641,0.0075733981504442
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,42626,0.0176699143586889,0.00662052684888273,0.00469368173487875,0.030646146982499,0.00761781856198139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,-0.0193664026006668,0.00726344039564392,-0.0336027457761289,-0.00513005942520475,0.00767886740643537
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,-0.0312336826220873,0.0117180023893657,-0.0542009673052442,-0.00826639793893049,0.00769964243572614
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,42495,-0.00871577667205432,0.00327020902646219,-0.0151253863639202,-0.00230616698018842,0.0077034363146165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,42611,0.0106584456170437,0.00400046244256973,0.00281753922960703,0.0184993520044804,0.00772401876773048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,42587,-0.021625953117184,0.00812854088514524,-0.0375578932520687,-0.00569401298229932,0.00781185564297591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,0.0149364685594563,0.00562878032224817,0.00390405912784991,0.0259688779910627,0.00797368089175149
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,-0.0138096935608993,0.00520769469285112,-0.0240167751588875,-0.0036026119629111,0.00801634767617158
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.00803538011280911,0.0030319274086684,0.00209280239181904,0.0139779578337992,0.00805468031201485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.00728398839272835,0.00275021033386729,0.00189357613834846,0.0126744006471082,0.00809383027956036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,42611,0.013330168437443,0.00503699249350572,0.00345766315017176,0.0232026737247142,0.00814355314297607
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,40483,-0.0120843215844935,0.00456620791891642,-0.0210340891055697,-0.0031345540634173,0.00814501221848183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,42681,-0.0138374027125086,0.00525504917772449,-0.0241372991008486,-0.00353750632416856,0.00846901351255426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0104131174988378,0.0039598394036722,0.00265183226764029,0.0181744027300353,0.00855645750783092
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,40136,0.0242524770127176,0.00922612878354234,0.00616926459697459,0.0423356894284606,0.00858384755297196
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,42591,-0.00652280670258173,0.00248288102061626,-0.0113892535029896,-0.00165635990217386,0.00862110264262153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,-0.0137857572834504,0.00525620664350418,-0.0240879223047186,-0.00348359226218224,0.00873411781215003
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,-0.0164606927588545,0.00627903376414066,-0.0287675989365702,-0.00415378658113882,0.00876559678962031
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,40483,-0.025889517390355,0.00990048459201859,-0.0452944671907114,-0.00648456758999855,0.00893526656504061
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,0.0082710958747935,0.00316658125394258,0.00206459661706605,0.014477595132521,0.00901143647751828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,40283,-0.00765380413438751,0.00293342778083307,-0.0134033225848203,-0.0019042856839547,0.00908846876778978
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,40116,0.00915894287667432,0.00351129252710212,0.00227680952355416,0.0160410762297945,0.00910838318148473
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,-0.0113529990657871,0.00435624677887344,-0.019891242752379,-0.00281475537919514,0.00916890110969092
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,-0.0184126021048736,0.00707902339709327,-0.0322874879631764,-0.00453771624657083,0.00930734813532976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,40483,-0.0136427544357265,0.00525267600856623,-0.0239379994125163,-0.00334750945893671,0.00940828318910868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,40182,-0.0107369000206063,0.00414338811565214,-0.0188579407272845,-0.00261585931392806,0.00957312329259567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,40449,-0.0156081037533907,0.00602408799634232,-0.0274153162262217,-0.0038008912805598,0.00958352082610111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,40482,-0.0125892663489092,0.00486170587364102,-0.0221182098612456,-0.00306032283657279,0.00962457755113598
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,-0.0256305257902832,0.00989981400773391,-0.0450341612454417,-0.00622689033512478,0.00963851128122419
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,40199,-0.0106833910276437,0.00412647632565659,-0.0187712846259306,-0.00259549742935673,0.00963855729672738
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,-0.0108286870928888,0.0041904617098921,-0.0190419920442774,-0.00261538214150034,0.00977327775589034
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,-0.0144143098785423,0.00559637692368532,-0.0253832086489655,-0.00344541110811902,0.010017953902783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,40539,0.0053744517678181,0.00208696256199076,0.0012840051463162,0.00946489838931999,0.010029292745461
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,-0.0150627962111085,0.0058528248185699,-0.0265343328555055,-0.00359125956671151,0.0100775023664163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.00747970884081953,0.00291552022154273,0.00176528920659579,0.0131941284750433,0.0103165177324004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,42505,0.0332253368764719,0.0129526342097938,0.00783817382527611,0.0586124999276678,0.0103242370685522
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.0129575443339491,0.00505302493576002,-0.0228614732080387,-0.00305361545985947,0.0103490184583961
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,-0.0144785403895121,0.00564662738418323,-0.0255459300625112,-0.00341115071651297,0.0103552572814339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,40199,-0.0206663110889356,0.00806014608301425,-0.0364641974116435,-0.00486842476622767,0.0103601525683375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,40539,-0.00833488644255177,0.00325402996204444,-0.0147127851681589,-0.00195698771694466,0.010437805502526
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0100375701082492,0.00392137316574332,-0.0177234615131061,-0.00235167870339226,0.0104889235862502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,-0.00995895425861986,0.00389925173608268,-0.0176014876613419,-0.00231642085589781,0.0106605961579727
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.010004394910584,0.00392389563438654,-0.0176952303539816,-0.00231355946718635,0.0107979585371813
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,42654,0.0210424319723922,0.00826586826311809,0.00484133017668074,0.0372435337681036,0.0109168964359368
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0107514463292984,0.00422808640622913,0.00246439697308933,0.0190384956855075,0.0110058988011013
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,-0.015065182431456,0.00593313129829295,-0.0266941197761101,-0.00343624508680179,0.0111228846845389
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,42357,-0.0124477424455025,0.00491968482629379,-0.0220903247050383,-0.00280516018596668,0.011411603825436
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,40199,-0.0126392175419009,0.00501051148414698,-0.022459820050829,-0.00281861503297281,0.0116650384398771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,42721,-0.00626851644875085,0.00248566283868681,-0.011140415612577,-0.0013966172849247,0.0116846969106547
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,40511,-0.0180268007561333,0.00714810973133259,-0.0320370958295452,-0.00401650568272146,0.0116859764398573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,42357,0.00980438297470247,0.00389402304882261,0.00217209779901015,0.0174366681503948,0.0118207028595069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,-0.00935235435709693,0.00371902732942123,-0.0166416479227625,-0.00206306079143132,0.011926452837012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,40116,-0.0152310623933347,0.00605747329660306,-0.0271037100546767,-0.00335841473199268,0.0119369177582194
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,-0.0122826413986493,0.00488962284856231,-0.0218663021818314,-0.00269898061546714,0.0120194198918888
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,40116,-0.0314591191696613,0.0125276843985491,-0.0560133805908174,-0.00690485774850513,0.0120475630830536
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,-0.00905566454501597,0.00360884638887503,-0.016129003467211,-0.00198232562282091,0.0121115567952649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,-0.0166687249979105,0.00667157579065155,-0.0297450135475876,-0.00359243644823346,0.01248537539317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,42794,-0.0132325557025871,0.0053037993606679,-0.0236280024494962,-0.00283710895567801,0.0126103150666706
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,-0.0175074997709878,0.00703002651912542,-0.0312863517484736,-0.00372864779350198,0.0127750844098047
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,40199,0.0140604616221298,0.00566687379790173,0.00295338897824244,0.0251675342660172,0.0131101140673324
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.00881956333488157,0.00355715894361724,-0.0157915948643714,-0.00184753180539177,0.0131733719179357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0424852018646336,0.017182075770066,0.00880833335530425,0.076162070373963,0.0134241419337909
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,-0.0224941922828433,0.00911364268994794,-0.0403569319551412,-0.00463145261054531,0.01359481071291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,40223,0.0134256402334394,0.00544025457862262,0.00276274125933909,0.0240885392075398,0.0136084327800106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,0.00645033182360961,0.00261487536970598,0.00132517609898589,0.0115754875482333,0.013645692303891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,-0.0147471936146784,0.00601401879482694,-0.0265346704525392,-0.00295971677681757,0.0142163915649087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,40344,-0.00794309528298247,0.00324942206057728,-0.0143119625217139,-0.001574228044251,0.0145221333144073
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,-0.00632147688555713,0.00258684868376194,-0.0113917003057305,-0.00125125346538374,0.0145503576630031
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,-0.00849991500162008,0.0034798712202211,-0.0153204625932534,-0.00167936740998672,0.0145951487228642
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,42346,-0.0117765544162817,0.00482193049086598,-0.021227538178379,-0.00232557065418441,0.0146074772414365
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.0072386330980234,0.00297064385683456,-0.0130610950574191,-0.00141617113862766,0.0148363783895379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.00888774038510062,0.00364942336294746,0.0017348705937236,0.0160406101764776,0.0148888688511271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,40136,-0.0155263731291511,0.00639266669620161,-0.0280559998537063,-0.00299674640459599,0.0151657725842057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,0.00506515015086762,0.00208823838775359,0.000972202910870579,0.00915809739086466,0.0153008315684525
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,-0.0144959196726871,0.00598286924302187,-0.02622234338901,-0.00276949595636426,0.0154125478875431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,0.00879801870375348,0.0036347227484439,0.00167396211680344,0.0159220752907035,0.0155104620873149
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,40482,0.0123433575999903,0.00510200543556637,0.00234342694628021,0.0223432882537004,0.0155654751924616
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,-0.0254731366215419,0.0105292554902093,-0.0461104773823522,-0.00483579586073159,0.0155675485402389
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,-0.0227841222175515,0.00942176284451685,-0.0412507773928045,-0.00431746704229847,0.0156113782419893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,40124,-0.0239061085925792,0.0099040340004975,-0.0433180152335543,-0.0044942019516041,0.0158045458772163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,-0.0110577792383128,0.00459084620697357,-0.020055837803981,-0.0020597206726446,0.0160277391071761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.00760916906501499,0.00316427140147783,0.00140719711811844,0.0138111410119115,0.016198491047874
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00737462967607879,0.00307105185090934,0.00135536804829648,0.0133938913038611,0.016349087133349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,42017,-0.00674418970768114,0.00281240630995358,-0.0122565060751902,-0.00123187334017212,0.0164984401550808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,40482,-0.0182588773341143,0.00763333273562277,-0.0332202094959349,-0.00329754517229368,0.0167734292410291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,42209,0.0165015365310497,0.00690406613273033,0.00296956691089829,0.0300335061512012,0.0168570710153898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0282881180764325,0.0118472941985613,-0.0515088147056127,-0.00506742144725227,0.0169666293305484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,42357,-0.0200103705535664,0.00838202524738389,-0.0364391400384389,-0.00358160106869402,0.0169868725474723
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.0169230963945535,0.00709223508106455,-0.03082387715344,-0.00302231563566695,0.0170424474979353
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,40080,0.0125960917463629,0.00528449744470173,0.00223847675474751,0.0229537067379783,0.0171615862217617
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,40451,-0.0109985550307844,0.0046189240822204,-0.0200516462319364,-0.00194546382963238,0.0172731415348011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,-0.0205343247516599,0.00863189890909061,-0.0374528466134775,-0.00361580288984234,0.017381755541056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,-0.0112940615579324,0.00474888490545464,-0.0206018759726235,-0.00198624714324134,0.0174113119256729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,40532,0.00534061174982176,0.00224722617915022,0.000936048438687324,0.0097451750609562,0.017492606492885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,-0.017195293660532,0.00724490302282419,-0.0313953035852674,-0.00299528373579654,0.0176377216670183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,42794,-0.00599063515989667,0.00252532150732225,-0.0109402653142483,-0.00104100500554506,0.017695070321199
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,0.0146193029913209,0.00618997336497149,0.0024869551959768,0.0267516507866651,0.0182052619366653
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,42370,-0.0131336695960938,0.00556587359900061,-0.024042781850135,-0.00222455734205264,0.018305302046714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,-0.0176593849249196,0.00749783977901547,-0.0323551508917899,-0.00296361895804932,0.018526889657029
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,40283,-0.0221634459798247,0.00942171418320298,-0.0406300057789026,-0.0036968861807469,0.0186711213916889
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.00709887898691733,0.00302370047825041,-0.0130253319242881,-0.00117242604954653,0.0189019195319329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,-0.0181376220877708,0.00772987138767207,-0.033288170007608,-0.0029870741679335,0.0189716965892724
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,42734,-0.0161319874715818,0.00687713308818058,-0.0296111683244157,-0.00265280661874788,0.0190035399043793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,42357,-0.0124803914725707,0.00533153614358148,-0.0229302023139904,-0.00203058063115104,0.0192541125009994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,-0.00938832813692805,0.0040184668027847,-0.0172645230703861,-0.00151213320347005,0.0194936326566235
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,0.0111777541647981,0.00478471640431243,0.00179971001234572,0.0205557983172504,0.0194987557995709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,42794,0.00953591993161481,0.00408413544318799,0.00153101446296636,0.0175408254002633,0.0195647536914961
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,-0.0202528625137486,0.00875953757364053,-0.0374215561580841,-0.00308416886941318,0.0207879324819698
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,-0.0153145167389228,0.00662788085763041,-0.0283051632198784,-0.00232387025796718,0.0208692249587052
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,40449,-0.00792706288812595,0.00345518501593167,-0.014699225519352,-0.00115490025689987,0.0217943917892373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,40283,-0.0103319065020186,0.00450351858908744,-0.01915880293663,-0.00150501006740725,0.0217984550474793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,-0.00693395695163937,0.00302813475360978,-0.0128691010687145,-0.000998812834564212,0.0220491828513426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,40383,0.00690830426413012,0.00302356909548438,0.00098210883698074,0.0128344996912795,0.0223421480797942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,-0.0183860855802828,0.00805388593903412,-0.0341717020207897,-0.00260046913977593,0.0224557216605689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,-0.00862282602741588,0.00378385869534213,-0.0160391890702864,-0.00120646298454531,0.0226949441070917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,42346,-0.00807312737901028,0.00354307585089202,-0.0150175560467586,-0.00112869871126193,0.022708916888165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,40136,0.0109978367335631,0.00482881570536958,0.00153335795103876,0.0204623155160875,0.0227730083848875
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0091490111518709,0.00401857758732605,-0.01702542322303,-0.00127259908071184,0.0228246605720729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,-0.0115537784773131,0.0050775996609152,-0.0215058738127069,-0.00160168314191931,0.0228954889489504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.0159223653065249,0.00702233023855258,0.00215859803896181,0.0296861325740879,0.0233855067945213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,-0.00974618449128168,0.00429944110448994,-0.018173089056082,-0.00131927992648139,0.0234156735318737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,42342,-0.0091770467002754,0.00405461195202368,-0.0171240861262418,-0.00123000727430899,0.0236297352306611
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,0.011418315869421,0.00504558067136403,0.00152897775354748,0.0213076539852945,0.0236528972362571
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,40116,-0.0143977984558563,0.00636540175054893,-0.0268739858869322,-0.00192161102478044,0.0237241612986977
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,42636,0.0266894494190015,0.0118106288532639,0.00354061686660413,0.0498382819713988,0.0238507068304591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,-0.0131546025048025,0.0058213063765637,-0.0245643630028673,-0.00174484200673764,0.0238540569703756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,-0.0116201840229208,0.00514812672715923,-0.0217105124081528,-0.00152985563768867,0.0240139496046865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,-0.00736041269076206,0.00326199896658796,-0.0137539306652745,-0.000966894716249661,0.0240639071662426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,40182,-0.0117866029464823,0.00522551699224981,-0.022028616251292,-0.00154458964167269,0.0241161572327042
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,42357,-0.0107371202156809,0.0047641463162887,-0.0200748469956068,-0.00139939343575509,0.0242292667523487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,-0.00662406928514032,0.00294585772042149,-0.0123979504171664,-0.000850188153114199,0.024553708252235
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,42636,-0.00679069245465216,0.00302152087883546,-0.0127128733771697,-0.000868511532134664,0.0246279529597582
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00789721424597621,0.0035153736049934,-0.0147873465117633,-0.00100708198018914,0.0246898288920373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.00835945920862628,0.0037369617451272,-0.0156839042290756,-0.00103501418817697,0.0253082724384367
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,-0.0188057520229829,0.00840782733880307,-0.0352850936070369,-0.00232641043892886,0.0253229226053265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,40483,-0.00870438753576314,0.00389340916868221,-0.0163354695063803,-0.001073305565146,0.0253927055603679
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,40080,0.0180251638924622,0.00806523047935826,0.00221731215291999,0.0338330156320044,0.0254426525770049
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,-0.00567649933004614,0.00255006835355965,-0.010674633303023,-0.000678365357069234,0.0260293135075727
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,40182,-0.0118326979292979,0.0053205269109037,-0.0222609306746692,-0.00140446518392666,0.0261706369256314
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,42370,-0.0125182231712861,0.00563852825208427,-0.0235697385453713,-0.00146670779720093,0.0264274069494943
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,42711,-0.00631059605215862,0.00284264016194979,-0.0118821707695802,-0.000739021334737027,0.0264368476639994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,-0.0132128640387234,0.00595344227397414,-0.0248816108957127,-0.00154411718173406,0.0264785614725511
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,42357,-0.0256549476497638,0.0116009993210182,-0.0483929063189594,-0.00291698898056819,0.0270222986868333
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,-0.0109852288246461,0.004971021000901,-0.020728429986412,-0.00124202766288013,0.0271324809948753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,-0.0144413856556252,0.00656442286550675,-0.0273076544720184,-0.00157511683923197,0.0278315574995402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,40199,-0.0119398547876269,0.00543345564327206,-0.0225894278484401,-0.00129028172681365,0.0280076713701573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,-0.0096955431063463,0.00442445378594614,-0.0183674725268007,-0.00102361368589186,0.0284469012382744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,-0.0121198714143428,0.00553686737721461,-0.0229721314736835,-0.00126761135500221,0.0286216565447999
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,42754,0.00865625685921149,0.00395984493204113,0.000894960792410872,0.0164175529260121,0.0288319829286337
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,-0.015279344505613,0.00700441466378232,-0.0290079972466263,-0.00155069176459965,0.0291756419560925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,40532,-0.00640900294305076,0.00294170391065109,-0.0121747426079269,-0.000643263278174619,0.029376694068541
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,40384,-0.00973989233046758,0.00447448437089799,-0.0185098816974276,-0.000969902963507524,0.0295190839461761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,0.0104828982825302,0.00481735707305843,0.00104087841933564,0.0199249181457247,0.0295715092577679
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0104933592613557,0.0048425100440221,-0.019984678947639,-0.00100203957507235,0.0302584634537412
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,42476,-0.00725907561701256,0.0033500750578506,-0.0138252227303997,-0.000692928503625387,0.0302647983219959
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,42689,-0.0103449820572079,0.00478960315959617,-0.0197326042500164,-0.000957359864399449,0.0307992877537854
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,-0.0269068371979824,0.0124640310207767,-0.0513363379987047,-0.00247733639726006,0.0308902657140559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,42794,-0.0154649697694321,0.00717846523957169,-0.0295347616389926,-0.00139517789987157,0.0312297708197783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.0128056434587969,0.00594931968661296,0.00114497687303546,0.0244663100445583,0.0313833277779186
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,-0.00526437113987192,0.00244645585865889,-0.0100594246228433,-0.0004693176569005,0.031431981089931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,40451,-0.0150519676772211,0.00701963316732017,-0.0288104486851687,-0.00129348666927361,0.0320328491735418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,-0.0101966401394866,0.00476893828244201,-0.0195437591730729,-0.000849521105900246,0.0325270560268046
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,42594,-0.0166073167972988,0.00779434977874291,-0.0318842423636349,-0.00133039123096273,0.0331331234364987
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.0122364696181673,0.005743348608551,-0.0234934328909273,-0.000979506345407367,0.0331445921905123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,40302,0.00758269940867279,0.00356268999798778,0.000599827012616736,0.0145655718047289,0.0333289029183032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,-0.0111305453399463,0.0052321827764254,-0.0213856235817401,-0.000875467098152545,0.0334112263209482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,42794,0.00637090389258611,0.00301501451598677,0.000461475441252044,0.0122803323439202,0.0346138766573709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,-0.020010693565912,0.0094919464206812,-0.0386149085504471,-0.00140647858137685,0.0350382669406334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,40116,-0.0126695295395259,0.00602429102322326,-0.0244771399450434,-0.000861919134008286,0.0354821230228215
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,-0.0154671038646637,0.00736550722837662,-0.0299034980322819,-0.00103070969704554,0.0357533501287708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.00652420832519318,0.00310899758412953,-0.0126178435900871,-0.000430573060299299,0.0358806621565665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,40116,0.00668707623927314,0.00319542199218874,0.000424049134583211,0.0129501033439631,0.0363984964434999
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,40116,0.00917808527578576,0.00438683218481291,0.000579894193552451,0.0177762763580191,0.036444574332289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,-0.0230785778949853,0.0110427763026874,-0.0447224194482526,-0.00143473634171809,0.0366437185612846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0143773646497421,0.00688152992077137,0.000889566005030245,0.027865163294454,0.0367025030277771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,-0.0157156717156535,0.00752524724808694,-0.0304651563219039,-0.000966187109403122,0.0367816058470788
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0168082842412549,0.00804980576894878,-0.0325859035483946,-0.00103066493411532,0.0368137770092337
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,42636,-0.0178468412458206,0.00855192595911758,-0.0346086161256911,-0.00108506636595019,0.0369177979622306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,-0.00651369188279935,0.00312266518036122,-0.0126341156363074,-0.000393268129291356,0.037007041254233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,-0.00728587331884743,0.00350023765872186,-0.0141463391299423,-0.000425407507752574,0.037407647107545
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,-0.0106450684112311,0.00511486852324118,-0.0206702107167838,-0.000619926105678341,0.037434382189892
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,42262,-0.00963651014622618,0.00463216848626401,-0.0187155603793036,-0.000557459913148718,0.0375133042758761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,40199,-0.0256359817062695,0.0123614338589451,-0.0498643920698019,-0.00140757134273716,0.0381147761749764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.0188338441418359,0.00910814970497259,0.000981870720089633,0.0366858175635822,0.0386820228219107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,-0.0167342326734867,0.00809557267362437,-0.0326015551137905,-0.000866910233182978,0.0387453523572493
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,-0.0126081208443369,0.00611006737326154,-0.0245838528959296,-0.000632388792744328,0.0390842301936579
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,0.0126358265621198,0.00614017616796751,0.000601081272903495,0.0246705718513361,0.0396201051205334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,-0.017361712719307,0.00844655406942825,-0.0339169586953864,-0.000806466743227655,0.0398524657803343
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,-0.0111594744731482,0.00543021331032037,-0.0218026925613761,-0.000516256384920257,0.0398918433287388
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,0.00737317323685088,0.00359762187016007,0.000321834371337148,0.0144245121023646,0.0404366856964922
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,42357,0.0108137159609825,0.00528220970017659,0.000460584948636367,0.0211668469733286,0.0406587027342942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,-0.00778549914479054,0.00381346376634544,-0.0152598881268276,-0.000311110162753481,0.041216208592922
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,42381,-0.00941311087875683,0.00461077347774149,-0.0184502268951301,-0.000375994862383515,0.0412163445501732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,-0.0117858864208612,0.00579631985319897,-0.0231466733331312,-0.000425099508591209,0.0420382297857101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.00443032921375475,0.00218323480701104,0.000151188992013118,0.00870946943549639,0.0424527771954163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,-0.00928270053300565,0.0045795137523547,-0.0182585474876209,-0.000306853578390442,0.0426858351601249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,40182,-0.0123935381200483,0.00612063388502824,-0.0243899805347036,-0.000397095705392926,0.0429040067586994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,40116,0.0115967558634493,0.00572991063795594,0.000366131013055651,0.0228273807138429,0.043004923959948
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,40199,-0.00906708058208684,0.00448368939567108,-0.0178551117976022,-0.000279049366571521,0.0431760634617823
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,-0.0111748776769606,0.00553159190768587,-0.0220167978160249,-0.000332957537896283,0.0433871149944204
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,-0.00813941282813441,0.0040443540137458,-0.0160663466950762,-0.000212478961192648,0.0441876554571099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,42559,-0.0145535198713461,0.00723640039236506,-0.0287368646403816,-0.000370175102310537,0.0443291708816089
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00693649137224134,0.00345454856106652,0.000165576192550964,0.0137074065519317,0.0446704800904438
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,42303,-0.0216235366269026,0.0107715365508768,-0.0427357482666212,-0.000511324987184106,0.044720126025494
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,40182,-0.0122846627691889,0.00612279630492121,-0.0242853435268344,-0.000283982011543286,0.044840062510934
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,40199,-0.0125852159640446,0.00627748848469598,-0.0248890933940488,-0.000281338534040504,0.0450070570675001
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,40136,-0.00891658937696042,0.00444995858224102,-0.0176385081981528,-0.000194670555768023,0.0451218193944609
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,40116,0.00958053535507177,0.00479497155261065,0.000182391111954892,0.0189786795981886,0.0457372924634746
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00634970003075474,0.0031802211559898,0.000116466565014722,0.0125829334964948,0.0458909745092732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00570353479321412,0.00285716215471198,-0.0113035726164496,-0.000103496969978631,0.0459341753190426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,40482,-0.00631164787296662,0.00316498385365966,-0.0125150162261395,-0.000108279519793694,0.0461529353152956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.00681301916654974,0.00341771368442745,0.000114300345071941,0.0135117379880275,0.0462331752533975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,40482,-0.00910902693096272,0.0045797069217824,-0.0180852524976562,-0.000132801364269217,0.0467255461530848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,42594,-0.00771957942553846,0.00388336109770443,-0.0153309671770391,-0.00010819167403778,0.0468474567938673
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,40182,0.00626823886954264,0.00315472933473652,8.49693734590691e-05,0.0124515083656262,0.0469545067137468
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.0156078890132131,0.00788240889459437,0.00015836757980818,0.0310574104466181,0.0477182855504146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,-0.00889646365082377,0.00449452236273891,-0.017705727481792,-8.71998198555025e-05,0.0477959048032433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,42370,-0.00971713676306499,0.00491708701790973,-0.0193546273181681,-7.96462079619108e-05,0.0481531984685767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,40527,0.0178718952747825,0.00906719322510868,0.000100196553569461,0.0356435939959955,0.0487423992312746
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,42679,0.00552892169247605,0.00280820634689802,2.48372525559282e-05,0.0110330061323962,0.0489913935723041
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,40428,0.00548900938720371,0.00279336529539069,1.4013408237961e-05,0.0109640053661695,0.0494369117529877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,-0.01213938363979,0.006178255845128,-0.0242487650962409,-3.00021833391471e-05,0.0494562055682898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,42370,0.00964607452967503,0.00491438621968365,1.38775390950748e-05,0.019278271520255,0.0496876518194439
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,0.0100421822651864,0.00511676324908443,1.33262969808905e-05,0.0200710382333919,0.0497175011246301
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,-0.0143822860100694,0.00734180765698285,-0.0287722290177558,7.65699761695604e-06,0.050142795158647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,-0.0100894186742216,0.00515661839208259,-0.0201963907227035,1.7553374260286e-05,0.050420435402947
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,42154,-0.00729300209082882,0.00372841468139304,-0.0146006948663592,1.46906847015354e-05,0.0504795596930898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,40116,0.00723911737288018,0.00370543918906185,-2.35434376810451e-05,0.0145017781834414,0.0507685587367354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,-0.0063297331329794,0.00324026306916323,-0.0126806487485393,2.1182482580543e-05,0.0507852639622628
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,-0.0102256537837115,0.00524164277635195,-0.0204992736253613,4.7966057938359e-05,0.0510997825987689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,40375,-0.0192553634830103,0.00987253757911451,-0.0386055371380747,9.48101720541633e-05,0.0511538217512799
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,-0.0163140456115544,0.00837219095986932,-0.0327235398928983,9.54486697894649e-05,0.0513686729304686
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,-0.012782308090796,0.00656341069146095,-0.0256465930460594,8.19768644674639e-05,0.051494831594225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,-0.0198181711378654,0.0101959867189453,-0.0398023051069982,0.000165962831267359,0.0519542969816635
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,40223,-0.0143274650561017,0.00737209402201265,-0.0287767693392465,0.000121839227043135,0.0519844496349525
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,42721,0.011752945630748,0.00605326200433164,-0.000111447897742015,0.023617339159238,0.0522076386097235
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,42549,-0.0071075876299186,0.00368477314037756,-0.0143297429850586,0.000114567725221411,0.0537634754710892
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.00413362287171232,0.00214355854864263,-6.77518836272309e-05,0.00833499762705186,0.0538273012145208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,0.0041677822770106,0.00216345216855537,-7.25839733579248e-05,0.00840814852737912,0.0540693984949946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,42652,-0.00737358367167811,0.0038276893775093,-0.0148758548515963,0.000128687508240125,0.0540779969472036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,42597,-0.00788539804499474,0.00409568783412877,-0.0159129461998871,0.000142150109897642,0.0542138802771149
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00788229993289561,0.00410094933628747,-0.000155560766227832,0.0159201606320191,0.05462245316765
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,40116,-0.00768464531041254,0.00400222355461777,-0.0155290034774634,0.000159712856638294,0.0548720454219522
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,-0.0082684254484821,0.00432019455444248,-0.0167360067751894,0.000199155878225164,0.0556544248689762
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.0117618510675795,0.00616443111788842,-0.0238441360586408,0.000320433923481838,0.0564102829612796
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,42476,-0.0141562269880526,0.00743328317880298,-0.0287254620185065,0.000413008042401197,0.0568747465548237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',40116,-0.00828491051236057,0.0043519061468029,-0.0168146465600943,0.000244825535373127,0.0569699307259657
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,42794,-0.00373389449630782,0.00196353957478997,-0.00758243206289617,0.000114643070280531,0.0572427376025239
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.00539501792361467,0.00284245271573258,-0.000176189399221178,0.0109662252464505,0.0577153876142118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,40449,0.0216431702773262,0.0114115602058652,-0.000723487726169703,0.044009828280822,0.05790627076488
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,42611,-0.0226585352024969,0.0119603802177272,-0.0461008804292422,0.000783810024248387,0.058184649244815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,-0.00661152370955738,0.00349711680069997,-0.0134658726389293,0.000242825219814565,0.0587044910463938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,-0.0108524188172595,0.00574285203557481,-0.0221084088069861,0.000403571172467162,0.0588202432225972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,42607,-0.0180036190318355,0.00953883593747787,-0.0366997374692921,0.000692499405621133,0.0591278330521853
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,40154,-0.0130223532233381,0.00692170445413154,-0.0265888939534359,0.000544187506759729,0.0599467889600603
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,40080,-0.0123512568937227,0.00656768921881517,-0.0252239277626004,0.000521413975155056,0.060051769959528
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,40182,-0.0102991303315352,0.00548646990733455,-0.0210526113499109,0.000454350686840542,0.0605189324339129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00921439701411918,0.00492584594515539,-0.0188690550666237,0.000440261038385382,0.0614191577299797
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,40223,-0.0219631997559746,0.0117414045164254,-0.0449763526081685,0.00104995309621924,0.0614302154827356
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,-0.0100745077476081,0.00539125074870799,-0.0206413592150758,0.000492343719859532,0.0616895014988493
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,-0.0188431789837363,0.010090681580105,-0.0386209148807421,0.000934556913269505,0.0618747247569956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,40384,-0.00589558457128527,0.00316419112235666,-0.0120973991711043,0.000306230028533778,0.0624574809436421
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,40136,0.00956614225091416,0.00513583565356926,-0.000500095630081594,0.0196323801319099,0.0625416491954795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,42636,0.0147790475827019,0.0079349653229855,-0.000773484450349648,0.0303315796157535,0.0625513453812271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,42681,-0.0128573286937693,0.00691166990049903,-0.0264042016987474,0.00068954431120883,0.0628740686359248
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,-0.00526203271486942,0.00283807998669659,-0.0108246694887947,0.000300604059055892,0.0637491948627731
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,-0.00931227693343562,0.00502543790842774,-0.019162135233954,0.000537581367082743,0.0639045030957745
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,42370,0.0115981904938291,0.00626317552160422,-0.00067763352851515,0.0238740145161734,0.0640759383664674
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00832525249871868,0.00449665180479246,-0.000488185038674534,0.0171386900361119,0.0641332899426399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,42311,-0.0112715944496582,0.00609590890839813,-0.0232195759101185,0.000676387010802134,0.0644741661974052
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,42459,0.012342004229236,0.00668195081578294,-0.000754619369698549,0.0254386278281706,0.0647598292021686
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,40451,-0.00725940420363634,0.00393134769692328,-0.014964845689606,0.000446037282333286,0.0648395730361009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,40199,-0.00754884605269026,0.0040955489946026,-0.0155761220821114,0.000478429976730831,0.065329178393712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,0.00871639839110446,0.00473425271381021,-0.000562736927963554,0.0179955337101725,0.0656240331729833
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,-0.0103565214805741,0.00563811056961545,-0.0214072181970204,0.000694175235872157,0.066254255153682
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,-0.00732233367760655,0.00398799562123893,-0.0151388050952348,0.000494137740021754,0.0663661055246744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,0.00902508745032565,0.00493780859055693,-0.000653017387165928,0.0187031922878172,0.0676095473882561
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,40527,-0.0170409329638905,0.00932574575841104,-0.0353193946503762,0.00123752872259511,0.0676809951106917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0105707318002242,0.00578584636611505,-0.0219109906778097,0.000769527077361288,0.0677223703400656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,40080,-0.0112614700606336,0.00616936523732803,-0.0233534259257966,0.000830485804529317,0.0679702562412171
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,-0.0129719904931586,0.00710845087141133,-0.0269045542011248,0.000960573214807638,0.0680476687445369
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,40116,-0.0130915110391365,0.00719205070620273,-0.0271879304232939,0.00100490834502081,0.0687444721179777
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,-0.0168791186531881,0.00927663307607707,-0.0350613194822992,0.00130308217592295,0.0688528192582834
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,-0.00451166003578402,0.00248624852799768,-0.00938470715065947,0.000361387079091425,0.069605392463247
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,-0.0053796258636766,0.00297398464647343,-0.0112086357707645,0.00044938404341131,0.0704899532150381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,42437,-0.00617468154699655,0.00341403322875491,-0.0128661866753562,0.000516823581363062,0.0705330596071291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,40136,0.00874896609033241,0.00483787612370683,-0.000733271112132974,0.0182312032927978,0.0705668575824284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,-0.00975714337657741,0.00539554042382672,-0.0203324026072778,0.000818115854122954,0.0705759316720218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,40116,0.0109612051013379,0.00607143989949451,-0.000938817101671331,0.0228612273043471,0.0710440791046606
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,0.00788117585647711,0.00437617672684712,-0.000696130528143241,0.0164584822410975,0.0717417157815491
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,-0.00390277527694103,0.00217191460951861,-0.00815972791159751,0.000354177357715456,0.072369492492866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,-0.00737582641566011,0.00410891283022183,-0.0154292955628949,0.000677642731574678,0.0726677567395882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,40302,0.00687475176201448,0.00383614170497315,-0.000644085979732897,0.0143935895037619,0.0731440624874476
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,-0.010914510952056,0.00610000147085138,-0.0228705138349247,0.00104149193081273,0.073599794202852
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,42594,-0.00558746459515857,0.00312324359197489,-0.0117090220354294,0.000534092845112215,0.073638332726968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,42794,0.00486786783816062,0.00272754709646699,-0.000478124470914675,0.0102138601472359,0.074331409010213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,-0.0153999310404936,0.00863192315674806,-0.0323185004277198,0.00151863834673256,0.0744352283304312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,-0.00482493390028469,0.00270715315030706,-0.0101309540748865,0.000481086274317143,0.0747297006383529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,42770,-0.0106032016049512,0.00595376945890031,-0.0222725897443958,0.00106618653449343,0.0749474763309591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,40182,-0.00559553410304,0.00314490289067524,-0.0117595437687635,0.000568475562683478,0.0752282103234348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,42721,-0.00384982683009257,0.00216555571917242,-0.00809431603967051,0.000394662379485362,0.0754666137958476
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,-0.0044460982029,0.00250457406926939,-0.009355063378668,0.000462866972867997,0.0758890046397749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,42495,0.00994344643406292,0.00560895374434254,-0.00105010290484847,0.0209369957729743,0.0762878910872621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,42570,-0.0117427188505362,0.00662576845723134,-0.0247292250267096,0.0012437873256372,0.0763707992925549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.00728292847848183,0.00411145237522573,-0.000775518176960597,0.0153413751339243,0.0765205704323439
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,40136,0.00884709394756929,0.00499835181648816,-0.000949675612747492,0.0186438635078861,0.0767546091471534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,40449,-0.0472533264142562,0.0267340322182706,-0.0996520295620666,0.00514537673355415,0.0771658346878381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,-0.0127274036388604,0.00721106751525432,-0.0268610959687588,0.0014062886910381,0.0775893139597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00604856433667293,0.0034398708376277,-0.000693582505077369,0.0127907111784232,0.0787074372936177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,42638,0.00599790433773833,0.003417586787594,-0.000700565765945914,0.0126963744414226,0.0792801052458691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,-0.00452069862466167,0.00257627379393965,-0.00957019526078337,0.00052879801146004,0.0793310280972216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.0129295564434528,0.00736963037004256,-0.00151491908183068,0.0273740319687362,0.0793835462475568
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,0.0054034203642473,0.00308241441626026,-0.000638111891622811,0.0114449526201174,0.0796330548520768
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,-0.00854960169831109,0.00488008379105714,-0.0181145659287831,0.00101536253216091,0.0798078209485812
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,40302,0.00649925143686573,0.00371077881329421,-0.000773875037190927,0.0137723779109224,0.0798956581101377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,40532,0.0256303268681425,0.0146364719381828,-0.00305715813069584,0.0543178118669808,0.0799510096058322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.0109364182636155,0.00624609739391103,-0.0231787691556812,0.00130593262845008,0.0799875122447637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,-0.00898871733738949,0.0051511507010762,-0.0190849727114988,0.00110753803671985,0.0810133462374272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,0.00919901008784869,0.00529875878949127,-0.0011865571395542,0.0195845773152516,0.0825790218065827
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,42594,-0.00706489417529903,0.00406969876144997,-0.015041503747741,0.000911715397142911,0.0825912899415781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,40136,0.0165464482756473,0.00953533662760742,-0.00214281151446329,0.0352357080657578,0.0827199467847085
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,-0.00755114193122021,0.00435512889648326,-0.0160871945683274,0.00098491070588698,0.0829720157199278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,42721,-0.00517543157554464,0.00298565778588524,-0.0110273208358797,0.000676457684790437,0.0830418895251189
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,40511,-0.0110570450145037,0.00638579505694083,-0.0235732033261077,0.00145911329710034,0.0833887361128901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,40182,0.0121457128525638,0.00702686586546457,-0.00162694424374673,0.0259183699488744,0.0839324438388735
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,-0.00504330000800135,0.0029180616349248,-0.010762700812454,0.000676100796451264,0.0839562860412751
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,40283,0.014429189522604,0.00835183330730205,-0.00194040375970805,0.030798782804916,0.0840757271497567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,-0.00938688110718658,0.00543470416920794,-0.0200389012788342,0.00126513906446099,0.0841575651421086
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,40080,-0.0127004959365702,0.00735660622296274,-0.0271194441335771,0.00171845226043679,0.0843026024147593
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,42734,-0.00593618417078511,0.00344414621128662,-0.0126867107449069,0.000814342403336671,0.084810577919397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,42718,0.00434882501020899,0.00252920700504419,-0.000608420719677632,0.0093060707400956,0.0855567827297891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.00470345159218064,0.00274393224970962,-0.0100815588016115,0.000674655617250219,0.0865325186219761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,40136,0.00604061032833215,0.00353405580180602,-0.000886139043207647,0.0129673596998719,0.0874316730578857
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,42611,0.00420286148232451,0.00246078600231208,-0.000620279082207173,0.00902600204685619,0.0876716164805598
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,42370,0.023704216588318,0.0139331061116383,-0.00360467139049311,0.051013104567129,0.0889126442654689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00749039321974552,0.00441217601775192,-0.00115747177504825,0.0161382582145393,0.0895988053034052
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,42370,-0.00503240911176478,0.00296666327411149,-0.0108470691290233,0.000782250905493735,0.089848989017461
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0164464759852758,0.00973834241513775,-0.00264067514839415,0.0355336271189458,0.0912737316998737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,40199,-0.00847509225512557,0.00501915684340606,-0.0183126396682014,0.0013624551579503,0.0913342231124145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,-0.0146504682066662,0.00868099350048312,-0.0316652154676131,0.00236427905428068,0.0915067410815098
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,0.00609638193491665,0.00362387312695524,-0.00100640939391563,0.0131991732637489,0.0925415390638452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,42794,0.00403304123044505,0.00240839181048773,-0.000687406718110903,0.00875348917900101,0.0940399459171124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,0.00941907846076516,0.00563377894592595,-0.0016231282732497,0.02046128519478,0.09456920863577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,-0.0112319229722293,0.00672116502168826,-0.0244054064147383,0.00194156047027965,0.094725166984978
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,40136,-0.0142122486950786,0.00853380640412312,-0.0309385092471599,0.0025140118570027,0.095860496688232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,40116,0.00821928189764956,0.00493657330587766,-0.00145640178187066,0.0178949655771698,0.095945990708112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00427347092025702,0.0025763875738536,-0.00932319056501008,0.000776248724496036,0.0972033758112643
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,42311,-0.0107644902493196,0.00651839468212875,-0.0235405438262919,0.00201156332765277,0.0986804470301771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,-0.00587336106050411,0.00356449804941335,-0.0128597772373543,0.00111305511634606,0.0994348693733558
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,-0.0106825004351341,0.00650500324578281,-0.0234323067968684,0.0020673059266002,0.100577578302829
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,40479,-0.0042632634095123,0.00259890421356965,-0.0093571156681088,0.000830588849084208,0.100948221152958
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.010468364232768,0.00638735346430437,-0.0229875770228046,0.00205084855726852,0.101258234251825
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00981655051712178,0.00599811812927812,-0.00193976101626334,0.0215728620505069,0.101736922578415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0116465497236052,0.00712318254997816,-0.00231488807435198,0.0256079875215624,0.102068028551172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,42370,-0.00845438369031697,0.00518190024924534,-0.0186109081788378,0.00170214079820388,0.102804143276746
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,40516,0.00363150041722473,0.00222679493389528,-0.000733017653210015,0.00799601848765948,0.102956243407564
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.0129214691228876,0.00792599848360669,-0.00261348790498148,0.0284564261507567,0.103074397737716
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,0.00999185372795774,0.00612935937139369,-0.00202169063997389,0.0220053980958894,0.103095873378199
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,-0.0107456028289545,0.00661662552588241,-0.0237141888596841,0.00222298320177501,0.104393181938018
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,40182,0.00640690664965725,0.0039582708556827,-0.00135130422748084,0.0141651175267953,0.105559366477723
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,0.00526409294017682,0.00326198869881469,-0.00112940490949997,0.0116575907898536,0.106606596152115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00679661025267077,0.00421214101855769,-0.0014591861437023,0.0150524066490438,0.106648231487571
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,40182,0.00969051002586682,0.00601256536355747,-0.00209411808670581,0.0214751381384395,0.107053842623081
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,-0.0164613735193923,0.0102169743770211,-0.0364866432983536,0.00356389625956897,0.107169413431111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,40182,-0.0104460231762268,0.00648746662517738,-0.0231614577615744,0.0022694114091209,0.107386141634771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,-0.00827966895993207,0.00515048394264138,-0.0183746174875092,0.00181527956764503,0.107962140339874
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,40482,-0.00766012773276977,0.00476624221257621,-0.0170019624694191,0.00168170700387959,0.108046603581155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,-0.0075424337555408,0.00469638604765138,-0.0167473504089375,0.0016624828978559,0.10830019202817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.00925994751801498,0.00576653525337615,-0.00204246157860227,0.0205623566146322,0.108340145422513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.00431170245138823,0.00268861062779884,-0.00958137928187396,0.000957974379097499,0.108810513542519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,0.00216903083063503,0.00135427943616004,-0.000485356864238648,0.00482341852550871,0.109269728876035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,40136,0.00452293324164321,0.00282643655175198,-0.00101688239979068,0.0100627488830771,0.109577641121203
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,-0.0190016223737748,0.0118871488560372,-0.0423004341316076,0.00429718938405801,0.109955043391132
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,-0.0238541192974698,0.0149419538919951,-0.0531403489257802,0.00543211033084069,0.110411897405825
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,40199,0.00470200244730415,0.00294698367448041,-0.00107408555467745,0.0104780904492857,0.110622361012208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,42370,-0.00617774021974372,0.00387356849179349,-0.013769934463659,0.00141445402417152,0.110770950287427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,-0.0157450441349284,0.00992592089889356,-0.0351998490967598,0.003709760826903,0.112709429498673
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,0.00916686013608739,0.00578207132819829,-0.00216599966718126,0.020499719939356,0.112905782323234
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,40182,0.00944054745159594,0.00596239739218667,-0.00224575143708992,0.0211268463402818,0.113371044267313
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,42311,-0.0108932637003633,0.006916164091466,-0.0244489453196367,0.00266241791891005,0.115270373788608
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,42603,-0.00629795141858246,0.00403505386593637,-0.0142066569958177,0.00161075415865283,0.118592245426916
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,-0.0185765781115829,0.0119090565233785,-0.0419183288974047,0.00476517267423884,0.118814258066624
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,40283,0.0145072534019237,0.00931421706275904,-0.00374861204108399,0.0327631188449314,0.119371180606102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,42370,0.0048482467834655,0.00311877724535474,-0.0012645566174298,0.0109610501843608,0.120080994726749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,42362,-0.00932571455528337,0.00601378399022925,-0.0211127311761327,0.00246130206556597,0.120992056213513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,42346,-0.0112548270495667,0.00726391963389561,-0.0254921095320021,0.00298245543286873,0.121306017849365
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,40483,0.00658780097472447,0.00425248610910477,-0.00174707179912088,0.0149226737485698,0.121370186736186
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,0.00567487164538989,0.00366525856529072,-0.00150903514257992,0.0128587784333597,0.121582047943055
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,40539,0.00230282424705907,0.00149283114566655,-0.000623124798447369,0.00522877329256552,0.122958526419327
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,40199,0.0060443739664292,0.00391972425489649,-0.00163828557316791,0.0137270335060263,0.123092478657313
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,-0.00857456848782008,0.00557165996720853,-0.0194950220235488,0.00234588504790864,0.123842564532745
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,-0.0162140283224071,0.0105443379138189,-0.0368809306334922,0.004452873988678,0.124150011840703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,42646,-0.0085711905171443,0.00557463914195306,-0.0194974832353723,0.00235510220108369,0.124186409454076
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.00931157991185589,0.00606414583914368,-0.0211973057565775,0.00257414593286573,0.124686624231354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00821516968785652,0.00536607137094467,-0.00230233019919503,0.0187326695749081,0.12581150782638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,-0.00612951137230689,0.00401561959912238,-0.0140001257865868,0.00174110304197297,0.126934744982876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,40080,0.00808582521035595,0.00530134595954108,-0.00230481287034457,0.0184764632910565,0.127228283176617
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,0.00654968195367846,0.00430722131595679,-0.00189247182559684,0.0149918357329538,0.128381953857611
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.0050673346309188,0.00334238362160446,-0.00148373726742594,0.0116184065292635,0.129526977753233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,40451,-0.00808355692586469,0.00533416269456566,-0.0185385158072134,0.002371401955484,0.129691301929928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,42346,-0.0111770396012327,0.00739579166851147,-0.0256727912715151,0.00331871206904981,0.130743646800673
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,40527,-0.0126756260976451,0.00838986651847575,-0.0291197644738576,0.0037685122785674,0.130860741179375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,40199,-0.00398688999146669,0.00263952256437305,-0.00916035421763788,0.00118657423470449,0.130955114339301
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,40451,-0.00876707962495066,0.00580861715263974,-0.0201519692441246,0.00261780999422324,0.131244318484744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,40182,-0.00726052961016487,0.00481579263998756,-0.0166994831845405,0.00217842396421075,0.13167288643105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,0.0225034406811173,0.0149263583152901,-0.00675222161685133,0.0517591029790859,0.131677058261607
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,40182,0.00735608047088004,0.00487928439896076,-0.00220731695108304,0.0169194778928431,0.13168193900295
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,42590,-0.0129823345743714,0.00865484365556005,-0.0299458281392691,0.0039811589905263,0.133635901028712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,40370,-0.00986812108756085,0.00658450528655401,-0.0227737514492067,0.00303750927408502,0.133982755366101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,-0.00652132498493271,0.00435798881695557,-0.0150629830661656,0.0020203330963002,0.13457593468201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.0115867969042141,0.00774816813514995,-0.026773206449108,0.0035996126406798,0.134832528545756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,-0.00734843658005743,0.00491468991556076,-0.0169812288145565,0.00228435565444166,0.13488614174865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,-0.0175350624534113,0.0117467286623706,-0.0405586506316576,0.00548852572483505,0.135523069362501
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,40116,0.00749482979970052,0.00502149433918705,-0.0023472991051061,0.0173369587045071,0.135583985717184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,40269,-0.00612844689180558,0.00410903242015812,-0.0141821504353155,0.00192525665170433,0.135869923875528
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,-0.00418424467610293,0.002808807159181,-0.00968950670809769,0.00132101735589183,0.136330488349515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,42311,0.00990361644611759,0.00670554512371413,-0.0032392519963621,0.0230464848885973,0.139718581689522
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,-0.00471169362484609,0.00319030292810303,-0.010964687363928,0.00154130011423584,0.139735713078265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,-0.0036286511360749,0.00246352964748858,-0.00845716924515251,0.00119986697300271,0.140788389823069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00544337863799074,0.00369971585871574,-0.0126948217210736,0.00180806444509211,0.141239880671404
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00418068514796166,0.00284227378555374,-0.00139017147172367,0.009751541767647,0.141343032352213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0061137967520978,0.00416481473574453,-0.0142768336341571,0.00204924012996149,0.142137696743102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,-0.00604500144061514,0.00412719613279398,-0.0141343058608913,0.00204430297966107,0.143032858736845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,-0.0095486297905052,0.00655167102709844,-0.0223899050036181,0.00329264542260774,0.145024815512099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.0109004763296975,0.00748083864850067,-0.0255629200807588,0.00376196742136381,0.145111124841188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,40449,-0.00969075848945989,0.00665768458075828,-0.0227398202677461,0.00335830328882634,0.145538065160163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.0104868146343678,0.00720489076556601,-0.00363477126614161,0.0246084005348771,0.145555940486306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00931693257582198,0.00640913333042477,-0.00324496875181056,0.0218788339034545,0.146059240369023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,40302,0.00649368808264626,0.00448433728826959,-0.00229561300236214,0.0152829891676547,0.147622344494848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",42721,0.0105436446100202,0.00729054522267554,-0.00374582402642384,0.0248331132464643,0.148142047790009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,40527,0.00472796662223907,0.00327627504227942,-0.00169353246062859,0.0111494657051067,0.149022167649806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,-0.0117034681532631,0.00811489692856392,-0.0276086661332484,0.0042017298267222,0.149263639257636
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,-0.00545463150019103,0.00378215339577927,-0.0128676521559184,0.00195838915553634,0.149268607918151
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0147306684708112,0.0102158094366135,-0.0052923180249512,0.0347536549665736,0.149344799036447
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,-0.0121029025154944,0.0084012793557935,-0.0285694100528496,0.00436360502186091,0.149725730159602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,40199,0.00653194539734681,0.00453882686878717,-0.00236415526547604,0.0154280460601697,0.150143165086049
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,42611,-0.00766275179489402,0.00534408511745893,-0.0181371586251135,0.00281165503532549,0.151631147797025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00453319299475027,0.00316869246694137,-0.00167744424045482,0.0107438302299554,0.152563054892179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,42346,0.0119901644839903,0.00842552824331446,-0.00452387087290604,0.0285041998408866,0.15473793165634
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,42201,0.00387831681650974,0.00272588217860035,-0.00146441225354694,0.00922104588656642,0.154825394123848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,40482,0.00510320672764761,0.00358894035563354,-0.00193111636939414,0.0121375298246894,0.155075434195705
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,-0.0139559220901044,0.00984055653832848,-0.0332434129052283,0.00533156872501939,0.156154307694802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,40483,-0.0138108275988322,0.00975434393312877,-0.0329293417077646,0.00530768651010019,0.156842819795292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,40116,0.0101895403220111,0.0071972478582795,-0.00391706548021672,0.0242961461242389,0.156875735948793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,40511,0.00429050619553206,0.00303144181958743,-0.0016511197708593,0.0102321321619234,0.156997767168609
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,42594,-0.00839291606923737,0.00593479950940819,-0.0200251231076774,0.00323929096920268,0.157330249096119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,40250,-0.0121142755468127,0.00858232854538089,-0.0289356394957593,0.00470708840213384,0.158114431417897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,40449,-0.0159024254487913,0.0112701418810344,-0.0379919035356188,0.00618705263803625,0.158265575815124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,40182,-0.00867313521473548,0.00616238241888558,-0.0207514047557512,0.00340513432628025,0.159327566404303
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.00460677714514542,0.00329027557975201,-0.00184216299116851,0.0110557172814594,0.161500876554744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00412491761599037,0.002947840992143,-0.00165285072860992,0.00990268596059065,0.161750846464804
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0052954436806622,0.00378808136800182,-0.00212919580062138,0.0127200831619458,0.162163846174906
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,42636,-0.00937115101485517,0.00670522456818111,-0.0225133911684902,0.00377108913877981,0.16225945735845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.0113652759056997,0.00815743962022213,-0.00462330574993564,0.0273538575613351,0.16357493057426
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,-0.00799617931833896,0.00576091791278271,-0.0192875784273931,0.00329521979071514,0.165163548055594
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,-0.00853348068217201,0.0061662184446208,-0.0206192688336288,0.00355230746928476,0.166414917533043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00816636233306724,0.00590935200681328,-0.00341596760028679,0.0197486922664213,0.167018874827938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,-0.0127305163263135,0.00921305847759023,-0.0307881109423903,0.0053270782897634,0.167059498778574
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,40421,0.00996712450679261,0.00723002677121624,-0.00420372796479122,0.0241379769783764,0.168053708504113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,0.0102850353077006,0.00748842224303696,-0.00439227228865186,0.024962342904053,0.169638123136209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,42357,0.0146023130669117,0.0106470401196919,-0.0062658855676845,0.0354705117015079,0.170245518904219
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.00516521559627316,0.00376669717465535,-0.00221751086605132,0.0125479420585976,0.170309925816867
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.00537637041161697,0.00392335553769679,-0.00231340644226875,0.0130661472655027,0.17060062808066
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00736581547751773,0.00538484219838169,-0.00318847523131038,0.0179201061863458,0.171377875462286
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0117913257831954,0.0086291798635248,-0.00512186674931319,0.028704518315704,0.171821352702428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,-0.0126527978140605,0.0092711565811329,-0.030824264713081,0.00551866908496,0.172354893763546
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,40199,-0.00424424650681273,0.00311334536912035,-0.0103464034302886,0.00185791041666315,0.17283380532229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,40065,0.00561750995426782,0.00414751714024038,-0.00251162364060332,0.013746643549139,0.175628280244296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,-0.00599635329449117,0.00442778375261916,-0.0146748094496247,0.00268210286064239,0.175682693542936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,42247,0.00903748162737566,0.00668022412652411,-0.00405575766061158,0.0221307209153629,0.176120271010017
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,42311,0.00450005204064344,0.00333878137687781,-0.00204395945803707,0.011044063539324,0.17774189938487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,-0.00373807315732658,0.00277637758947316,-0.00917977323269398,0.00170362691804082,0.178201567718759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,42587,-0.00987184776372954,0.00736811206047336,-0.0243133474022573,0.00456965187479826,0.180330846600263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00452807100467198,0.00338346408929114,-0.0111596606196826,0.00210351861033865,0.180828349396369
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,-0.00533434526620741,0.00399134092476287,-0.0131573734787426,0.00248868294632781,0.181415222516217
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,42370,-0.00681641929932275,0.00514601264249441,-0.0169026040786118,0.00326976547996629,0.185326123094756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.00383088867054181,0.00289538444797511,-0.00950584218857303,0.0018440648474894,0.185823997850347
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,40302,0.00741896333889734,0.0056558735182877,-0.00366654875694654,0.0185044754347412,0.189639292815868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,40136,0.00688779558360579,0.0052652958626195,-0.00343218430712843,0.01720777547434,0.190849993804278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00927386130022414,0.00708959653345024,-0.00462174790533834,0.0231694705057866,0.190868371399289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,42636,-0.00531637183822675,0.00407053094230649,-0.0132946124851475,0.00266186880869398,0.191553317400549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.00339905967820348,0.0026106835252618,-0.00851599938771661,0.00171788003130966,0.192945396705746
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,40539,-0.00666378018868091,0.00512025426314005,-0.0166994785444354,0.00337191816707359,0.193129207226161
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,40182,0.00881193369080491,0.0067723791946718,-0.00446192953075182,0.0220857969123616,0.193231745592827
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,40511,0.0138583965458672,0.0106828383086203,-0.00707996653902854,0.0347967596307629,0.194568904099402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,42500,0.0062707877978451,0.00483462305012375,-0.00320507338039746,0.0157466489760877,0.194633628684523
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.0078094636359775,0.00602211620636398,-0.0039938841284959,0.0196128114004509,0.194728358031875
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.0043135609470772,0.00333134528730465,-0.00221587581603991,0.0108429977101943,0.195397953592277
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,-0.00594679386932537,0.00459282027522958,-0.0149487216087753,0.0030551338701246,0.195415023851625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,-0.0140574365114972,0.0108586396668762,-0.0353403702585745,0.00722549723558019,0.195485579642278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,40532,0.00682108451098944,0.00527412935319113,-0.00351620902126517,0.017158378043244,0.19593019440711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,40080,0.0103000364149405,0.00798044146270791,-0.00534162885196696,0.025941701681848,0.196849018248685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,40080,0.00339823193793188,0.00263432402408,-0.00176504314926492,0.00856150702512867,0.197084130044662
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,-0.00408663191266484,0.00317029144947841,-0.0103004031536425,0.00212713932831285,0.197406426297927
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,0.00561148952172564,0.00435384511720467,-0.00292204690799551,0.0141450259514468,0.197474642801127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,-0.0309934318236039,0.0240499875606874,-0.0781314074425511,0.0161445437953433,0.197525733002138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,-0.00752927252582457,0.00584369855849208,-0.018982921700469,0.0039243766488199,0.197619179988329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,-0.0114377331696855,0.00891314576058456,-0.0289074988604312,0.00603203252106026,0.19943392765801
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,40116,-0.00594709485144476,0.00463820481566253,-0.0150379762901433,0.0031437865872538,0.199800569405686
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,0.00598721253966861,0.00467794262427372,-0.00318155500390788,0.0151559800832451,0.200613171202432
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,40527,-0.00600157521342215,0.0047049503583814,-0.0152232779158497,0.00322012748900539,0.202127569224245
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,40080,0.0151536196581532,0.0118909803412658,-0.00815270181072779,0.0384599411270342,0.202556214074707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,42346,0.0109062217345897,0.00856201182553642,-0.00587532144346167,0.0276877649126411,0.202759668732786
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,40080,0.00439786410897578,0.00345282806958528,-0.00236967890741138,0.0111654071253629,0.202797258758553
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,-0.00528275489243962,0.00415507831620873,-0.0134267083922087,0.0028611986073295,0.20361370421069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,40199,-0.00281232368676939,0.00221376364447946,-0.00715130042994913,0.00152665305641034,0.203975737770585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,-0.00691113130368719,0.00545110914547258,-0.0175953052288134,0.00377304262143906,0.204877325984372
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,42346,-0.0101066775085842,0.0079794270475728,-0.0257463545218268,0.00553299950465853,0.205323687803897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,-0.00683471404034577,0.00539889256590224,-0.0174165434695141,0.00374711538882262,0.205558110491557
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,42311,-0.00490687770946193,0.00389421226889018,-0.0125395337564867,0.00272577833756283,0.207676008089714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.0107285481579106,0.00852276150064671,-0.0274331606991781,0.00597606438335697,0.208125155432485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00618943709154529,0.00492367382249294,-0.00346096360054087,0.0158398377836315,0.208752434833083
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,0.00340910415911101,0.00271289487824944,-0.00190816980225789,0.00872637812047992,0.20891365944301
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0115138187128594,0.00919061877850782,-0.00649979409301596,0.0295274315187347,0.21031191923496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,40116,0.00926045589778468,0.00740199827149593,-0.00524746071434734,0.0237683725099167,0.210933868191762
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,-0.0082426923995485,0.00659667075560616,-0.0211721670805366,0.00468678228143958,0.211496010345304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,40539,-0.00331615569160105,0.00267244884597118,-0.00855415542970456,0.00192184404650246,0.214680251999215
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,-0.00417200751149921,0.00336535687030617,-0.0107681069772993,0.00242409195430089,0.215115012349925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,0.00603186889682523,0.00486582634532338,-0.0035051507400086,0.0155688885336591,0.21513552282356
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,42370,0.00577535344613518,0.00467002838605563,-0.00337790219053385,0.0149286090828042,0.216226140431055
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,-0.00775274266459981,0.00629241714202877,-0.0200858802629762,0.00458039493377657,0.217946042699985
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,-0.00423293038099965,0.00343924175925558,-0.0109738442291406,0.00250798346714128,0.218433880629744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,42322,-0.0105564169290384,0.00858473813886148,-0.0273825036812069,0.0062696698231301,0.218841782982724
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,40182,-0.00642990635134396,0.00524058636001546,-0.0167014556169743,0.00384164291428634,0.219869901705671
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,40199,0.00414434742858713,0.00337878563771088,-0.00247807242132619,0.0107667672785005,0.220007117101843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,-0.0125827928899265,0.010296182222732,-0.0327633100464813,0.00759772426662826,0.221702077168292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,-0.00642833994952303,0.00526266309307486,-0.0167431596119497,0.00388647971290369,0.221922905864977
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,42711,-0.00783596130829227,0.00641790692157989,-0.0204150588745889,0.00474313625800432,0.222125194835895
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0111421088946766,0.00912846981493283,-0.00674969194259179,0.0290339097319449,0.222268015243382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,40182,-0.00406838700307252,0.0033538006894255,-0.0106418363543465,0.00250506234820146,0.225130047815929
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,40199,0.00681537869533878,0.00562800383871106,-0.00421550882853489,0.0178462662192125,0.225930531454359
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,40136,0.0114666219473324,0.00947131046687846,-0.00709714656774941,0.0300303904624141,0.226048438463874
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,0.00352585777804609,0.00291262440132173,-0.0021828860485445,0.00923460160463668,0.226096266263983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,42721,0.00538026802280805,0.00445502693287253,-0.0033515847656221,0.0141121208112382,0.227189666395281
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,42346,0.0201491287488288,0.0166870928331897,-0.0125575732042231,0.0528558307018807,0.227273718284769
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,42594,-0.00799270757409195,0.0066209599085592,-0.020969788994868,0.00498437384668408,0.227383139560844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,42569,0.00344328821624585,0.00285711352586749,-0.00215665429445444,0.00904323072694614,0.228161609314399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,42587,0.0025660831575014,0.00213042151361939,-0.0016095430091926,0.00674170932419539,0.228419399415594
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.00347998266965205,0.00289647940100387,-0.00915708229561963,0.00219711695631554,0.229597079890244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,40116,0.00620479484276906,0.00516590169660221,-0.00392037248257127,0.0163299621681094,0.229736183041494
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00447358662208277,0.00373164374095323,-0.00284043511018556,0.0117876083543511,0.230621976212917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00864419731609861,0.00721125945236639,-0.00548987121053951,0.0227782658427367,0.230667200060806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,42370,0.00524111293964889,0.00437841880408483,-0.00334058791635739,0.0138228137956552,0.231315126941709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,42531,-0.00545664246979336,0.00455899008342747,-0.0143922630333112,0.00347897809372449,0.231367899707917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,-0.00439277734912563,0.00367301897955172,-0.011591894549047,0.00280633985079574,0.231738424218817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00542514182935768,0.00455201919135136,-0.0143470994444063,0.00349681578569098,0.233361749052614
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00610443157854468,0.00512297930917241,-0.00393660786743325,0.0161454710245226,0.233452327988763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,-0.00895874680398371,0.0075229294214055,-0.0237036884699385,0.00578619486197108,0.233734056493317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,42636,-0.0101074211155578,0.00849046020409027,-0.0267487231155748,0.00653388088445909,0.233892779124882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,-0.0042120568380157,0.00356432382522257,-0.0111981315354519,0.00277401785942054,0.237334860935182
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,40116,0.00409124596766578,0.00346752432098319,-0.00270510170146128,0.0108875936367928,0.238075550522637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,42346,0.00928082030201122,0.00786717075796932,-0.00613883438360865,0.0247004749876311,0.238144990305425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,-0.00555640789999386,0.0047242743022592,-0.0148159855324219,0.00370316973243418,0.239563743745475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00423901094109552,0.00361034882191632,-0.00283727274986046,0.0113152946320515,0.240365097164463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,-0.00897482165162307,0.00764574046784795,-0.023960472968605,0.00601082966535891,0.240487407676068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,42794,0.0020365692698524,0.00173771002222842,-0.00136934237371531,0.00544248091342011,0.241223795830978
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,42332,-0.00590558438956214,0.00506197807782115,-0.0158270614220916,0.00401589264296731,0.243370710338108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,40199,-0.00714588195518456,0.0061355921498182,-0.0191716425688282,0.00487987865845911,0.244181680774079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,-0.00635318135292533,0.00545983551596424,-0.0170544589642153,0.00434809625836459,0.244602475910474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,-0.00897616175006328,0.00772600862640872,-0.0241191386578244,0.0061668151576978,0.245333331320195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,42689,-0.00522717670565482,0.00450341597145219,-0.0140538720097011,0.00359951859839148,0.245778872373647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,40080,0.00478273088078259,0.00412113934835539,-0.00329470224199398,0.0128601640035592,0.245856064771811
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,40539,-0.00301261360313662,0.00259919225080182,-0.00810703041470819,0.00208180320843494,0.246457091059226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00814461654632838,0.00702812705126929,-0.0219197455668162,0.00563051247415942,0.246538520646756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,-0.00750238318765922,0.0064767459538153,-0.0201968052571372,0.00519203888181878,0.246743567653595
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,0.00840492954388923,0.00725972432668877,-0.00582413013642075,0.0226339892241992,0.246987635267604
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,0.00459620905012612,0.00397246899354967,-0.00318983017723123,0.0123822482774835,0.247290326366233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,42553,-0.00690079781124172,0.00596447752876376,-0.0185911737676187,0.00478957814513525,0.247300081976577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00293144915379363,0.00253611295049663,-0.00790223053676702,0.00203933222917977,0.247753495601928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,0.0090459966837623,0.00783003410991343,-0.00630087017166802,0.0243928635391926,0.247995004579855
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,-0.00786567263003299,0.00683348649147315,-0.0212593061533204,0.00552796089325438,0.249732782118364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,-0.00442828896994577,0.00385212295119117,-0.0119784499542805,0.00312187201438892,0.250345698513298
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,40302,0.00681641584460893,0.00595272004373757,-0.00485091544111671,0.0184837471303346,0.252195459578858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,0.00424237130532835,0.00371438111955195,-0.00303781568899346,0.0115225582996502,0.25341685623453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,40116,-0.00383404309670253,0.0033590640451935,-0.0104178086252818,0.00274972243187673,0.253727613268019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,42782,0.0051928621560135,0.00455836597313417,-0.00374153515132947,0.0141272594633565,0.254642422281751
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00388376261684294,0.00341206750296698,-0.0105714149226582,0.00280388968897235,0.255043913194524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,40199,-0.0038044080538138,0.00334757508240818,-0.0103656552153338,0.00275683910770623,0.255785984881358
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,42611,0.00714024264013732,0.00629135355133542,-0.0051908103204801,0.0194712956007547,0.256425139813342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,-0.00750390950438202,0.00662827025411931,-0.0204953192024559,0.00548750019369182,0.257610281876909
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,0.00449155256641415,0.00397855163552586,-0.00330640863921654,0.0122895137720448,0.258947012736752
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00293330515508734,0.00260035093300882,-0.00216338267360994,0.00802999298378462,0.259326946314218
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,40511,0.00436155035062252,0.00386877597771686,-0.00322125056570253,0.0119443512669476,0.259609064262959
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00855291932965691,0.00759810012566053,-0.00633935691663774,0.0234451955759516,0.260331812597776
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,0.00223486808343305,0.00198988234674663,-0.00166530131619034,0.00613503748305645,0.261412171680502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,40293,0.00277225117329318,0.00246907522938113,-0.00206713627629384,0.0076116386228802,0.261551290541015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,0.00284178613473967,0.00253816565056419,-0.00213301854036614,0.00781659080984547,0.262899573113237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,40136,0.00866090056384482,0.00773778634213686,-0.00650516066674343,0.0238269617944331,0.263036948794742
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,40136,0.00385222139030292,0.00345366152469356,-0.00291695519809645,0.0106213979787023,0.264702636878585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.00825378978280841,0.00747165946397589,-0.0228982423322012,0.00639066276658434,0.269318245674028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,0.00409299222922661,0.00373945680905171,-0.00323634311651474,0.0114223275749679,0.273741365352815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,-0.0051846070268982,0.00474658938015891,-0.0144879222120097,0.00411870815821325,0.274733739005946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,-0.00756207436739705,0.00692550324639258,-0.0211360607303265,0.00601191199553241,0.274893024110567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,-0.00355709164014622,0.00325794529814835,-0.00994266442451699,0.00282848114422456,0.274936022292287
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,42495,-0.00980363103213014,0.00899309451587361,-0.0274300962832424,0.00782283421898214,0.275676174686205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,-0.0044216351766591,0.00405939087707943,-0.0123780412957348,0.00353477094241657,0.27607380586253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00385939556142006,0.00354954932950924,-0.00309772112441806,0.0108165122472582,0.276931723689296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,-0.00592106836390034,0.00545652965119895,-0.0166158664802503,0.00477372975244961,0.277885278320139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,40136,0.00594307040372333,0.00549093340920672,-0.00481915907832183,0.0167052998857685,0.279124234426392
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,40182,0.00533580445567611,0.0049336878348308,-0.00433422370059225,0.0150058326119445,0.27949659736293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,-0.00788002058802692,0.00729315815044693,-0.0221746105629029,0.00641456938684906,0.27995390248059
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,42357,0.00773337642756748,0.00716290280329186,-0.00630591306688457,0.0217726659220195,0.280321057091484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,0.00715616725449584,0.00664289424004413,-0.00586390545599066,0.0201762399649823,0.281385107003934
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,-0.00690711355629777,0.00641908332954069,-0.0194885168821975,0.00567428976960198,0.281938311537194
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,40223,-0.00755142724014889,0.00701905661275002,-0.0213087782011389,0.00620592372084114,0.282019461569737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,0.0103234501459818,0.00961614901118844,-0.00852420191594758,0.0291711022079111,0.283046578896101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,40199,0.00497547913401275,0.00463781914112629,-0.00411464638259478,0.0140656046506203,0.283381795216035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,-0.00293608703355656,0.0027395883246967,-0.00830568014996208,0.00243350608284897,0.283866194413184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,0.00482148509512918,0.00450964026548813,-0.00401740982522755,0.0136603800154859,0.28502138624227
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,40283,-0.0118825180738198,0.0111189424952,-0.0336756453644118,0.00991060921677223,0.285240124474643
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,40182,-0.00435335527909107,0.00408001588755023,-0.0123501864186895,0.00364347586050739,0.285997676981814
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,0.00427935570171543,0.0040155506928999,-0.00359112365636837,0.0121498350597992,0.286584317988257
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,42370,-0.00341632030226737,0.00320687123594222,-0.00970178792471412,0.00286914732017938,0.286754018311596
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,42353,-0.00945902185816131,0.00888231880922916,-0.0268683667242505,0.00795032300792785,0.286928467819737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,40116,0.00577088856377017,0.00542053032197325,-0.00485335086729739,0.0163951279948377,0.287064481363018
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.00377427445818055,0.00354992724683162,-0.00318358294560943,0.0107321318619705,0.287711443520049
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,42656,-0.00337226622372014,0.00317203825285756,-0.00958946119932095,0.00284492875188067,0.28774533088497
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,40511,-0.00553895665591526,0.00521283761867507,-0.0157561183885184,0.00467820507668788,0.288003866999634
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,-0.00940070151303331,0.00884967318183509,-0.0267460609494301,0.00794465792336346,0.288138355989491
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,40136,-0.00799216421323812,0.00753045912701143,-0.0227518641021805,0.00676753567570428,0.288571704558079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,40116,-0.00984562183810707,0.009279875088278,-0.0280341770111319,0.0083429333349178,0.288729308386849
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,42608,-0.00622037407167057,0.00587108698769829,-0.0177277045675592,0.00528695642421807,0.28939450839897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,0.00308528674782241,0.00291475309781371,-0.00262762932389245,0.00879820281953727,0.289843817415645
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,42652,0.00484188776109375,0.00457435252097299,-0.00412384318001331,0.0138076187022008,0.289852961867029
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,-0.00487412550698148,0.00460624223209979,-0.0139023602818971,0.00415410926793412,0.290003005022675
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,0.00897869073557057,0.00851338483730276,-0.00770754354554285,0.025664925016684,0.291606177891084
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,-0.00453038093958504,0.00430157739452748,-0.0129614726328589,0.00390071075368882,0.292276711825764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,40136,0.0102893173191347,0.0097973195126409,-0.00891342892564144,0.0294920635639109,0.29364127672846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,0.00413412653505219,0.00393739995002391,-0.00358317736699467,0.0118514304370991,0.293758090450143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,40182,-0.00291528726992678,0.0027848359324426,-0.00837356569751427,0.00254299115766071,0.295194811244828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,0.00563018134013079,0.00538177931633229,-0.00491810611988051,0.0161784688001421,0.295511761465244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,40182,-0.00905950839353407,0.00867843754372101,-0.0260692459792272,0.0079502291921591,0.296549961409966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,0.00459115083697438,0.00440600130475695,-0.00404461172034924,0.013226913394298,0.297424486084272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,40539,-0.00272968788178129,0.00262165952467836,-0.00786814055015087,0.0024087647865883,0.29780209423095
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,40136,-0.004744863500353,0.00459789544739277,-0.0137567385772428,0.00426701157653682,0.302111696850538
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,42794,0.00321405142114472,0.00312213634003775,-0.00290533580532926,0.0093334386476187,0.30329136039206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00599999600555838,0.00582864550133711,-0.00542414917706235,0.0174241411881791,0.303315560503299
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,40333,-0.00644688935882,0.00628810528551521,-0.0187715757184298,0.00587779700078981,0.305266798847474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,40451,0.00564367837841036,0.00552980001076652,-0.00519472964269201,0.0164820863995127,0.307468965982783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,-0.00458604063713709,0.00449656935137792,-0.0133993165658378,0.00422723529156363,0.307799203229294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,0.000836302386012729,0.00082131839761008,-0.000773481673303028,0.00244608644532849,0.308584224425829
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,40302,-0.00451877303861452,0.00447590325296211,-0.0132915434144203,0.00425399733719122,0.312719549366651
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,0.00751573716277455,0.00744664551352216,-0.00707968804372888,0.022111162369278,0.312863204417542
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,42721,0.00463773061042624,0.00460374589318881,-0.00438561134022384,0.0136610725610763,0.313769271184625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,0.0051838809160012,0.00516164970942286,-0.00493295251446762,0.01530071434647,0.315252870861674
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",40451,-0.00431029626003272,0.00429688341603088,-0.0127321877554532,0.00411159523538781,0.315823790233368
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.00860967834808287,0.00860656586190586,-0.0254785474374184,0.00825919074125261,0.317154176120611
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,40199,-0.00287950352057019,0.00288045947169636,-0.00852520408509505,0.00276619704395468,0.317493121900358
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,42611,-0.00438594738646108,0.0043923764472823,-0.0129950052231344,0.00422311045021222,0.318037372564641
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,-0.00483476262825495,0.00486338570686745,-0.0143669986137151,0.00469747335720525,0.320185362823214
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,42679,0.00796658153472832,0.0080172547483926,-0.00774723777212118,0.0236804008415778,0.320396765161665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,40060,-0.00442242584673004,0.00445315309261305,-0.0131506059082516,0.00430575421479153,0.320683391486877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,-0.00224749361384781,0.00226317764686528,-0.00668332180170377,0.00218833457400815,0.320697159755802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,40302,0.00280091284104592,0.00282606593291569,-0.00273817638746883,0.00834000206956068,0.321658532172792
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,42651,0.00347494667556604,0.00351131296677012,-0.00340722673930339,0.0103571200904355,0.322366385566936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,-0.00459625399823762,0.00465789067245097,-0.0137257197162415,0.00453321171976629,0.323774902907225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,40182,-0.00600738896677707,0.00610232516631003,-0.0179679462927447,0.00595316835919059,0.324919607506524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,-0.0105569193457255,0.0108020492053719,-0.0317289357882544,0.0106150970968034,0.328438656498209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,40116,-0.00831835883097758,0.00851928942521182,-0.0250161661043927,0.00837944844243758,0.328880659953512
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,40199,-0.00852488606351417,0.00873102937820037,-0.0256377036447869,0.00858793151775856,0.328892907485004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,40116,-0.00487117174138324,0.00499953271768632,-0.0146702558680484,0.00492791238528194,0.32991657233958
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,-0.00513357853549506,0.00527753002619638,-0.01547753738684,0.00521038031584985,0.330708210159804
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00397461992158037,0.00409673283965244,-0.00405497644413841,0.0120042162872991,0.331968383224795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,42311,-0.00722358825552607,0.00746068496727069,-0.0218465307913766,0.00739935428032448,0.332952102020237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,0.00409168574044071,0.00422639182725804,-0.00419204224098504,0.0123754137218665,0.33300205442768
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,42754,-0.00741867235972376,0.00772256537633083,-0.0225549004973322,0.00771755577788467,0.336745964012696
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,-0.00429938304923862,0.00447794690885408,-0.0130761589905926,0.00447739289211537,0.337013572542904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,42357,0.00592090015485571,0.00617807688761512,-0.00618813054486992,0.0180299308545813,0.337892464296637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,-0.00278753465187877,0.00291142777923289,-0.00849393309917523,0.00291886379541769,0.33836349207427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00499970324989035,0.005225114806615,-0.00524152177107504,0.0152409282708557,0.338659111897375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,40199,-0.00458431295029462,0.00480723420740981,-0.0140064919968179,0.00483786609622861,0.340292942697951
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,-0.00603304922474327,0.00632947371455453,-0.0184388177052701,0.00637271925578362,0.340525491925602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,40182,-0.00723072414410377,0.00762890458746298,-0.0221833771355312,0.00772192884732367,0.343248895391452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,-0.0041226660993772,0.00435659754135657,-0.0126615972804361,0.00441626508168167,0.344013877927131
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,0.00257963760143138,0.00273840920526779,-0.00278764444089349,0.00794691964375625,0.346202980960021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,-0.00380575220123074,0.00404769264916414,-0.0117392297935924,0.00412772539113097,0.347121639006112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,0.00352640324616026,0.00376521554290895,-0.00385341921794128,0.0109062257102618,0.348994522353613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,-0.0116907362591311,0.0125686588648941,-0.0363253076343236,0.0129438351160615,0.352313390204936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,42587,-0.0178225060356109,0.0192004253429611,-0.0554553397078146,0.0198103276365927,0.353302431953305
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,-0.0252648693108312,0.0272338738533379,-0.0786432620633735,0.0281135234417112,0.353583423098612
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,40302,0.00507088405057729,0.00547308101335659,-0.00565635473560163,0.0157981228367562,0.354199256433846
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,-0.00721207665067826,0.00782245676359077,-0.0225440919073162,0.00811993860595966,0.35656424381865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,42594,-0.00506752070537623,0.00551316726207581,-0.0158733285390448,0.00573828712829236,0.358024841093486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,40223,-0.00167741559263441,0.00182942366315873,-0.00526308597242552,0.0019082547871567,0.359210212665559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,40182,-0.00327021470247624,0.00357497252525876,-0.0102771608519834,0.00373673144703092,0.360341700832234
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,40083,0.00805775011254775,0.00883098267381642,-0.00925097592813242,0.0253664761532279,0.36155684776614
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,0.00347418698915617,0.00381092382009629,-0.00399522369823257,0.0109435976765449,0.361978755552003
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,-0.00306907487912312,0.00336689061974436,-0.00966818049382206,0.00353003073557581,0.36202780752126
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,42711,0.0027121220096407,0.00297642189422468,-0.00312166490303967,0.00854590892232106,0.362205124099258
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,42346,-0.0126846119954831,0.0139655757080809,-0.0400571403833218,0.0146879163923555,0.363748503606639
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,42636,-0.00592140762329089,0.00652160342271689,-0.018703750331816,0.00686093508523421,0.363911373021141
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,40136,0.00568554539687122,0.00626843570990679,-0.00660058859454607,0.0179716793882885,0.364420510477555
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,0.00379749859566125,0.00419368776595991,-0.00442212942562016,0.0120171266169427,0.365205948537938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,42370,-0.00380655002245694,0.00420782055069348,-0.0120538783018162,0.00444077825690227,0.36567428429851
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,-0.00365645235293769,0.00404545725319985,-0.0115855485692094,0.00427264386333402,0.366096025006486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.0038489883609707,0.00427046010251316,-0.0045211134399551,0.0122190901618965,0.367445735993692
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,40182,-0.00619133321968747,0.00687263915311847,-0.0196617059597997,0.00727903952042474,0.367678829141442
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.00517977204556186,0.00575997319360609,-0.0164693195050298,0.00610977541390609,0.368524933880304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,0.00551670592313542,0.00616188202508284,-0.00656058284602696,0.0175939946922978,0.370648816712633
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0068537980627894,0.0076654066716887,-0.00817039901372046,0.0218779951392992,0.371276875701265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,0.00258867369595441,0.00289697111717002,-0.00308938969369883,0.00826673708560766,0.371562925699249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00813563328738452,0.00911084002467982,-0.025992879735757,0.00972161316098794,0.371896649108409
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,-0.00435428325046629,0.00495450493610496,-0.014065112925232,0.00535654642429943,0.379500014271036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,40482,-0.00196001132860223,0.00223140634015853,-0.00633356775531294,0.00241354509810848,0.379758995119656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,-0.010636465532092,0.0121287407847021,-0.0344087974701082,0.0131358664059241,0.380525601907798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,40116,-0.00425154544483777,0.00485422130044678,-0.0137658191937135,0.00526272830403792,0.381133565087209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,-0.00460709295344503,0.0052668183780611,-0.0149300569744448,0.00571587106755472,0.38173434147287
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,42370,0.00563036396690003,0.00644517286005036,-0.00700217483879868,0.0182629027725987,0.382363799717636
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,42311,0.00430705531120014,0.00493371641583276,-0.00536302886383208,0.0139771394862323,0.382687799074541
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,40483,0.0090628386520205,0.0103916063070117,-0.0113047097097224,0.0294303870137634,0.383155639910547
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,40116,0.00519914381281541,0.00597914852247205,-0.00651998729122981,0.0169182749168606,0.384567747012421
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,40482,0.00316297753545351,0.00365058659985069,-0.00399217220025385,0.0103181272711609,0.386272845710358
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.00289180610635383,0.00334189183990385,-0.00365830189985771,0.00944191411256537,0.386881476303692
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,-0.00316560988304063,0.00366061381877396,-0.0103404129678376,0.00400919320175634,0.387177653747314
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00416107382541841,0.00482856057051317,-0.0053029048927874,0.0136250525436242,0.388836984582189
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,-0.00344587933554769,0.00400481668974502,-0.0112953200474479,0.00440356137635254,0.389568889757598
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,40199,-0.00259263311491885,0.00301469799277547,-0.00850144118075877,0.00331617495092108,0.389809085291136
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,-0.00833507759739213,0.00972836999260976,-0.0274026827829073,0.010732527588123,0.391584452185913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,-0.00469527708837688,0.00548346983443214,-0.0154428779638639,0.00605232378711012,0.391872329844112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,42370,0.00431178161779801,0.00505196277115444,-0.00559006541366469,0.0142136286492607,0.393405130825606
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,-0.00729880505854838,0.00856328234034959,-0.0240828384456336,0.00948522832853682,0.394042463900772
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,-0.00540684861082213,0.00635527723691023,-0.0178631919951662,0.00704949477352192,0.394918517520863
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.00588285203111664,0.00694696645537862,-0.00773320222142545,0.0194989062836587,0.397112075693705
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,-0.00380095459721258,0.00449396180561523,-0.0126091197362184,0.00500721054179327,0.397684439654791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,0.00416596402958321,0.00492805628190761,-0.0054930262829557,0.0138249543421221,0.397930446716453
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,42689,0.00252678397819113,0.00302064923570598,-0.00339368852379259,0.00844725648017485,0.402886460621871
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,42611,0.00201545110373324,0.00241707543889079,-0.0027220167564927,0.00675291896395918,0.404386714172435
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,40080,-0.00643761144580145,0.00773951516303741,-0.0216070611653548,0.00873183827375187,0.405548642742587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,0.00299942308940263,0.00361709133486089,-0.00409007592692471,0.01008892210573,0.406988296642265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00313375907094273,0.00381222903446143,-0.0106057279784871,0.00433820983660167,0.411078863480409
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,-0.00453763114269271,0.00553373364448708,-0.0153837490858874,0.00630848680050197,0.412237030271859
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,40302,-0.00683788244717192,0.00835230424114862,-0.0232083987598232,0.00953263386547938,0.412985342313873
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,0.00555292499128995,0.00679554473070481,-0.00776634268089147,0.0188721926634714,0.413865108826247
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,40199,0.00860818627567958,0.010565189908162,-0.0120995859443179,0.0293159584956771,0.415222339041621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,40116,0.00332260471191496,0.00409336511652556,-0.00470039091647513,0.0113456003403051,0.416978644668307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0042825546367471,0.00529296233559422,-0.00609165154101758,0.0146567608145118,0.418470220649489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00362509778982036,0.00448194294129498,-0.0124097059547585,0.0051595103751178,0.418634645908648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,40116,0.00422697078227777,0.00523927205885772,-0.00604200245308336,0.0144959440176389,0.419807415912197
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,-0.00396968920192619,0.00496412073017136,-0.0136993658330621,0.00575998742920967,0.423915252989159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,42710,0.00355656094992752,0.00444951629660813,-0.00516449099142441,0.0122776128912794,0.424122372672802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,40482,0.00266250693589561,0.00333189981681264,-0.00386801670505716,0.00919303057684837,0.424251715367784
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,-0.00475088858618924,0.00594606567375172,-0.0164051773067426,0.00690340013436413,0.424309588073828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,40451,-0.00365428829046,0.00457674053545473,-0.0126246997399513,0.00531612315903128,0.424627533284984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,42495,0.000956650550015292,0.00119829256726906,-0.00139200288183206,0.00330530398186265,0.424684723928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,42636,-0.00600589371643469,0.00753584675507799,-0.0207761533563876,0.00876436592351818,0.42547868320406
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00444054153882369,0.0055892837406786,-0.0153955376705538,0.00651445459290637,0.42693676177572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,0.00164450154353802,0.00207256399486085,-0.00241772388638925,0.00570672697346529,0.427522447828505
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,42293,0.00448409060444181,0.00567715245093589,-0.00664312819939254,0.0156113094082762,0.429630521777379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,40080,0.00548502063577622,0.00694763395884193,-0.00813234192355395,0.0191023831951064,0.429848492543476
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,40080,-0.00419653956949004,0.0053402253451928,-0.0146633812460679,0.00627030210708785,0.431980869295864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,-0.00354337172087171,0.00451023122184444,-0.0123834249156868,0.00529668147394339,0.432101486269752
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,0.00352593739308982,0.00451536515799407,-0.00532417831657856,0.0123760531027582,0.434892225865304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,0.0028357450391731,0.00364499770844487,-0.00430845046937884,0.00997994054772504,0.436596083559535
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,-0.00286200642294734,0.00368215424944795,-0.0100790287518653,0.00435501590597063,0.43701928589181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,-0.00245157895117995,0.00318577660749279,-0.00869570110186582,0.00379254319950592,0.441589991275237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,40080,-0.00328350658898837,0.00428510912797084,-0.0116823204798112,0.00511530730183446,0.4435383858504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,40080,0.00729920459750014,0.00953944297040822,-0.0113981036245,0.0259965128195003,0.444192587206479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,40482,-0.00277718976994018,0.00365372877039356,-0.00993849815991156,0.0043841186200312,0.447212236282262
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,0.00307312096770167,0.00404701832850516,-0.00485903495616844,0.0110052768915718,0.44765409146004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,40539,-0.00554410338133491,0.00730150411282982,-0.0198550514424814,0.00876684467981154,0.447683052763206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,42594,-0.00416675501634083,0.00550140880131131,-0.014949516266911,0.00661600623422934,0.448824881468414
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,40302,0.00265703471444556,0.00353945802640705,-0.00428030301731226,0.00959437244620338,0.452855319416579
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,0.00308878493451204,0.00412630824389098,-0.00499877922351428,0.0111763490925384,0.454139205522156
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,-0.00706660076257301,0.00949674033497527,-0.0256802118191245,0.0115470102939785,0.456826654836376
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,-0.00639173819738091,0.00860180827051796,-0.0232512824075961,0.0104678060128343,0.457455780387226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,-0.00436682705305133,0.00588031282215301,-0.0158922401844712,0.00715858607836857,0.457728744798004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,42676,-0.00162427799988496,0.00219063322724776,-0.00591791912529058,0.00266936312552066,0.45842442368457
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,-0.00842809701690981,0.0113738593864965,-0.0307208614144429,0.0138646673806233,0.458706204116831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,0.00376151686662383,0.00508519051180591,-0.00620545653651576,0.0137284902697634,0.459497678296916
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00336618212117856,0.00456585474624976,-0.00558289318147097,0.0123152574238281,0.460982758916623
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,40080,0.00235372898141429,0.00319632739667297,-0.00391107271606472,0.00861853067889331,0.461512025940534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,0.00514504903245031,0.006992911763208,-0.00856105802343737,0.018851156088338,0.461897418351592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00166568460400658,0.00227382652906785,-0.00279101539296641,0.00612238460097956,0.463847444362715
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,42357,-0.00174762881405512,0.00240771922249711,-0.00646675849014945,0.00297150086203921,0.467947247795146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,42638,-0.00214532203946455,0.00295689464982226,-0.00794083555311619,0.00365019147418708,0.468138276965098
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,42587,-0.0060694786014493,0.00841278674645261,-0.0225585406244964,0.0104195834215978,0.470639906110104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,40136,0.00473873919643029,0.00659473198869962,-0.00818693550142096,0.0176644138942815,0.472424738912557
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,40527,0.00345629948589505,0.00481013391268115,-0.00597156298296002,0.0128841619547501,0.472435892823549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,-0.00284359857364532,0.00396330867685761,-0.0106116835802862,0.0049244864329956,0.47309271561193
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00292271415103742,0.00408262152133138,-0.00507922403077209,0.0109246523328469,0.474073608042606
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00293694617228354,0.00413235718509109,-0.00516247391049499,0.0110363662550621,0.477273233861894
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,40136,0.00406784626069033,0.00572962287869784,-0.00716221458155742,0.0152979071029381,0.477739394955957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,40451,-0.00784013132130746,0.0110687215705024,-0.0295348255994921,0.0138545629568772,0.4787649023237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,-0.00233634839600157,0.00329917420796501,-0.00880272984361299,0.00413003305160986,0.478857244058242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,40136,0.00526916553251827,0.00744826619685201,-0.00932943621331168,0.0198677672783482,0.47931114809212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,40080,0.00408629009681932,0.00579008510206958,-0.00726227670323704,0.0154348568968757,0.480365432779328
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,0.00215642771828037,0.00306204279653361,-0.00384517616292551,0.00815803159948625,0.481292713256689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,40080,-0.00317705614475455,0.00451510494806845,-0.0120266618429687,0.00567254955345961,0.48166546332892
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,40080,0.00470014504111898,0.00668231825877611,-0.0083971987460822,0.0177974888283202,0.48183997440224
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,-0.00338773927217383,0.00488961933856021,-0.0129713931757519,0.00619591463140418,0.488422719935484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,42276,-0.00336205606139357,0.00486863901969776,-0.0129045885400012,0.00618047641721405,0.489858384754636
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.0025532868835705,0.00370714531930627,-0.00471271794226979,0.00981929170941079,0.490996752298918
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,0.0032712202184168,0.00475083325047425,-0.00604041295251274,0.0125828533893463,0.491116590277868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,40515,-0.00760505321615869,0.011045314520486,-0.0292538696763112,0.0140437632439938,0.491131893834903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,42346,-0.00509831176389865,0.00746214089321112,-0.0197241079145924,0.00952748438679514,0.494477512692659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,40182,-0.00444461088754606,0.00651526905315077,-0.0172145382317216,0.00832531645662945,0.49513712765869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,0.00280735823937542,0.00411593896263914,-0.00525988212739729,0.0108745986061481,0.495208721020372
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00754023196587587,0.0110825443957016,-0.0141815550496992,0.0292620189814509,0.49628456265902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,40116,-0.0026210062001671,0.003862699033114,-0.0101918963050706,0.00494988390473635,0.49744204099815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,-0.00447318139942809,0.00662788045363569,-0.017463827088554,0.00851746428969787,0.499750776263641
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,0.00312145138602897,0.0046349314491686,-0.00596301425434149,0.0122059170263994,0.50066741875482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,42370,-0.00390813711536199,0.00582735142890659,-0.0153297459160189,0.00751347168529492,0.502452666018836
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,-0.0059353441789158,0.00886479890361206,-0.0233103500299954,0.0114396616721638,0.503164790186693
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,0.00184777041126334,0.00276867058769409,-0.00357882394061707,0.00727436476314375,0.504537381644306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,40302,-0.00274581958612677,0.00411899021593291,-0.0108190404093553,0.00532740123710174,0.505025893077037
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,42711,-0.00844422102821259,0.0127222137580591,-0.0333797599940084,0.0164913179375832,0.506869116886485
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,42721,-0.00420670654964148,0.0063522254573866,-0.0166570684461192,0.00824365534683626,0.507827820797328
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.00265454829136692,0.0040360293701486,-0.0105651658568582,0.00525606927412434,0.51073643417579
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,40451,-0.00285346063875448,0.00437677521032855,-0.0114319400509984,0.00572501877348949,0.514443490099488
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00177116189615925,0.00273953936687107,-0.00359833526290804,0.00714065905522654,0.517954763055735
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,40199,0.00373541663687638,0.00579039402234973,-0.00761375564692909,0.0150845889206819,0.518872088191082
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,40302,0.00265590195586098,0.00411928081075816,-0.00541788843322502,0.010729692344947,0.519103207254572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,42346,-0.00680560054771711,0.0105718999098404,-0.0275265243710044,0.0139153232755702,0.519752468287065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,-0.00382360945155281,0.00595187287118268,-0.0154892802790709,0.00784206137596524,0.520613207330911
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,0.00542284605019098,0.00844701917956916,-0.0111333115417646,0.0219790036421465,0.520897413354299
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,-0.00564597582121928,0.00881420932606875,-0.022921826100314,0.0116298744578755,0.521825921088706
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,-0.00309172371004167,0.00483739814603458,-0.0125730240762695,0.00638957665618611,0.522749886920166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.00391454730286726,0.0062125861011714,-0.00826212145542869,0.0160912160611632,0.528642654227118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,40516,-0.000929617557227814,0.00147716285541436,-0.00382485675383996,0.00196562163938433,0.529148099981947
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,40080,-0.00374211826885038,0.0059557414512163,-0.0154153715132343,0.00793113497553356,0.529806766153984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00353101180015829,0.00564679483236645,-0.00753670607127996,0.0145987296715965,0.531778970882143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,42636,0.00293640486458191,0.00470327872949937,-0.00628202144523686,0.0121548311744007,0.532420524588357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,-0.00409909036362927,0.00657206734436449,-0.0169803423585837,0.00878216163132513,0.532826277694423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00186047171549443,0.00301542453724867,-0.00404976037751296,0.00777070380850183,0.537257012587784
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,42706,-0.00370975071220521,0.00602771433868082,-0.0155240708160196,0.0081045693916092,0.53826861104319
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,0.00344067128476318,0.00559455959147872,-0.00752466551453512,0.0144060080840615,0.538565385953608
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,42689,0.00360872286426739,0.0058682684098461,-0.00789308321903096,0.0151105289475658,0.538594598018594
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.00348912119106941,0.00567951676343825,-0.00764273166526956,0.0146209740474084,0.539005137378488
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,-0.00252344172653997,0.00411336635000654,-0.0105856397725528,0.00553875631947285,0.539573832642584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.00592357178067696,0.00969115304500174,-0.0130710881875264,0.0249182317488804,0.541056788751515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,40080,-0.00253772465915416,0.00415271720372451,-0.0106770503784542,0.00560160106014589,0.541146270746602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,42311,0.00198163375633165,0.00324310207114722,-0.00437484630311689,0.00833811381578019,0.541190083623178
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.00748004114211377,0.0122815060565277,-0.0165917107286805,0.031551793012908,0.542502363725237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,-0.00524982514035368,0.00871403341271654,-0.0223293306292781,0.0118296803485707,0.546882930268462
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,0.00105515723735235,0.00175184249366004,-0.00237845405022133,0.00448876852492602,0.546976071509554
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0020397435064491,0.00339235965417683,-0.00460928141573749,0.00868876842863569,0.547666431478917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,0.00196143820243692,0.00326501202295194,-0.00443798536254889,0.00836086176742272,0.548022602460362
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,40223,0.00517161289637781,0.00861747172914611,-0.0117186316927486,0.0220618574855042,0.548431189131374
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,42292,0.00209434760427781,0.00350775410384552,-0.00478085043925941,0.00896954564781503,0.550476131837273
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,42346,0.00523392155351252,0.00879968831621433,-0.0120134675462676,0.0224813106532926,0.551997508276579
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,-0.00160445942404578,0.00270301184709041,-0.00690236264434298,0.00369344379625143,0.552801690285434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,42611,-0.00348691149762536,0.00588726392409361,-0.0150259487888488,0.00805212579359811,0.553672766242678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,42594,0.00288706639568154,0.00487741374546688,-0.00667266454543354,0.0124467973367966,0.553910350281795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,40198,-0.00414264736666569,0.00700261462170134,-0.0178677720252003,0.00958247729186893,0.554140138208812
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,42370,0.00385752977023619,0.00653304055542332,-0.00894722971839351,0.0166622892588659,0.554889278253492
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,40337,0.0020217656793625,0.00344178872465599,-0.00472414022096324,0.00876767157968824,0.556935489372471
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,40116,0.00256253093726285,0.00436728284079956,-0.00599734343070428,0.01112240530523,0.557379483911058
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,42346,0.00186230540749899,0.00318265549258565,-0.00437569935796888,0.00810031017296686,0.558462277200286
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,40283,-0.00205130806145446,0.00350667279612682,-0.00892438674186302,0.0048217706189541,0.558577935682888
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,40199,-0.00164921147855306,0.00283545304147533,-0.0072066994398447,0.00390827648273858,0.56082144656933
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,0.003182506662269,0.00547855741689268,-0.00755546587484066,0.0139204791993787,0.561318102644933
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00114790443398652,0.00198724838868826,-0.00504291127581552,0.00274710240784247,0.56352196351957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,-0.00157920905119557,0.00274479266050222,-0.00695900266577992,0.00380058456338879,0.565067875525961
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,42711,-0.00169340241555385,0.00295508421618209,-0.00748536747927075,0.00409856264816305,0.566622341663766
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,40302,0.00995072147303968,0.0173702719160527,-0.0240950114824235,0.0439964544285029,0.566751572276782
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,42370,0.00269250869364085,0.00471144683073058,-0.00654192709459108,0.0119269444818728,0.567682471059715
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,40182,0.00409862083609726,0.00717202135616703,-0.00995854102199011,0.0181557826941846,0.567690342288577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,42483,-0.00584445192229767,0.0102719668665096,-0.0259775069806565,0.0142886031360611,0.569385392326601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00375985973495895,0.00661733198213625,-0.00921011095002809,0.016729830419946,0.569921767864288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,42346,0.00306684176153486,0.00539838003721308,-0.00751398311140277,0.0136476666344725,0.569973991349201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,-0.00409615212719281,0.00723854115161382,-0.0182836927843559,0.0100913885299703,0.571485950364675
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,42460,0.00320707168291678,0.00567113511570407,-0.0079083531438632,0.0143224965096968,0.571737919617022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,40136,0.00285676440660464,0.00505713239792495,-0.00705521509332826,0.0127687439065376,0.572154667058963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,42676,-0.00186029810087216,0.00330823278658904,-0.00834443436258669,0.00462383816084236,0.573904760441853
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,40451,-0.00337347277834775,0.0060690538287762,-0.0152688182827491,0.00852187272605361,0.578325664164413
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,0.004209113945569,0.00757907955790875,-0.0106458819879322,0.0190641098790701,0.578659783892492
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,-0.00103746005037482,0.00188283562074083,-0.00472781786702685,0.00265289776627722,0.581638108662904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,42721,-0.00178439518528704,0.00324807921716387,-0.00815063045092822,0.00458184008035414,0.582761068824361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.0013042917157727,0.00238396232686117,-0.00597685787642059,0.00336827444487518,0.584313376719472
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00156835129537873,0.00287237677677384,-0.00719820977785545,0.00406150718709799,0.585068645133175
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,40302,0.00296816653589273,0.00547135159592432,-0.00775568259211893,0.0136920156639044,0.587490240328529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00318272230265524,0.00587603968109968,-0.0146997600776106,0.00833431547230013,0.588074724750725
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,-0.00456776290455563,0.00845237221121433,-0.0211344124385357,0.0119988866294245,0.588923925289597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,-0.00311701770583243,0.00584725646386562,-0.0145776403750091,0.00834360496334418,0.593991498208465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,0.00284650992891078,0.00534606533789779,-0.00763177813336887,0.0133247979911904,0.594425362937855
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,-0.00300133435105212,0.00564783135885352,-0.014071083814405,0.00806841511230079,0.595141212730902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,40429,-0.0028516983335853,0.00536901115502114,-0.0133749601974267,0.00767156353025612,0.595332041281697
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,0.0029602078356377,0.00559241815892602,-0.0080009317558573,0.0139213474271327,0.59659067368924
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.00264604709505135,0.00501755637132426,-0.0124804575828469,0.0071883633927442,0.597955844659329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,40283,-0.00214337178425391,0.00406653011175531,-0.0101137708032943,0.00582702723478649,0.598151124110609
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,42346,-0.00226064788370143,0.0043230489507433,-0.0107338238271583,0.00621252805975544,0.601032436553315
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,40482,-0.00355723611911746,0.00684234115647733,-0.016968224785813,0.00985375254757812,0.603153356314992
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00297536116161739,0.0057236499625676,-0.0141937150882499,0.0082429927650151,0.603188174932594
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00197428425737682,0.00380076299701175,-0.00547521121676621,0.00942377973151984,0.603461161896428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,42587,-0.00456830144201146,0.00879544906604805,-0.0218073816114656,0.0126707787274427,0.603494758480153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,0.00213863748700803,0.0041221327816642,-0.00594074276505379,0.0102180177390699,0.603897977020867
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,0.00121100731223079,0.00234638733874697,-0.00338791187171328,0.00580992649617485,0.605782133078868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,40269,0.00193424384724885,0.00375307111609069,-0.0054217755402889,0.0092902632347866,0.60630038809534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,40182,-0.00216423086858798,0.00420730176956668,-0.0104105423369387,0.00608208059976271,0.606983562328202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,0.00216818293063375,0.00422465547525027,-0.00611214180085679,0.0104485076621243,0.607806886680145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,0.00247775177981535,0.00484808523260926,-0.0070244952760988,0.0119799988357295,0.609306471061153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,40302,-0.00315147335360481,0.00616962345017093,-0.0152439353159398,0.00894098860873022,0.609497889867532
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.00732935734133824,0.0144247564521732,-0.0356018799875976,0.0209431653049211,0.61138677317555
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,40136,0.00371368681599734,0.00731813182289243,-0.0106298515568718,0.0180572251888665,0.611839673797599
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,40182,0.00148282623866374,0.00292998847820377,-0.00425995117861566,0.00722560365594313,0.612806409760349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,40182,0.00175480518954648,0.00347694999655026,-0.00506001680369203,0.00856962718278498,0.613782000104282
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,40532,-0.00249616404899768,0.00494877552722281,-0.0121957640823544,0.00720343598435903,0.613989882406108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,40199,-0.00240106075359026,0.00476137016495744,-0.0117333462769068,0.00693122476972632,0.614075167156591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.00132475405295154,0.00263181077174689,-0.00648310316557545,0.00383359505967237,0.614719829224399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,40483,0.00114087856957439,0.00227052906509271,-0.00330935839800732,0.0055911155371561,0.615344945333278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,42311,-0.0027832070036022,0.00554123901968439,-0.0136440354821836,0.00807762147497921,0.615484913088556
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,40461,0.0012042793200088,0.00240393108639115,-0.00350742560931786,0.00591598424933546,0.61640730318645
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,-0.00238657903454877,0.00476898355872974,-0.011733786809659,0.00696062874056152,0.616775305849983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,40451,-0.00389917351960239,0.00779863558447657,-0.0191844992651765,0.0113861522259717,0.617097876698633
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,40116,-0.00328582239296015,0.00659851025306131,-0.0162189024889603,0.00964725770304002,0.618519246598986
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,40065,-0.00178333937604726,0.00359690412059662,-0.00883327145241664,0.00526659270032212,0.620046663198673
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,42754,0.00212750208134712,0.00434725704056729,-0.00639312171816478,0.010648125880859,0.624573862939994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,40199,0.00230455537323365,0.00470973843960429,-0.00692653196839076,0.0115356427148581,0.624626996167763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,0.00226829937292069,0.00464757081250048,-0.00684093941958026,0.0113775381654216,0.625514350573621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,40080,-0.00206573935686077,0.00425591431551273,-0.0104073314152657,0.00627585270154419,0.627415973736548
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,40451,0.00174447622478146,0.00359980404383119,-0.00531113970112768,0.00880009215069059,0.627967337951119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00142223064148468,0.00293876719691723,-0.0043377530644731,0.00718221434744246,0.628426220675291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,42311,0.00281122245721941,0.0058316274676813,-0.00861876737943594,0.0142412122938748,0.629767941880655
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.00238854163573491,0.00498115359079069,-0.00737451940221484,0.0121516026736847,0.631581362422501
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,-0.00540065033467118,0.0113346010451852,-0.0276164683832342,0.0168151677138918,0.633745495896572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,42587,-0.00198732856157985,0.00418774645154544,-0.0101953116066089,0.00622065448344921,0.635109788955828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,40483,-0.00388174869702014,0.0081965069201944,-0.0199469022606012,0.0121834048665609,0.6358045127518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,0.00285661908179026,0.0060695237619972,-0.00903964749172426,0.0147528856553048,0.637900345019461
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,40483,-0.00144592322374442,0.00307571529186231,-0.00747432519579454,0.0045824787483057,0.638285811376781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,40302,-0.00193875203108994,0.00413018702338814,-0.0100339185969307,0.00615641453475082,0.638785652684729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,40482,0.00746056014500606,0.016062804784959,-0.0240225372335136,0.0389436575235257,0.642325838656174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,-0.00174791115935242,0.00376697228644389,-0.00913117684078244,0.0056353545220776,0.642648385187431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,40116,-0.00156553904955899,0.00338924055120202,-0.00820845052991495,0.00507737243079696,0.644151900000512
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,-0.00400909952748356,0.00873071737021297,-0.021121305573101,0.0131031065181339,0.646103310128777
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,42611,-0.00166674395488576,0.00363670747080111,-0.00879469059765594,0.00546120268788442,0.646736264095835
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,40511,-0.0043878999324899,0.00968746509337524,-0.0233753315155054,0.0145995316505256,0.650596207785673
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,-0.00237861265464057,0.00529765858339371,-0.0127620234780922,0.00800479816881111,0.653443983043549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,40080,0.00215142459446742,0.00481239805949235,-0.00728087560213759,0.0115837247910724,0.654841545578904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,-0.00169333218148569,0.00379665745266224,-0.00913478078870368,0.00574811642573231,0.655601586042854
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,0.00141277002304759,0.00318851607624884,-0.00483672148640014,0.00766226153249532,0.657716067369101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.00247579756523831,0.0055924288374971,-0.00848536295625601,0.0134369580867326,0.657987457621302
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.00243009785913481,0.0054998197603004,-0.0132097445893236,0.00834954887105398,0.658606578196
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,40483,0.00115734990467607,0.00262136240286526,-0.00398052040493985,0.00629522021429198,0.658854436103534
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,0.0013651963864321,0.0030950834989113,-0.00470116727143404,0.00743156004429825,0.659159875530503
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.00272241218512768,0.00618689546706777,-0.0148487273005805,0.00940390293032515,0.659924890312382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,0.00237029907262952,0.00541157611370008,-0.00823639011022264,0.0129769882554817,0.66139108033594
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,0.00175941352299008,0.00402030244264432,-0.00612037926459279,0.00963920631057294,0.661661545348984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00252897285996615,0.00580514536403836,-0.00884911205354904,0.0139070577734813,0.663104165283419
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,40199,0.001272425694839,0.00292659399101602,-0.0044636985275524,0.00700854991723041,0.663730360889137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,40511,-0.00213017908489098,0.00490675367171343,-0.0117474162814493,0.00748705811166734,0.664200820944898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,42699,-0.00663511829818914,0.0154189266231605,-0.0368562144795838,0.0235859778832055,0.666967587067238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00148488673907006,0.00345704634019431,-0.00529092408771078,0.00826069756585091,0.667549911356795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,42594,-0.00263314853867623,0.00615925182088556,-0.0147052821076119,0.00943898503025947,0.669013969541165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,42538,-0.0025030137842841,0.00585886587985091,-0.0139863909087919,0.00898036334022369,0.669227343012644
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,42311,0.00163922263777844,0.00383853923201814,-0.00588431425697712,0.00916275953253399,0.669354765427995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00166812817284788,0.00392416872750937,-0.00602324253307048,0.00935949887876623,0.670777398434228
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,0.00165989083387606,0.00390659310536667,-0.00599703165264262,0.00931681332039474,0.670921784576729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,42679,0.0015792001386808,0.00371976050100281,-0.0057115304432847,0.0088699307206463,0.671176261741678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00213554861325807,0.00508873565942738,-0.00783837327921959,0.0121094705057357,0.67474072362868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00252921875971198,0.00602861219111303,-0.0143452986542935,0.00928686113486955,0.674832833402603
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,-0.00144071574432034,0.00344029928158333,-0.00818370233622366,0.00530227084758298,0.675387607498894
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,42370,0.00186778300080545,0.0044688310364107,-0.00689112583055953,0.0106266918321704,0.67598474783104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00113962929029977,0.0027295540245574,-0.00421029659783273,0.00648955517843227,0.676309818526773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,0.00234455971520829,0.00562697775990699,-0.00868431669420941,0.013373436124626,0.676932243718215
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,-0.00327138851004757,0.00786257704272095,-0.0186820395137806,0.0121392624936855,0.677366375865893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,-0.00153842025800599,0.0037056626134729,-0.00880151898041287,0.00572467846440088,0.678036009266526
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00228705472439831,0.00551396910661188,-0.0130944341733576,0.00852032472456097,0.678314948066786
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,-0.00357222075876378,0.00865880706285456,-0.0205434826019587,0.0133990410844311,0.679941681713375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,42611,-0.000828974645997125,0.00201746923062686,-0.00478321433802577,0.00312526504603152,0.681153682506856
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,40199,-0.00174054399488124,0.00424889924057392,-0.0100683865064061,0.00658729851664364,0.682073721614016
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00274583232776331,0.00674087020606741,-0.0159579379316554,0.0104662732761288,0.68376545576213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,40182,0.00137077667986904,0.00336616274316565,-0.00522690229673563,0.00796845565647371,0.683852625316014
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00313164506574852,0.00770658555622231,-0.0119732626244472,0.0182365527559443,0.684486120151053
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,0.00173414655089062,0.00427360585688531,-0.00664212092860459,0.0101104140303858,0.684911754691191
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,-0.001817258079846,0.00448661332018363,-0.0106110201874059,0.00697650402771392,0.685455945509516
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,40302,0.00288218938093653,0.0071236893786841,-0.0110802418012843,0.0168446205631574,0.685785060139334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,42416,0.00168611205732291,0.00417365049667635,-0.00649424291616273,0.00986646703080854,0.686226783952913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00105756600577293,0.00262264785477734,-0.00619795580113652,0.00408282378959066,0.686776652689166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,42114,-0.00197038431224497,0.00488685048940199,-0.0115486112714729,0.00760784264698292,0.686806839142827
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00107127535358658,0.0026658935156057,-0.00415387593700058,0.00629642664417375,0.687806178976305
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,0.00190150887187635,0.00475476536106758,-0.00741783123581612,0.0112208489795688,0.689224376883355
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,40451,0.00137212264198937,0.00343127955930915,-0.00535318529425657,0.00809743057823532,0.689247645690912
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00114334713696171,0.0028600107211934,-0.00446227387657734,0.00674896815050076,0.689333519726893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00151669540838345,0.00380955306674886,-0.00898341941921121,0.0059500286024443,0.690542521361132
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,-0.00309301231838227,0.00778788372204395,-0.0183572644135884,0.0121712397768239,0.691258148930707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,42370,0.00247158234650662,0.00625987368085739,-0.00979777006797386,0.0147409347609871,0.692975166070532
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,40116,0.00199350169204614,0.00506684630721093,-0.00793751707008728,0.0119245204541796,0.694001965730307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,42588,0.00309061527178216,0.00785826753354476,-0.0123115890939656,0.0184928196375299,0.694108063875531
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.00206254269697998,0.00526969877320444,-0.00826606689850072,0.0123911522924607,0.695511668283818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,-0.0015265346686954,0.00392414703701662,-0.00921786286124797,0.00616479352385717,0.697275937248516
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,40199,-0.00379014451700885,0.00983812150181036,-0.0230728626605572,0.0154925736265394,0.700059029578326
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,42311,0.00204784977399665,0.00533013085290724,-0.00839920669770154,0.0124949062456948,0.700834569106612
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,-0.00240023329441238,0.00626431967277806,-0.0146782998530574,0.00987783326423262,0.701608885147775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,-0.00258306502862936,0.00678760251780593,-0.015886765963529,0.0107206359062703,0.703539855350311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,42370,-0.00130527048571562,0.00344102404428072,-0.00804967761250583,0.0054391366410746,0.704451778191914
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,0.00105617864364781,0.00280860839450925,-0.00444869380959032,0.00656105109688594,0.706886378200599
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,42370,0.00176301037914111,0.0047462548492194,-0.00753964912532892,0.0110656698836111,0.710306164034662
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.00164684166961095,0.00443549725611202,-0.00704673295236862,0.0103404162915905,0.710431045727612
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,0.00415172909599609,0.0112558882821392,-0.0179098119369967,0.0262132701289889,0.712247020889095
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,40199,-0.00121242037890057,0.0032891090008179,-0.00765907402050364,0.00523423326270251,0.712420565470995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,40199,-0.000642664605897236,0.00174600520194582,-0.00406483480171105,0.00277950558991658,0.712822792989024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,42594,-0.00231805754116597,0.00631314393415819,-0.014691819652116,0.0100557045697841,0.713490867913477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,41779,-0.00183366318987955,0.00499860265293944,-0.0116309243896409,0.00796359800988176,0.713748148814802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,0.00188688198614198,0.00518386958187386,-0.00827350239433077,0.0120472663666147,0.715871746618517
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,-0.00264807818444394,0.00727519587441302,-0.0169074620982934,0.0116113057294056,0.715874384002843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,42477,-0.00252701542566589,0.00695865532339833,-0.0161659798595266,0.0111119490081948,0.716500788661953
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,-0.00127029647728384,0.00350853922775701,-0.00814703336368757,0.0056064404091199,0.717314033770154
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,-0.00157242672846989,0.00435578357393601,-0.0101097625333845,0.00696490907644468,0.718108288574627
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,-0.00155215004936527,0.00430572884327824,-0.00999137858219062,0.00688707848346007,0.718491507559576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,0.00157663693959692,0.00440772602926735,-0.00706250607776709,0.0102157799569609,0.720574656052988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,40199,-0.00230426902729229,0.00645404346773943,-0.0149541942240616,0.010345656169477,0.721078293515504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.0018030362434258,0.00505476530237234,-0.00810430374922397,0.0117103762360756,0.721323067350126
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,40199,-0.00211413447225844,0.00594500423195534,-0.0137663427668909,0.00953807382237402,0.722135498736032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,40136,-0.00171751403050172,0.00483672622626841,-0.0111974974339878,0.00776246937298436,0.722522675080802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,42357,0.00117212647932833,0.00332407440257907,-0.00534305934972664,0.00768731230838331,0.724380935568317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,0.00120348306966311,0.00342608101472301,-0.00551163571919399,0.0079186018585202,0.725390584996369
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,-0.00105683506258256,0.00301150437338036,-0.00695938363440806,0.00484571350924294,0.725644548817652
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,40199,-0.00193967393054645,0.00556316455991748,-0.0128434764679847,0.00896412860689181,0.727348416327764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,0.00150886050940663,0.00434545944152789,-0.00700823999598804,0.0100259610148013,0.728427524297861
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,0.00196947326738237,0.00567469881702988,-0.00915293641399619,0.0130918829487609,0.728551302269748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00144609920005211,0.00417560852935003,-0.00963029191757817,0.00673809351747395,0.729107235548728
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00164416499650282,0.00476099994498791,-0.0109757248886791,0.00768739489567348,0.729845116306184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,42311,0.00100849262027564,0.00292330395326356,-0.00472118312812094,0.00673816836867222,0.730112051754433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,40116,-0.00132131036540994,0.00386068151649373,-0.00888824613773765,0.00624562540691777,0.73217088211127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,42636,-0.00132316588316256,0.00387548275765745,-0.00891911208817117,0.00627278032184605,0.732793037225605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.00117855650087166,0.00346826158140641,-0.00797634920042822,0.00561923619868491,0.734003467744296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,40080,0.00145538146487514,0.00429299019586264,-0.00695887931901563,0.00986964224876591,0.734606128558351
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,-0.00133635978826269,0.00395574601233617,-0.00908962197244158,0.0064169023959162,0.735498576326017
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00213631751805692,0.00637458897365949,-0.0103578768703157,0.0146305119064295,0.737533301446456
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,42578,-0.0036868017827107,0.0110022572925724,-0.0252512260761525,0.0178776225107311,0.737558650345169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.00194519952105148,0.00583205598716167,-0.00948563021378539,0.0133760292558883,0.738736253559167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,40482,-0.00254876787807932,0.00767996741638247,-0.017601504014189,0.0125039682580303,0.739991905308057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00144324677397882,0.00436716467276726,-0.0100028895326027,0.00711639598464502,0.741045923464972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,42636,0.00134029698504796,0.00405994093736077,-0.00661718725217915,0.00929778122227508,0.741308986723748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,40199,-0.00117052314842317,0.00357691096976646,-0.00818126864916544,0.0058402223523191,0.743489463616985
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,40199,-0.00179878153175184,0.00557521656871278,-0.0127262060064289,0.00912864294292521,0.746974887590929
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,-0.00109661425412169,0.00339917657706871,-0.00775900034517635,0.00556577183693298,0.746995279565158
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.00459547082642158,0.0142492311743663,-0.0325239639281796,0.0233330222753364,0.747074902212052
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,-0.00226554796824339,0.0070514159718895,-0.0160863232731468,0.01155522733666,0.747996928327124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.00214127803114916,0.00669422999579147,-0.0109794127606021,0.0152619688229004,0.74907257724093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,40199,-0.00102556761953969,0.00322801908538405,-0.00735248502689242,0.00530134978781305,0.750712439054514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,-0.00110800978486192,0.00349013269922001,-0.00794866987533314,0.0057326503056093,0.750893642748234
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,40527,0.00136826241850712,0.00434836488889675,-0.00715453276373052,0.00989105760074475,0.753024576312328
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,-0.00191308927991577,0.00608504553930416,-0.0138397785369519,0.0100135999771204,0.753229370079828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,40080,-0.00233188301463408,0.0075186984269214,-0.0170685319314,0.0124047659021319,0.756457005331505
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,40080,0.00207243781691245,0.00671038317195006,-0.0110799132001097,0.0152247888339346,0.757448801070205
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.000676382052250535,0.00222946664845378,-0.00369337257871887,0.00504613668321994,0.76160278287611
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0026650328393297,0.00884578059446289,-0.0146726971258176,0.020002762804477,0.763208789291243
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,42594,-0.00151552517029804,0.00506583910518226,-0.0114445698164553,0.00841351947585918,0.764818278281711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,42475,0.00138313013331435,0.00465101175545163,-0.00773285290737085,0.0104991131739995,0.766179050412646
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,42673,-0.00112542728437496,0.00378557967958457,-0.00854516345636071,0.00629430888761079,0.76624721622262
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,42674,0.0018110923763117,0.00610680292946422,-0.0101582413654382,0.0137804261180616,0.766799657624311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,42311,0.00140599731171582,0.00475006095574385,-0.00790412216154212,0.0107161167849738,0.767238100146016
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,40199,0.00122784177760814,0.00417156832703041,-0.00694843214337146,0.00940411569858773,0.768506893049827
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,40302,0.000689131459604472,0.0023548182964806,-0.00392631240149751,0.00530457532070645,0.769797142650988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,0.00091850152581433,0.00317517833467614,-0.0053048480101509,0.00714185106177956,0.772376013754401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.00128371659682103,0.00446341362270776,-0.00746457410368618,0.0100320072973282,0.773651577568973
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,-0.00131439797688093,0.00462447440671663,-0.0103783678140455,0.00774957186028366,0.776241315814472
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00133011982583566,0.00478376751752799,-0.0080460645085192,0.0107063041601905,0.780980320459963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,-0.00126325952736639,0.00459173512346748,-0.0102630603693626,0.00773654131462986,0.783231393579095
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,40539,0.000415742459197237,0.00151221020941681,-0.00254818955125971,0.00337967446965419,0.783379847896455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.000814729844580203,0.00297434715372162,-0.00501499057671417,0.00664445026587458,0.7841512550591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,0.0011115614467336,0.00410116806897223,-0.00692672796845197,0.00914985086191917,0.78636898031415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,42332,-0.00199305098677674,0.00745269696929262,-0.0166003370465903,0.0126142350730368,0.789144756204133
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,-0.00336652579073522,0.0126914187207946,-0.0282417064834926,0.0215086549020222,0.790813329991778
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,42636,0.000716817455439449,0.0027262679995815,-0.0046266678237403,0.0060603027346192,0.79260861625849
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,-0.00188190676960216,0.00716815798862476,-0.0159314964273067,0.0121676828881024,0.792912377253578
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,-0.00167787161533795,0.00640008678435315,-0.0142220417126701,0.0108662984819942,0.793199956815202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,42711,0.000790217133225015,0.00302435543373278,-0.00513751951689123,0.00671795378334126,0.79387711582557
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,40283,0.000934459453594242,0.00362914484462702,-0.00617866444187472,0.00804758334906321,0.796807237027068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,42654,0.00281643167176984,0.0109583931494274,-0.0186620189011079,0.0242948822446476,0.797173921774933
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,40223,0.0016161900024472,0.00629884852237829,-0.0107295531014142,0.0139619331063087,0.797503947196076
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,40116,0.00121925024375031,0.00475860042333826,-0.00810760658599269,0.0105461070734933,0.797785525089803
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.000918393952389449,0.00364846344680438,-0.00623259440334713,0.00806938230812603,0.801261625326056
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,0.00131729648633656,0.00523866338759984,-0.00895048375335912,0.0115850767260322,0.801465865174484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,-0.00196606715158986,0.00790234288528936,-0.017454659206757,0.0135225249035773,0.803523641388124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,42620,-0.00230516115062788,0.00929008523403293,-0.0205137282093324,0.0159034059080767,0.804036594947393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,40451,-0.00104106690174324,0.00422142645699038,-0.00931506275744439,0.00723292895395791,0.805210725282913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,-0.00120876974689211,0.00492530510309297,-0.0108623677489543,0.00844482825517011,0.806135605901352
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,-0.0023783281093114,0.00971786539367345,-0.0214253442809114,0.0166686880622886,0.806663989239878
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,40080,-0.00153148814300847,0.00629581234990396,-0.0138712803488202,0.0108083040628033,0.807812407531189
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,40116,0.00125046322013579,0.00518818803692956,-0.00891838533224615,0.0114193117725177,0.80954322261984
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,-0.00120289363906674,0.00500247367854246,-0.01100774204901,0.00860195477087648,0.809978388860578
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,40116,-0.00160285656828644,0.00667181252354668,-0.0146796091144379,0.011473895977865,0.810146352939966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.00117799647726642,0.00492633282525942,-0.0108336088147749,0.00847761586024204,0.811014319422811
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,42590,0.00173243849013937,0.00727379721529004,-0.0125242040518291,0.0159890810321078,0.811748813188729
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,-0.0041679848977271,0.0175961962701588,-0.0386565295872383,0.0303205597917841,0.812763106405206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,42357,0.00144250128312856,0.00611413124206441,-0.0105411959513177,0.0134261985175748,0.813491382791771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,40136,-0.00145994372036908,0.00622135105945762,-0.013653791796906,0.0107339043561679,0.814471851724434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,40036,0.000824505096940638,0.00351918359073947,-0.00607309474090872,0.00772210493479,0.814765249080714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,-0.00169680879448759,0.00740423730784792,-0.0162091139178695,0.0128154963288943,0.818743174845434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.00125230398993018,0.00548199717260688,-0.0094924104683793,0.0119970184482397,0.819308935247919
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,42587,0.000436824423694891,0.00193585309156017,-0.00335744763576304,0.00423109648315282,0.821477424363007
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00129150036512885,0.00576147859089911,-0.0100009976730334,0.0125839984032911,0.82263601062889
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,40451,-0.000828512620510272,0.00375658190423216,-0.00819141315280531,0.00653438791178476,0.825447150935702
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.00200658949884004,0.00917137268088878,-0.015969300955702,0.0199824799533821,0.826818970472838
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,40199,-0.00160205979624832,0.00738239919244736,-0.0160715622134451,0.0128674426209485,0.828204010033903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,0.00085996881158248,0.00396500941204035,-0.00691144963601661,0.00863138725918157,0.828298389344041
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,42334,-0.00126717800339784,0.00587816085210929,-0.012788373273532,0.0102540172667364,0.829323255591496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,40434,0.00129171382458914,0.00599892565055159,-0.010466180450492,0.0130496080996703,0.829518475458622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,40080,-0.00133354196863717,0.00622023490995267,-0.0135252023921444,0.0108581184548701,0.830248734044524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,-0.000583647072379454,0.00274447196307085,-0.00596281211999833,0.00479551797523942,0.831593841269027
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,42311,-0.00123359100822736,0.00582206431602118,-0.0126448370676289,0.0101776550511741,0.832202335199515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,40527,0.000689466235752199,0.00329542226628426,-0.00576956140616495,0.00714849387766935,0.834280736868104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,40009,0.000814641155063969,0.00393966993993846,-0.0069071119272154,0.00853639423734334,0.836186321346257
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,-0.00108950254133061,0.00528608486580653,-0.0114502288783114,0.00927122379565018,0.836710598722523
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.000904197737167139,0.00441383092559127,-0.00955530635132602,0.00774691087699175,0.837688742399802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,0.00100058699184336,0.00488878713850547,-0.00858143579962736,0.0105826097833141,0.837833945784564
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,-0.000845691757950492,0.00419515599954632,-0.00906819751706128,0.0073768140011603,0.840242845352257
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.000815872351594496,0.00407482491162977,-0.00717078447519986,0.00880252917838885,0.841310098042038
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.000736640532312745,0.0037090225008683,-0.00653304356938913,0.00800632463401462,0.842573170468972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,40302,0.00149522485450342,0.00754535697136035,-0.0132936748093629,0.0162841245183697,0.842919680666192
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.00176028358474213,0.00900303947177186,-0.0158856737799307,0.019406240949415,0.844988037384587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,40116,-0.00218795584872032,0.0112503908477198,-0.024238721910251,0.0198628102128104,0.845805074694401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,-0.000568675262990867,0.00292578709060588,-0.00630321796057839,0.00516586743459666,0.845892435143394
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,40199,0.00138598134377083,0.00714147159665547,-0.0126113029856739,0.0153832656732155,0.846120711900358
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,-0.00200561468104107,0.0103468881466063,-0.0222855154483894,0.0182742860863073,0.846306725075297
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,40302,0.00118645562909174,0.00619582538701478,-0.0109573621294572,0.0133302733876407,0.848143061729645
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00069786675848155,0.00370478798694389,-0.00656351769592847,0.00795925121289156,0.850590935279869
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,42370,-0.000535856077415593,0.00286368125796807,-0.006148671343033,0.00507695918820182,0.851568322266573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,-0.000676827830283755,0.00364090415840755,-0.00781299998076256,0.00645934432019505,0.852530114328848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,-0.00131778228184129,0.00711813216193811,-0.01526932131924,0.0126337567555574,0.85313017896484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.00160160257896721,0.00879019280967513,-0.015627175327996,0.0188303804859305,0.855426425323138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,0.000887074476124692,0.00488969754381773,-0.00869673270975806,0.0104708816620074,0.856043607815536
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,-0.00152942504087618,0.00845452935378626,-0.0181003025742973,0.0150414524925449,0.856449342012937
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.000914380017555483,0.00508520664492481,-0.00905262500649713,0.0108813850416081,0.857303119097637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,0.000501998648767435,0.00279726153705978,-0.00498063396386973,0.0059846312614046,0.8575791480447
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,0.000570911818659166,0.00318683554694332,-0.00567528585334975,0.00681710949066808,0.857825089333786
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,42711,-0.000569650899459031,0.00319863376212851,-0.00683897307323091,0.00569967127431284,0.858653438760203
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00102733247613342,0.0057787089395093,-0.0123536019975717,0.0102989370453048,0.858899932298671
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,39926,0.00121326422229885,0.00702882753145282,-0.0125632377393487,0.0149897661839464,0.862959199140749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,42594,0.00093237021494272,0.00566569737358351,-0.010172396637281,0.0120371370671664,0.869289596310452
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,0.000555182523083165,0.00339184016898622,-0.00609282420812983,0.00720318925429615,0.869984111212562
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.000464553212231318,0.00283951555384487,-0.00510089727330463,0.00603000369776726,0.870046694699725
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.000847435035575116,0.00520979666488879,-0.0110586364987571,0.00936376642760691,0.870787696653979
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.00083637060197058,0.00518444320950269,-0.0093251380886547,0.0109978792925959,0.87184190105195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.00142321199148144,0.00882614530248215,-0.0158760328013836,0.0187224567843465,0.871899273564559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.00169485797122988,0.0106867592298386,-0.0192511901192538,0.0226409060617136,0.873991583246993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,40136,0.00055767480038303,0.00359366272441551,-0.00648590413947138,0.00760125374023744,0.876680035669406
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.00108426500924436,0.00715877432944281,-0.0129469326764636,0.0151154626949523,0.879615453743107
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,40482,0.00089396336546641,0.00594166323966641,-0.0107516965842798,0.0125396233152126,0.880406955738831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,42611,-0.000517211142000712,0.00346903432177014,-0.00731651841267019,0.00628209612866876,0.881481942444574
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,42370,0.00138114630571653,0.00936279692829342,-0.0169699356737386,0.0197322282851716,0.882728361424716
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,40199,0.000554851977994363,0.00376556960351953,-0.00682566444490392,0.00793536840089265,0.88285945389251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00115797535354391,0.00810274244233747,-0.0170393505405253,0.0147233998334375,0.886362641220073
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,40283,0.00111035018199946,0.00788128972086917,-0.0143369776709041,0.016557678034903,0.887963884517719
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,0.00041862043260321,0.00297424086980059,-0.00541089167220594,0.00624813253741236,0.888071074415318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,-0.00117461612957496,0.00843577186129667,-0.0177087289777164,0.0153594967185665,0.889260834907749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,42346,-0.000542781609547664,0.00390392747181951,-0.00819447945431391,0.00710891623521858,0.889424811971187
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,0.000977679145622185,0.00715528496191833,-0.0130466793797377,0.0150020376709821,0.891319969432935
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,40080,0.000631863569708031,0.00464983865385663,-0.00848182019185096,0.00974554733126702,0.89191126451281
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,40302,0.000476069614712865,0.00354097711940641,-0.00646424553932369,0.00741638476874942,0.893052477734566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,-0.00107803066322889,0.00803484658359631,-0.0168263299670777,0.0146702686406199,0.893271041452064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,0.000316734320294811,0.00237113199217464,-0.00433068438436747,0.0049641530249571,0.893737634622229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,0.000641623449918898,0.00483145094540288,-0.00882802040307075,0.0101112673029085,0.894352478726312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,0.000827474148706478,0.00629093749399314,-0.0115027633395201,0.013157711636933,0.895355061894951
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,0.000260788105750188,0.00201701088267902,-0.00369255322430069,0.00421412943580106,0.897127047423535
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,-0.00049402140209747,0.00382398834875348,-0.00798903856565429,0.00700099576145935,0.897209602511698
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,42357,0.000354174643585148,0.00276442914913339,-0.0050641064887163,0.00577245577588659,0.898057116496152
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,0.000692660331690548,0.00542855673628168,-0.00994731087142154,0.0113326315348026,0.898471303013464
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,-0.000513806089185843,0.0040362274670636,-0.0084248119246305,0.00739719974625881,0.898706345325315
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,0.000607764107102864,0.00480122201898204,-0.00880263105010193,0.0100181592643077,0.899270973791002
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,40136,0.0014003982873553,0.0110888948173844,-0.0203338355547181,0.0231346321294287,0.899505994003104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,-0.000570911051661745,0.00474811400975877,-0.00987721451078893,0.00873539240746544,0.904295232016403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,40116,-0.000443952057384227,0.00373470947623984,-0.00776398263081431,0.00687607851604585,0.905379020813209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,42474,0.000339056516199481,0.00287367449073484,-0.0052933454856408,0.00597145851803976,0.906079664510236
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,42495,0.000700094267376119,0.00602262659996756,-0.0111042538685603,0.0125044424033125,0.907460913045351
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,40286,-0.0011183911092449,0.0100267459604603,-0.020770813191747,0.0185340309732572,0.911189544311121
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,0.000359868923924369,0.0032487052421533,-0.00600759335069611,0.00672733119854485,0.91179802272838
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,-0.000362716873104981,0.00327467164971338,-0.0067810733065432,0.00605563956033324,0.911805251995393
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,0.000375383137582091,0.00340515573674849,-0.00629872210644495,0.00704948838160913,0.912220979186293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,-0.000711729253466426,0.00657837454768107,-0.0136053433669213,0.0121818848599885,0.913844779988066
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.000563412318488835,0.0052091267427725,-0.00964647609734526,0.0107733007343229,0.913871464082762
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,-0.000326406874670874,0.00302488408302543,-0.00625517967740071,0.00560236592805896,0.914071248885006
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,40065,0.00085087439007899,0.00812689969477009,-0.0150778490116704,0.0167795977918284,0.916616965965533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.000757913981528007,0.00724172898301876,-0.0134358748251888,0.0149517027882448,0.916648051276721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,40451,-0.000398658368893698,0.0038452017698674,-0.0079352538378338,0.00713793710004641,0.917427653445069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,40080,-0.000736726418286225,0.00731015106492583,-0.0150646225055409,0.0135911696689684,0.919725939516524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,42357,-0.000489080964113782,0.00487592420492438,-0.0100458924057656,0.009067730477538,0.92010348989778
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,40182,0.000233248099475266,0.00233015666705828,-0.00433385896795896,0.00480035516690949,0.920266960109845
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,40136,0.000695168561690703,0.00732801315891894,-0.0136677372297904,0.0150580743531718,0.924424163388366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0005351941024095,0.00566403151792605,-0.0105663076727256,0.0116366958775446,0.924721398238909
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,0.000595024875515628,0.00629743686541372,-0.0117479513806953,0.0129380011317265,0.924723848453381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,42584,0.000657570007605876,0.00713049810409889,-0.013318206276428,0.0146333462916397,0.9265251321102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,40080,0.000316351925885003,0.00343659326765787,-0.00641937087872441,0.00705207473049442,0.926656883085289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,42629,0.00170337294865218,0.018556774677811,-0.0346679054198574,0.0380746513171618,0.926864262635195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.000584389585684552,0.00644354081573709,-0.0120449504131602,0.0132137295845293,0.927737518516049
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,40302,-0.000275968170195426,0.00307563159966483,-0.00630420610553849,0.00575226976514764,0.928505525709537
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,-0.000810659314506308,0.00930077345444182,-0.0190401752852123,0.0174188566561997,0.930545603477127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,40080,0.000332011215614696,0.00382675119500681,-0.00716842112659865,0.00783244355782804,0.930863404760732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.000426557407441711,0.00501847461722734,-0.00940965284232387,0.0102627676572073,0.932264994867668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,40539,-0.000178803358526065,0.002107435382835,-0.00430937670888267,0.00395176999183054,0.932386867926021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,-0.000480825100922827,0.00572526280564816,-0.0117023401999932,0.0107406899981476,0.933071426345043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,0.000316960587840055,0.00379382994453626,-0.00711894610345102,0.00775286727913113,0.933418667172402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,42370,0.000489616981550275,0.00606669556622069,-0.0114011063282423,0.0123803402913428,0.935677220341577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,0.00027568481869401,0.00348187215364676,-0.00654878460245363,0.00710015423984165,0.936893150541572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,42654,0.00025252046400483,0.0032324265239117,-0.00608303552286209,0.00658807645087175,0.937732946278774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,42595,0.00101234742864027,0.0131612703613029,-0.0247837424795134,0.0268084373367939,0.938689392291638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,40080,-0.000233821772510248,0.00314568986199268,-0.00639937390201591,0.00593173035699541,0.940748503191184
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,42445,0.00028165338384407,0.00384205265648804,-0.0072487698228725,0.00781207659056064,0.941562093346115
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.000376470178236674,0.00551616230320522,-0.0111881482925189,0.0104352079360455,0.945589012404783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,40511,0.000244857959918208,0.00366747862522173,-0.00694340014551639,0.00743311606535281,0.946770237995562
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,-0.00025590631453769,0.00383356596204956,-0.00776969560015482,0.00725788297107944,0.946778651811366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,40451,0.000162039292107499,0.00265648905336656,-0.00504467925249097,0.00536875783670597,0.951362252613074
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,40482,0.000292029251277203,0.00481286095435412,-0.00914117821925688,0.00972523672181129,0.951617641405895
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.000370922698854549,0.00632841031386399,-0.0120327615163189,0.012774606914028,0.953261965971868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,-0.000148773168391617,0.00257723578534992,-0.00520015530767745,0.00490260897089422,0.95396801446976
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,40136,0.00050888028088011,0.00914853011164466,-0.0174222387379434,0.0184399992997036,0.955642147797399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.000282850180352026,0.00519535150947413,-0.0104657391389213,0.00990003877821727,0.956583294114954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.000263924821536488,0.00493502381978727,-0.00940872186524656,0.00993657150831954,0.957350484369835
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.000592998714895662,0.011390335743678,-0.0229180567725046,0.0217320593427133,0.958480426602128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.000357733137342705,0.00702247305291281,-0.0134063140463664,0.0141217803210518,0.959373130968736
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,40199,0.0001339299644663,0.00267430557099087,-0.0051077089546758,0.0053755688836084,0.960059325338339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,-0.000208760564881145,0.0044628294327829,-0.00895590625313562,0.00853838512337333,0.962691315264787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.000164633027615628,0.00400761066283896,-0.00769028387154873,0.00801954992677998,0.967232769392674
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.000398108435133185,0.0100484987428952,-0.0200931659712079,0.0192969491009415,0.968397844570131
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.000426155462274742,0.0115758879150722,-0.0222625848512667,0.0231148957758162,0.970633912299255
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.000233674963650116,0.00637329063506879,-0.0127253246083849,0.0122579746810847,0.97075299203361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,-0.000613519513025513,0.0183419443554584,-0.036563730449724,0.035336691423673,0.97331704222705
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,40136,0.000119588435833529,0.0037392914532589,-0.00720942281255392,0.00744859968422098,0.974487326480478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,-0.000115563566506004,0.00380077168422015,-0.0075650760675775,0.00733394893456549,0.975744381290459
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,-5.56375135237951e-05,0.00200131144070865,-0.00397820793731276,0.00386693291026517,0.977821659538181
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,40116,0.000123959111371828,0.00455910427662389,-0.008811885270811,0.00905980349355466,0.978309201617503
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,42370,8.67922552196444e-05,0.00327263864314933,-0.00632757948535304,0.00650116399579232,0.978842525344472
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,-0.000206725281935819,0.00816016202326444,-0.0162006428475341,0.0157871922836625,0.979789420341794
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,8.23209060002062e-05,0.00358555931617105,-0.00694537535369506,0.00711001716569547,0.981683308385682
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,42611,7.53029975592911e-05,0.00335906954435383,-0.00650847330937422,0.0066590793044928,0.98211500346372
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,-6.70332414732665e-05,0.00421873656902236,-0.0083357569167571,0.00820169043381056,0.987322898902842
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,42488,7.67850964519546e-05,0.00516599095333726,-0.0100485571720891,0.010202127364993,0.988141242313446
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,42370,-0.000106571918595798,0.00755468901041236,-0.014913762379004,0.0147006185418124,0.988745048979725
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.000138871578060768,0.0100806799542685,-0.0196192611323055,0.019897004288427,0.989008886264897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,42636,-3.35850308085111e-05,0.00262406198465058,-0.00517674652072364,0.00510957645910662,0.989788447183731
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,7.85309935525832e-05,0.0074737674363623,-0.0145700531817175,0.0147271151688227,0.991616533004093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,40182,-7.75728454412565e-05,0.00914786804522686,-0.0180073942140859,0.0178522485232034,0.993234267768706
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,-5.17108902828828e-05,0.00640866510421013,-0.0126126944945347,0.012509272713969,0.993562160562416
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,40482,2.35331768662088e-05,0.00385715151205629,-0.00753648378676412,0.00758355014049654,0.995132100443002
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,42721,3.69808011701066e-05,0.006085132787616,-0.0118898794625572,0.0119638410648975,0.995151184965828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,42587,1.36688977345418e-05,0.00284232334899824,-0.005557284866302,0.00558462266177109,0.996163013314154
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,1.88522116966768e-05,0.00396995177194852,-0.00776225326132243,0.00779995768471578,0.996211163694155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,-2.73956076059154e-05,0.00773516135440565,-0.015188311862241,0.0151335206470292,0.997174193395837
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,7.99603151546626e-06,0.00372797642012536,-0.00729883775193023,0.00731482981496117,0.998288679115455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,42311,-3.65568833476577e-07,0.00449621924415327,-0.00881295528737388,0.00881222414970693,0.999935128570738
